|
G |
A2m |
alpha-2-macroglobulin |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of A2M mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of A2M mRNA |
CTD |
PMID:36189433 PMID:38113427 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aamdc |
adipogenesis associated, Mth938 domain containing |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of AAMDC mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 1:151,861,990...151,893,621
Ensembl chr 1:151,845,255...151,892,398
|
|
G |
Abca12 |
ATP binding cassette subfamily A member 12 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ABCA12 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ABCA12 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 9:72,822,661...72,995,748
Ensembl chr 9:72,823,350...72,996,049
|
|
G |
Abca4 |
ATP binding cassette subfamily A member 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ABCA4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:210,164,813...210,302,069
Ensembl chr 2:210,164,813...210,302,069
|
|
G |
Abca7 |
ATP binding cassette subfamily A member 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ABCA7 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:9,691,452...9,711,466
Ensembl chr 7:9,691,449...9,711,425
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ABCB11 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ABCB1B mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcb5 |
ATP binding cassette subfamily B member 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ABCB5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:139,836,528...139,932,830
Ensembl chr 6:139,835,949...139,932,830
|
|
G |
Abcb9 |
ATP binding cassette subfamily B member 9 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ABCB9 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr12:32,499,213...32,531,932
Ensembl chr12:32,499,225...32,531,931
|
|
G |
Abcc10 |
ATP binding cassette subfamily C member 10 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ABCC10 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:14,657,242...14,677,178
Ensembl chr 9:14,657,264...14,677,178
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of ABCC2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ABCC6 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Ablim2 |
actin binding LIM protein family, member 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ABLIM2 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr14:74,865,409...74,990,334
Ensembl chr14:74,866,281...74,990,334
|
|
G |
Acaa1b |
acetyl-Coenzyme A acyltransferase 1B |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ACAA1B mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 8:118,872,996...118,881,852
Ensembl chr 8:118,872,997...118,881,825
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ACAA2 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ACADM mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of ACADS mRNA |
CTD |
PMID:22087261 |
|
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
|
|
G |
Acap1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ACAP1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:54,605,323...54,619,472
Ensembl chr10:54,605,323...54,619,472
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACE2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Ackr1 |
atypical chemokine receptor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ACKR1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:85,782,396...85,784,015
Ensembl chr13:85,782,398...85,783,983
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACKR3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
|
|
G |
Ackr4 |
atypical chemokine receptor 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACKR4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:104,716,537...104,720,972
Ensembl chr 8:104,716,067...104,723,617
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ACOX1 mRNA |
CTD |
PMID:22087261 PMID:32522588 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acoxl |
acyl-CoA oxidase-like |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ACOXL mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:115,061,069...115,367,032
Ensembl chr 3:115,061,060...115,364,686
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACP5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
|
|
G |
Acp7 |
acid phosphatase 7, tartrate resistant |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACP7 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of ACP7 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:83,896,485...83,923,436
Ensembl chr 1:83,898,153...83,920,634
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ACSL1 protein |
CTD |
PMID:27384973 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
decreases expression increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ACSL4 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of ACSL4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of ACSL4 protein ferrostatin-1 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ACSL4 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ACSL4 protein] |
CTD |
PMID:22401849 PMID:34863575 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACSS2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Actn2 |
actinin alpha 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ACTN2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:58,143,334...58,210,622
Ensembl chr17:58,142,625...58,210,622
|
|
G |
Acvrl1 |
activin A receptor like type 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ACVRL1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:132,239,200...132,256,592
Ensembl chr 7:132,239,729...132,256,591
|
|
G |
Adam22 |
ADAM metallopeptidase domain 22 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ADAM22 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:25,716,055...25,970,932
Ensembl chr 4:25,715,990...25,964,962
|
|
G |
Adam23 |
ADAM metallopeptidase domain 23 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ADAM23 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:64,862,649...65,009,718
Ensembl chr 9:64,862,878...65,006,515
|
|
G |
Adam33 |
ADAM metallopeptidase domain 33 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADAM33 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:118,262,395...118,283,456
Ensembl chr 3:118,271,029...118,283,461
|
|
G |
Adamts14 |
ADAM metallopeptidase with thrombospondin type 1 motif, 14 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ADAMTS14 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr20:29,143,029...29,219,846
Ensembl chr20:29,144,354...29,219,866
|
|
G |
Adamts15 |
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ADAMTS15 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 8:29,307,864...29,331,249
Ensembl chr 8:29,307,865...29,331,249
|
|
G |
Adamts17 |
ADAM metallopeptidase with thrombospondin type 1 motif, 17 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ADAMTS17 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:120,445,800...120,768,204
Ensembl chr 1:120,445,749...120,768,202
|
|
G |
Adamts18 |
ADAM metallopeptidase with thrombospondin type 1 motif, 18 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADAMTS18 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:41,686,951...41,840,035
Ensembl chr19:41,688,617...41,839,781
|
|
G |
Adamts20 |
ADAM metallopeptidase with thrombospondin type 1 motif, 20 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ADAMTS20 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:125,396,227...125,528,020
Ensembl chr 7:125,397,734...125,527,777
|
|
G |
Adamts4 |
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ADAMTS4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
|
|
G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ADAMTS5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
|
|
G |
Adamts6 |
ADAM metallopeptidase with thrombospondin type 1 motif, 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ADAMTS6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:35,421,510...35,633,298
|
|
G |
Adamtsl4 |
ADAMTS-like 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADAMTSL4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:183,235,634...183,247,091
Ensembl chr 2:183,235,646...183,246,848
|
|
G |
Adarb2 |
adenosine deaminase RNA specific B2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ADARB2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr17:61,750,437...62,300,984
Ensembl chr17:61,756,067...62,300,831
|
|
G |
Adcy4 |
adenylate cyclase 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ADCY4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:29,266,280...29,282,153
Ensembl chr15:29,266,287...29,282,108
|
|
G |
Adcy7 |
adenylate cyclase 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ADCY7 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311
|
|
G |
Adgrd1 |
adhesion G protein-coupled receptor D1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ADGRD1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr12:27,488,908...27,603,714
Ensembl chr12:27,488,908...27,603,696
|
|
G |
Adgre4 |
adhesion G protein-coupled receptor E4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ADGRE4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:9,758,106...9,901,908
Ensembl chr 9:9,760,355...9,900,760
|
|
G |
Adgrf3 |
adhesion G protein-coupled receptor F3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADGRF3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:26,133,176...26,144,601
Ensembl chr 6:26,133,192...26,144,601
|
|
G |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ADGRG1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108
|
|
G |
Adgrg2 |
adhesion G protein-coupled receptor G2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADGRG2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:34,297,402...34,422,590
Ensembl chr X:34,297,402...34,422,609
|
|
G |
Adgrg6 |
adhesion G protein-coupled receptor G6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADGRG6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ADIPOQ protein |
CTD |
PMID:27384973 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adipor2 |
adiponectin receptor 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ADIPOR2 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adm |
adrenomedullin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADM mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adm2 |
adrenomedullin 2 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ADM2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADM2 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 7:120,393,179...120,394,965
Ensembl chr 7:120,393,179...120,396,331
|
|
G |
Adora1 |
adenosine A1 receptor |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ADORA1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADRA1A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Adra1b |
adrenoceptor alpha 1B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADRA1B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
|
|
G |
Adra1d |
adrenoceptor alpha 1D |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ADRA1D mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
|
|
G |
Afm |
afamin |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of AFM mRNA |
CTD |
PMID:22401849 |
|
NCBI chr14:17,531,022...17,563,868
Ensembl chr14:17,531,024...17,563,870
|
|
G |
Afp |
alpha-fetoprotein |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of AFP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Agbl3 |
AGBL carboxypeptidase 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of AGBL3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:63,448,789...63,535,538
Ensembl chr 4:63,453,940...63,531,188
|
|
G |
Agl |
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
multiple interactions |
EXP |
mono-(2-ethylhexyl)phthalate binds to and affects the activity of AGL protein |
CTD |
PMID:19240039 |
|
NCBI chr 2:204,705,053...204,760,966
Ensembl chr 2:204,705,053...204,760,828
|
|
G |
Agmat |
agmatinase |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of AGMAT mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of AGMAT mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:154,043,665...154,074,278
Ensembl chr 5:154,060,151...154,074,276
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of AGT mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of AGTR1A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Agtr1b |
angiotensin II receptor, type 1b |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of AGTR1B mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:102,844,969...102,920,232
Ensembl chr 2:102,844,969...102,920,232
|
|
G |
Ahcy |
adenosylhomocysteinase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of AHCY mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression affects expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of AHR mRNA mono-(2-ethylhexyl)phthalate affects the expression of AHR mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of AHR mRNA |
CTD |
PMID:12706301 PMID:28381288 PMID:31884101 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of AHRR mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of AHSG protein |
CTD |
PMID:27384973 |
|
NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of AIFM1 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of AIFM1 mRNA; Estradiol affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of AIFM1 mRNA] |
CTD |
PMID:24412242 PMID:31884101 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Aifm3 |
apoptosis inducing factor, mitochondria associated 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of AIFM3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr11:83,504,859...83,523,630
Ensembl chr11:83,504,861...83,521,248
|
|
G |
Ajuba |
ajuba LIM protein |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of AJUBA mRNA |
CTD |
PMID:16809437 |
|
NCBI chr15:28,019,775...28,031,537
Ensembl chr15:28,019,778...28,030,021
|
|
G |
Ak5 |
adenylate kinase 5 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of AK5 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:241,397,297...241,581,458
|
|
G |
Ak7 |
adenylate kinase 7 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of AK7 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:124,611,789...124,679,978
Ensembl chr 6:124,611,902...124,679,961
|
|
G |
Akap4 |
A-kinase anchoring protein 4 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of AKAP4 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of AKAP4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:15,435,391...15,445,684
Ensembl chr X:15,435,410...15,445,684
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions affects response to substance increases activity increases phosphorylation |
ISO EXP |
AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 mRNA]; AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 protein]; AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NFKB1 mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased expression of and results in increased phosphorylation of AKT1 protein] AKT1 protein affects the susceptibility to mono-(2-ethylhexyl)phthalate mono-(2-ethylhexyl)phthalate results in increased activity of AKT1 protein mono-(2-ethylhexyl)phthalate results in increased phosphorylation of AKT1 protein mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of AKT1 protein; HDAC6 protein affects the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:18755736 PMID:28526321 PMID:31009676 PMID:34910997 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt1s1 |
AKT1 substrate 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of AKT1S1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:95,333,186...95,339,678
Ensembl chr 1:95,332,898...95,339,677
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ALDH1A1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ALDH2 mRNA |
CTD |
PMID:38113427 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Alkbh5 |
alkB homolog 5, RNA demethylase |
decreases expression increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ALKBH5 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of ALKBH5 mRNA |
CTD |
PMID:36174712 PMID:36314267 |
|
NCBI chr10:45,344,888...45,366,331
Ensembl chr10:45,343,395...45,366,331
|
|
G |
Alpg |
alkaline phosphatase, germ cell |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ALPPL2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ALPPL2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:87,748,721...87,761,500
Ensembl chr 9:87,753,648...87,757,836
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate analog results in decreased expression of ALPL protein; mono-(2-ethylhexyl)phthalate results in decreased expression of ALPL protein |
CTD |
PMID:25777084 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Alpp |
alkaline phosphatase, placental |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ALPP mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 9:87,765,846...87,768,606
Ensembl chr 9:87,765,860...87,768,606
|
|
G |
Alx4 |
ALX homeobox 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ALX4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:79,611,682...79,648,260
Ensembl chr 3:79,611,719...79,648,260
|
|
G |
Amh |
anti-Mullerian hormone |
decreases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of AMH mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of AMH protein [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of AMH mRNA |
CTD |
PMID:19165384 PMID:19440488 PMID:36189433 |
|
NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:8,906,836...8,909,282
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of AMIGO2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Ang |
angiogenin |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ANG mRNA |
CTD |
PMID:36695872 |
|
NCBI chr15:24,312,711...24,323,361
|
|
G |
Angpt4 |
angiopoietin 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ANGPT4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:140,420,389...140,454,213
Ensembl chr 3:140,420,389...140,453,583
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ANGPTL4 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased methylation of ANGPTL4 mRNA |
CTD |
PMID:36189433 PMID:36314267 PMID:36695872 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Angptl8 |
angiopoietin-like 8 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ANGPTL8 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:20,376,462...20,378,488
Ensembl chr 8:20,376,462...20,378,490
|
|
G |
Ank1 |
ankyrin 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ANK1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr16:68,876,294...69,054,963
Ensembl chr16:68,877,504...69,054,759
|
|
G |
Ank2 |
ankyrin 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ANK2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Ank3 |
ankyrin 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ANK3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
|
|
G |
Ankrd34b |
ankyrin repeat domain 34B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ANKRD34B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:23,651,083...23,668,041
Ensembl chr 2:23,651,474...23,668,030
|
|
G |
Ankrd37 |
ankyrin repeat domain 37 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ANKRD37 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
|
|
G |
Ankrd63 |
ankyrin repeat domain 63 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ANKRD63 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:105,675,148...105,679,970
Ensembl chr 3:105,663,638...105,682,404
|
|
G |
Ano9 |
anoctamin 9 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ANO9 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ANO9 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 1:196,208,863...196,230,381
Ensembl chr 1:196,197,341...196,229,900
|
|
G |
Antxr2 |
ANTXR cell adhesion molecule 2 |
decreases expression increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ANTXR2 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of ANTXR2 mRNA |
CTD |
PMID:22401849 PMID:36695872 |
|
NCBI chr14:11,541,718...11,682,110
Ensembl chr14:11,541,772...11,682,094
|
|
G |
Anxa2 |
annexin A2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ANXA2 mRNA |
CTD |
PMID:38113427 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa9 |
annexin A9 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ANXA9 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ANXA9 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 2:182,873,185...182,884,501
Ensembl chr 2:182,872,929...182,883,374
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of AOX1 mRNA |
CTD |
PMID:23360888 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Apba2 |
amyloid beta precursor protein binding family A member 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of APBA2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:118,053,270...118,286,858
Ensembl chr 1:118,103,219...118,285,699
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of APC mRNA |
CTD |
PMID:37364752 |
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apln |
apelin |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of APLN mRNA |
CTD |
PMID:32522588 |
|
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
|
|
G |
Apoe |
apolipoprotein E |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of APOE mRNA |
CTD |
PMID:22087261 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Aqp12a |
aquaporin 12A |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of AQP12 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of AQP12 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:93,554,527...93,560,011
Ensembl chr 9:93,554,527...93,560,011
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [cyclopamine results in increased expression of AR] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of AR mRNA |
CTD |
PMID:26710974 PMID:31884101 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arap2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ARAP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:46,717,657...46,917,326
Ensembl chr14:46,718,760...46,917,154
|
|
G |
Arhgap27 |
Rho GTPase activating protein 27 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ARHGAP27 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr10:88,280,470...88,313,225
Ensembl chr10:88,280,455...88,313,185
|
|
G |
Arhgap28 |
Rho GTPase activating protein 28 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ARHGAP28 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 9:107,832,584...107,998,030
Ensembl chr 9:107,833,330...107,998,000
|
|
G |
Arhgap9 |
Rho GTPase activating protein 9 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ARHGAP9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:63,148,573...63,157,025
Ensembl chr 7:63,148,900...63,157,524
|
|
G |
Arhgef37 |
Rho guanine nucleotide exchange factor 37 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ARHGEF37 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:54,935,256...55,001,017
Ensembl chr18:54,949,110...55,000,669
|
|
G |
Arhgef4 |
Rho guanine nucleotide exchange factor 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ARHGEF4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:36,861,800...37,005,079
Ensembl chr 9:36,861,835...37,005,075
|
|
G |
Arl4d |
ADP-ribosylation factor like GTPase 4D |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ARL4D mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions increases expression |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of ARNT mRNA mono-(2-ethylhexyl)phthalate results in increased expression of ARNT mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of ARNT protein |
CTD |
PMID:31884101 PMID:34863575 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Arrb2 |
arrestin, beta 2 |
multiple interactions |
EXP |
mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased expression of ARRB2 protein] |
CTD |
PMID:28526321 |
|
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ARRDC3 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Artn |
artemin |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ARTN mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:131,458,596...131,470,193
Ensembl chr 5:131,464,756...131,468,025
|
|
G |
Asb14 |
ankyrin repeat and SOCS box-containing 14 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ASB14 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:2,095,567...2,123,259
Ensembl chr16:2,095,644...2,115,135
|
|
G |
Ascc3 |
activating signal cointegrator 1 complex subunit 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ASCC3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr20:53,510,137...53,795,446
Ensembl chr20:53,510,184...53,790,165
|
|
G |
Asgr1 |
asialoglycoprotein receptor 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ASGR1 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr10:54,775,727...54,779,642
Ensembl chr10:54,776,024...54,779,631
|
|
G |
Asic4 |
acid sensing ion channel subunit family member 4 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ASIC4 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of ASIC4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:76,941,532...76,962,900
Ensembl chr 9:76,941,532...76,962,900
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ASNS mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ASNS mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Aspn |
asporin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ASPN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:15,079,910...15,104,369
Ensembl chr17:15,080,639...15,104,041
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ASS1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Astn1 |
astrotactin 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ASTN1 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr13:70,537,423...70,855,440
Ensembl chr13:70,537,703...70,855,440
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of ATF3 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein] |
CTD |
PMID:37692514 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atf7ip2 |
activating transcription factor 7 interacting protein 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ATF7IP2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:5,403,099...5,445,989
Ensembl chr10:5,403,105...5,446,142
|
|
G |
Atoh8 |
atonal bHLH transcription factor 8 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ATOH8 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 4:104,259,992...104,292,168
Ensembl chr 4:104,259,992...104,292,168
|
|
G |
Atp12a |
ATPase H+/K+ transporting non-gastric alpha2 subunit |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ATP12A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229
|
|
G |
Atp13a4 |
ATPase 13A4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ATP13A4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr11:71,222,196...71,359,933
Ensembl chr11:71,226,161...71,359,933
|
|
G |
Atp1a3 |
ATPase Na+/K+ transporting subunit alpha 3 |
decreases expression increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ATP1A3 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of ATP1A3 mRNA |
CTD |
PMID:22401849 PMID:37364752 |
|
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
|
|
G |
Atp6v0a4 |
ATPase H+ transporting V0 subunit a4 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ATP6V0A4 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of ATP6V0A4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:66,760,163...66,842,126
Ensembl chr 4:66,760,159...66,842,110
|
|
G |
Atp6v1c2 |
ATPase H+ transporting V1 subunit C2 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ATP6V1C2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ATP6V1C2 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028
|
|
G |
Atp6v1h |
ATPase H+ transporting V1 subunit H |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of ATP6V1H mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 5:14,379,029...14,484,703
Ensembl chr 5:14,378,257...14,537,962
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ATP8B1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
|
|
G |
Atp8b4 |
ATPase phospholipid transporting 8B4 (putative) |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ATP8B4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:113,554,979...113,757,635
Ensembl chr 3:113,556,192...113,757,225
|
|
G |
Atp9b |
ATPase phospholipid transporting 9B (putative) |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ATP9B mRNA |
CTD |
PMID:22401849 |
|
NCBI chr18:74,176,863...74,368,993
Ensembl chr18:74,176,863...74,368,953
|
|
G |
Atrnl1 |
attractin like 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ATRNL1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:256,670,976...257,219,291
Ensembl chr 1:256,670,627...257,213,197
|
|
G |
Aurkc |
aurora kinase C |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of AURKC mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:66,843,653...66,849,775
Ensembl chr 1:66,843,653...66,864,386
|
|
G |
Avpi1 |
arginine vasopressin-induced 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of AVPI1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:240,930,236...240,936,154
Ensembl chr 1:240,930,236...240,936,154
|
|
G |
Avpr1a |
arginine vasopressin receptor 1A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of AVPR1A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
|
|
G |
B3galt1 |
Beta-1,3-galactosyltransferase 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of B3GALT1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 3:52,253,413...52,826,508
Ensembl chr 3:52,253,618...52,825,313
|
|
G |
B3galt2 |
Beta-1,3-galactosyltransferase 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of B3GALT2 mRNA |
CTD |
PMID:22401849 PMID:36695872 |
|
NCBI chr13:55,389,406...55,398,419
Ensembl chr13:55,389,406...55,398,419
|
|
G |
B3gat1 |
beta-1,3-glucuronyltransferase 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of B3GAT1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:25,087,123...25,114,692
Ensembl chr 8:25,087,547...25,113,395
|
|
G |
B4galnt3 |
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of B4GALNT3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:153,409,019...153,509,019
Ensembl chr 4:153,409,004...153,509,321
|
|
G |
Bace2 |
beta-secretase 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BACE2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546
|
|
G |
Baiap2l1 |
BAR/IMD domain containing adaptor protein 2 like 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of BAIAP2L1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:10,250,434...10,339,937
Ensembl chr12:10,250,473...10,339,928
|
|
G |
Barhl2 |
BarH-like homeobox 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BARHL2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:3,340,465...3,345,362
Ensembl chr14:3,340,465...3,345,353
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of BAX mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of BAX protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BAX mRNA; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BAX protein]; GW 6471 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BAX protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BAX mRNA PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BAX mRNA] |
CTD |
PMID:12927354 PMID:24706461 PMID:26597031 PMID:31884101 PMID:33159713 PMID:35861251 PMID:36889213 PMID:37286014 PMID:37979351 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Baz1a |
bromodomain adjacent to zinc finger domain, 1A |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of BAZ1A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 6:72,389,701...72,512,516
Ensembl chr 6:72,389,703...72,512,459
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of BBC3 protein |
CTD |
PMID:24706461 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcan |
brevican |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BCAN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:173,454,479...173,467,717
Ensembl chr 2:173,454,482...173,467,460
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions affects expression |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 protein [mono-(2-ethylhexyl)phthalate co-treated with Estradiol] results in decreased expression of BCL2 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of BCL2 mRNA; epigallocatechin gallate affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of BCL2 protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BCL2 mRNA; MIR16-1 mRNA affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 protein] |
CTD |
PMID:12927354 PMID:24412242 PMID:24706461 PMID:26597031 PMID:31884101 PMID:33159713 PMID:35861251 PMID:36889213 PMID:37286014 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions increases expression |
ISO |
AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 mRNA]; AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 protein] mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 protein |
CTD |
PMID:18755736 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l10 |
Bcl2-like 10 |
multiple interactions decreases expression |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of BCL2L10 mRNA; Estradiol affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2L10 mRNA] |
CTD |
PMID:24412242 PMID:31884101 |
|
NCBI chr 8:76,107,326...76,113,373
Ensembl chr 8:76,107,326...76,113,367
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein GW 6471 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein] |
CTD |
PMID:37979351 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl6 |
BCL6, transcription repressor |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of BCL6 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BDNF mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bean1 |
brain expressed, associated with NEDD4, 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of BEAN1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr19:739,551...786,395
Ensembl chr19:739,551...787,537
|
|
G |
Bfsp2 |
beaded filament structural protein 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BFSP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:104,006,226...104,063,399
Ensembl chr 8:104,006,226...104,063,399
|
|
G |
Bgn |
biglycan |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of BGN mRNA |
CTD |
PMID:38113427 |
|
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of BHMT mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of BICRA mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:76,661,897...76,736,146
Ensembl chr 1:76,661,897...76,737,157
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BID mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Bik |
BCL2-interacting killer |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of BIK mRNA mono-(2-ethylhexyl)phthalate results in increased expression of BIK mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
|
|
G |
Blk |
BLK proto-oncogene, Src family tyrosine kinase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BLK mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:37,626,746...37,665,053
Ensembl chr15:37,627,039...37,665,031
|
|
G |
Blnk |
B-cell linker |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BLNK mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
|
|
G |
Bmf |
Bcl2 modifying factor |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of BMF mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Bmp3 |
bone morphogenetic protein 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BMP3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:10,712,489...10,737,153
Ensembl chr14:10,712,489...10,737,153
|
|
G |
Bmp5 |
bone morphogenetic protein 5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of BMP5 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 8:76,517,164...76,639,925
Ensembl chr 8:76,517,164...76,639,925
|
|
G |
Bmp8a |
bone morphogenetic protein 8a |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Triiodothyronine] results in increased expression of BMP8B mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 5:135,589,839...135,617,785
Ensembl chr 5:135,591,716...135,617,785
|
|
G |
Bmper |
BMP-binding endothelial regulator |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of BMPER mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BMPER mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:21,732,225...21,977,261
Ensembl chr 8:21,732,225...21,977,256
|
|
G |
Bok |
BCL2 family apoptosis regulator BOK |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of BOK mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of BOK mRNA |
CTD |
PMID:24412242 PMID:31884101 |
|
NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476
|
|
G |
Bpifb1 |
BPI fold containing family B, member 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BPIFB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:142,672,995...142,706,258
Ensembl chr 3:142,672,995...142,706,256
|
|
G |
Bpifb6 |
BPI fold containing family B, member 6 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of BPIFB6 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:142,381,478...142,395,304
Ensembl chr 3:142,381,374...142,395,308
|
|
G |
Brd3 |
bromodomain containing 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of BRD3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:10,773,163...10,829,675
Ensembl chr 3:10,775,272...10,829,577
|
|
G |
Brinp3 |
BMP/retinoic acid inducible neural specific 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BRINP3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:58,413,883...58,846,828
Ensembl chr13:58,413,883...58,846,770
|
|
G |
Brsk1 |
BR serine/threonine kinase 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of BRSK1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:69,134,166...69,159,947
Ensembl chr 1:69,134,565...69,160,365
|
|
G |
Brsk2 |
BR serine/threonine kinase 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of BRSK2 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 1:197,035,505...197,088,624
Ensembl chr 1:197,035,633...197,088,092
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of BST2 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of BTG2 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Btn1a1 |
butyrophilin, subfamily 1, member A1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of BTN1A1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:41,653,499...41,664,246
Ensembl chr17:41,654,249...41,664,272
|
|
G |
Btnl9 |
butyrophilin-like 9 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of BTNL9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:33,466,059...33,489,229
Ensembl chr10:33,470,536...33,489,025
|
|
G |
Bves |
blood vessel epicardial substance |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of BVES mRNA |
CTD |
PMID:22401849 |
|
NCBI chr20:48,819,241...48,860,282
Ensembl chr20:48,822,308...48,857,472
|
|
G |
C1ql2 |
complement C1q like 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of C1QL2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:31,471,150...31,472,685
Ensembl chr13:31,471,150...31,472,689
|
|
G |
C1qtnf6 |
C1q and TNF related 6 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of C1QTNF6 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:110,077,867...110,084,584
Ensembl chr 7:110,077,878...110,084,412
|
|
G |
C1r |
complement C1r |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of C1RB mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
|
|
G |
C2 |
complement C2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of C2 mRNA |
CTD |
PMID:38113427 |
|
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
|
|
G |
C2cd4a |
C2 calcium-dependent domain containing 4A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of C2CD4A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:68,467,017...68,469,781
Ensembl chr 8:68,466,664...68,470,031
|
|
G |
C2cd4c |
C2 calcium-dependent domain containing 4C |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of C2CD4C mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:10,090,651...10,095,426
Ensembl chr 7:10,092,138...10,095,421
|
|
G |
C2cd6 |
C2 calcium dependent domain containing 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of C2CD6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:60,434,926...60,530,842
Ensembl chr 9:60,434,925...60,530,806
|
|
G |
C7h19orf25 |
similar to human chromosome 19 open reading frame 25 |
affects expression |
EXP |
mono-(2-ethylhexyl)phthalate affects the expression of C7H19ORF25 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 7:9,390,255...9,392,383
|
|
G |
C8a |
complement C8 alpha chain |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of C8A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:119,583,168...119,637,675
Ensembl chr 5:119,583,174...119,637,754
|
|
G |
Cables1 |
Cdk5 and Abl enzyme substrate 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CABLES1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:3,076,556...3,181,181
Ensembl chr18:3,075,524...3,181,181
|
|
G |
Cabp1 |
calcium binding protein 1 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CABP1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CABP1 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr12:41,385,234...41,448,930
Ensembl chr12:41,378,897...41,448,927
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CACNA1A mRNA |
CTD |
PMID:36314267 |
|
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of CADM1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Cadm3 |
cell adhesion molecule 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CADM3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:85,784,785...85,817,412
Ensembl chr13:85,786,483...85,817,749
|
|
G |
Caln1 |
calneuron 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CALN1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:25,811,743...26,303,670
Ensembl chr12:25,819,628...26,303,344
|
|
G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CAMK1D mRNA |
CTD |
PMID:22401849 |
|
NCBI chr17:72,581,899...72,982,704
Ensembl chr17:72,581,979...72,980,556
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CAMK2B mRNA |
CTD |
PMID:36314267 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CAMK2N1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
|
|
G |
Capn6 |
calpain 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CAPN6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:107,380,774...107,405,489
Ensembl chr X:107,380,774...107,405,489
|
|
G |
Capn8 |
calpain 8 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CAPN8 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:94,252,218...94,316,146
Ensembl chr13:94,253,054...94,316,146
|
|
G |
Car10 |
carbonic anhydrase 10 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CAR10 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:78,055,875...78,556,490
Ensembl chr10:78,054,114...78,555,834
|
|
G |
Car11 |
carbonic anhydrase 11 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CA11 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CAR11 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 1:96,169,900...96,175,191
Ensembl chr 1:96,170,080...96,175,191
|
|
G |
Card11 |
caspase recruitment domain family, member 11 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CARD11 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112
|
|
G |
Card14 |
caspase recruitment domain family, member 14 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CARD14 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:104,572,059...104,601,606
Ensembl chr10:104,566,424...104,601,905
|
|
G |
Caskin1 |
CASK interacting protein 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CASKIN1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr10:13,512,684...13,533,380
Ensembl chr10:13,513,465...13,533,377
|
|
G |
Casp1 |
caspase 1 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein]; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein]; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein] |
CTD |
PMID:33159713 PMID:37286014 PMID:37692514 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity increases cleavage |
ISO EXP |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of CASP3 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased cleavage of CASP3 protein; PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]; Rosiglitazone promotes the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]] mono-(2-ethylhexyl)phthalate results in increased expression of CASP3 protein mono-(2-ethylhexyl)phthalate results in increased cleavage of CASP3 protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CASP3 mRNA PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP3 protein] |
CTD |
PMID:12927354 PMID:19165384 PMID:19720108 PMID:23360888 PMID:24706461 PMID:30476341 PMID:31884101 PMID:33159713 PMID:35861251 PMID:36889213 PMID:37941498 PMID:38113427 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases activity increases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in increased activity of CASP7 protein mono-(2-ethylhexyl)phthalate results in increased expression of CASP7 protein PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP7 protein] |
CTD |
PMID:23360888 PMID:36889213 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases expression |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CASP8 mRNA; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP8 protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CASP8 mRNA |
CTD |
PMID:31884101 PMID:35861251 PMID:37286014 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
mono-(2-ethylhexyl)phthalate results in increased activity of CASP9 protein |
CTD |
PMID:24706461 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions increases expression increases activity |
EXP ISO |
Cycloheximide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CAT protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CAT mRNA mono-(2-ethylhexyl)phthalate results in increased activity of CAT protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CAT mRNA |
CTD |
PMID:2306265 PMID:6845354 PMID:31884101 PMID:32522588 PMID:35861251 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Catsper4 |
cation channel, sperm associated 4 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CATSPER4 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of CATSPER4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:146,427,682...146,447,346
Ensembl chr 5:146,427,683...146,446,942
|
|
G |
Cbln1 |
cerebellin 1 precursor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CBLN1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:19,608,763...19,612,572
Ensembl chr19:19,608,716...19,612,572
|
|
G |
Cbln2 |
cerebellin 2 precursor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CBLN2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:79,940,412...79,948,766
Ensembl chr18:79,942,590...79,947,855
|
|
G |
Cbr1 |
carbonyl reductase 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of CBR1 mRNA |
CTD |
PMID:34942354 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cbs |
cystathionine beta synthase |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of CBS mRNA |
CTD |
PMID:21195148 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Ccdc160 |
coiled-coil domain containing 160 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CCDC160 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:132,468,141...132,478,616
Ensembl chr X:132,468,213...132,478,431
|
|
G |
Ccdc163 |
coiled-coil domain containing 163 |
multiple interactions |
ISO |
[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of CCDC163 mRNA |
CTD |
PMID:37160244 |
|
NCBI chr 5:130,172,014...130,178,934
Ensembl chr 5:130,172,774...130,178,929
|
|
G |
Ccdc187 |
coiled-coil domain containing 187 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CCDC187 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:9,070,192...9,127,001
Ensembl chr 3:9,070,185...9,126,946
|
|
G |
Ccdc27 |
coiled-coil domain containing 27 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CCDC27 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:164,585,285...164,599,391
Ensembl chr 5:164,585,267...164,599,355
|
|
G |
Ccdc3 |
coiled-coil domain containing 3 |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CCDC3 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of CCDC3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:73,031,891...73,135,173
Ensembl chr17:73,035,045...73,135,337
|
|
G |
Ccdc63 |
coiled-coil domain containing 63 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CCDC63 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:34,424,388...34,453,080
Ensembl chr12:34,424,344...34,453,085
|
|
G |
Ccdc68 |
coiled-coil domain containing 68 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CCDC68 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:63,541,828...63,584,122
Ensembl chr18:63,541,896...63,584,119
|
|
G |
Ccdc88b |
coiled-coil domain containing 88B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CCDC88B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:204,036,913...204,052,878
Ensembl chr 1:204,036,918...204,052,970
|
|
G |
Ccdc92b |
coiled-coil domain containing 92B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CCDC92B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:59,479,798...59,501,486
Ensembl chr10:59,479,743...59,501,495
|
|
G |
Ccdc96 |
coiled-coil domain containing 96 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of CCDC96 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr14:74,276,568...74,279,072
Ensembl chr14:74,276,960...74,278,888
|
|
G |
Ccdc9b |
coiled-coil domain containing 9B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CCDC9B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:105,736,120...105,745,039
Ensembl chr 3:105,739,174...105,744,697
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CCL17 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CCL2 mRNA |
CTD |
PMID:27384973 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of CCN1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression multiple interactions |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of CCN2 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of CTGF protein STAT5A protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CTGF protein] |
CTD |
PMID:16809437 PMID:35143864 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccn5 |
cellular communication network factor 5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CCN5 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636
|
|
G |
Ccna1 |
cyclin A1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CCNA1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNA2 mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNB1 mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNB2 mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of CCND1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
multiple interactions decreases expression |
ISO |
Estradiol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CCND2 mRNA] |
CTD |
PMID:19874833 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccnd3 |
cyclin D3 |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCND3 mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNE1 mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccno |
cyclin O |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of CCNO mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 2:44,630,873...44,633,912
Ensembl chr 2:44,626,369...44,633,914
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
multiple interactions |
ISO |
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of CCR7 mRNA |
CTD |
PMID:30398665 |
|
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Ccrl2 |
C-C motif chemokine receptor like 2 |
increases expression decreases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CCRL2 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of CCRL2 mRNA |
CTD |
PMID:16809437 PMID:22401849 |
|
NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
|
|
G |
Cd109 |
CD109 molecule |
affects expression decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of CD109 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of CD109 mRNA |
CTD |
PMID:21195148 PMID:22401849 |
|
NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:79,454,480...79,569,194
|
|
G |
Cd163 |
CD163 molecule |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CD163 protein mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CD163 mRNA] [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in decreased expression of CD163 mRNA |
CTD |
PMID:22143055 PMID:29718165 PMID:30398665 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd22 |
CD22 molecule |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CD22 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
|
|
G |
Cd24 |
CD24 molecule |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of CD24A mRNA |
CTD |
PMID:21195148 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd248 |
CD248 molecule |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CD248 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 1:202,373,676...202,376,240
Ensembl chr 1:202,373,676...202,376,240
|
|
G |
Cd27 |
CD27 molecule |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CD27 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:158,030,700...158,035,862
Ensembl chr 4:158,030,703...158,035,592
|
|
G |
Cd34 |
CD34 molecule |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CD34 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:106,480,313...106,500,844
Ensembl chr13:106,480,043...106,499,832
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions increases expression decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CD36 mRNA] mono-(2-ethylhexyl)phthalate results in increased expression of CD36 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of CD36 mRNA |
CTD |
PMID:29718165 PMID:35421560 PMID:38113427 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd38 |
CD38 molecule |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CD38 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CD38 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
|
|
G |
Cd40 |
CD40 molecule |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of CD40 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd59b |
CD59b molecule |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of CD59 mRNA |
CTD |
PMID:38113427 |
|
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Cd69 |
Cd69 molecule |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of CD69 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cd74 |
CD74 molecule |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CD74 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CD74 mRNA |
CTD |
PMID:36189433 PMID:38113427 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CD86 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdh17 |
cadherin 17 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of CDH17 mRNA |
CTD |
PMID:38113427 |
|
NCBI chr 5:25,262,820...25,314,884
Ensembl chr 5:25,262,758...25,314,884
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CDH2 protein]; mono-(2-ethylhexyl)phthalate results in increased expression of and affects the localization of CDH2 protein |
CTD |
PMID:29940330 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdh23 |
cadherin-related 23 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CDH23 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr20:28,240,643...28,622,490
Ensembl chr20:28,240,645...28,622,419
|
|
G |
Cdh4 |
cadherin 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CDH4 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 3:166,525,092...167,003,380
Ensembl chr 3:166,525,099...167,003,371
|
|
G |
Cdh8 |
cadherin 8 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CDH8 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:5,494,038...5,901,810
Ensembl chr19:5,494,174...5,895,669
|
|
G |
Cdhr2 |
cadherin-related family member 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CDHR2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr17:9,876,853...9,913,356
Ensembl chr17:9,876,860...9,912,575
|
|
G |
Cdk15 |
cyclin-dependent kinase 15 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CDK15 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:60,710,787...60,803,638
Ensembl chr 9:60,711,715...60,802,777
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDK2 mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CDK4 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDK4 mRNA; Estradiol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CDK4 mRNA] |
CTD |
PMID:19874833 PMID:31884101 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression increases activity multiple interactions increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CDKN1A mRNA mono-(2-ethylhexyl)phthalate results in increased activity of CDKN1A protein Selenomethionine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CDKN1A protein]; Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CDKN1A protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN1A mRNA mono-(2-ethylhexyl)phthalate results in increased expression of CDKN1A protein |
CTD |
PMID:21515331 PMID:22401849 PMID:31884101 PMID:36174712 PMID:37364752 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1B mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1C mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN2A mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN2A mRNA |
CTD |
PMID:31884101 PMID:35861251 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN2B mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN2C mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
|
|
G |
Cdkn2d |
cyclin dependent kinase inhibitor 2D |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of CDKN2D mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of CDO1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cdr2l |
cerebellar degeneration-related protein 2-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CDR2L mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:100,625,150...100,638,669
Ensembl chr10:100,624,607...100,638,666
|
|
G |
Cdx1 |
caudal type homeo box 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CDX1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:54,472,587...54,490,913
Ensembl chr18:54,473,444...54,490,814
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
decreases expression multiple interactions increases expression |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein Colforsin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein] mono-(2-ethylhexyl)phthalate results in increased expression of CEBPA mRNA |
CTD |
PMID:21832167 PMID:25543134 PMID:27384973 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CEBPB mRNA |
CTD |
PMID:25543134 PMID:36695872 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpe |
CCAAT/enhancer binding protein epsilon |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CEBPE mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814
|
|
G |
Cela3b |
chymotrypsin like elastase 3B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CELA3B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:149,628,773...149,636,937
Ensembl chr 5:149,628,773...149,636,937
|
|
G |
Celf4 |
CUGBP, Elav-like family member 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CELF4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:16,786,578...17,065,045
Ensembl chr18:16,786,867...17,064,786
|
|
G |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
multiple interactions affects transport increases phosphorylation |
ISO |
[IC 261 results in decreased activity of CSNK1A1 protein] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of CELSR2 protein] mono-(2-ethylhexyl)phthalate affects the transport of CELSR2 protein |
CTD |
PMID:16484285 |
|
NCBI chr 2:196,029,206...196,053,848
Ensembl chr 2:196,029,434...196,053,845
|
|
G |
Cfap161 |
cilia and flagella associated protein 161 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CFAP161 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:137,743,783...137,768,685
Ensembl chr 1:137,743,784...137,768,730
|
|
G |
Cfap52 |
cilia and flagella associated protein 52 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CFAP52 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:52,613,761...52,654,922
Ensembl chr10:52,613,762...52,654,934
|
|
G |
Cfap99 |
cilia and flagella associated protein 99 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CFAP99 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:76,423,923...76,468,170
Ensembl chr14:76,410,555...76,468,125
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
multiple interactions |
ISO |
[FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate] which affects the expression of CFLAR protein |
CTD |
PMID:20100735 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Cga |
glycoprotein hormones, alpha polypeptide |
multiple interactions increases secretion increases expression affects expression |
ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [CGA protein results in increased abundance of Estradiol] mono-(2-ethylhexyl)phthalate inhibits the reaction [CGA protein results in increased abundance of Progesterone] mono-(2-ethylhexyl)phthalate results in increased secretion of CGA protein mono-(2-ethylhexyl)phthalate results in increased expression of CGA mRNA mono-(2-ethylhexyl)phthalate affects the expression of CGA mRNA |
CTD |
PMID:19501113 PMID:27181934 PMID:28381288 PMID:29089286 |
|
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
|
|
G |
Cgn |
cingulin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CGN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:182,308,389...182,335,747
Ensembl chr 2:182,308,714...182,334,645
|
|
G |
Ch25h |
cholesterol 25-hydroxylase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CH25H mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:232,014,877...232,016,195
Ensembl chr 1:232,014,880...232,016,195
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CHAC1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CHAC1 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chaf1a |
chromatin assembly factor 1 subunit A |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CHAF1A mRNA |
CTD |
PMID:38113427 |
|
NCBI chr 9:873,953...900,701
Ensembl chr 9:874,051...900,654
|
|
G |
Chat |
choline O-acetyltransferase |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of CHAT mRNA |
CTD |
PMID:21145954 |
|
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
|
|
G |
Chchd6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CHCHD6 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 4:121,803,501...122,024,209
Ensembl chr 4:121,792,717...122,024,216
|
|
G |
Chd5 |
chromodomain helicase DNA binding protein 5 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CHD5 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:162,848,273...162,898,997
Ensembl chr 5:162,848,394...162,896,291
|
|
G |
Chek2 |
checkpoint kinase 2 |
increases phosphorylation multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased phosphorylation of CHEK2 protein gingerol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of CHEK2 protein] |
CTD |
PMID:28988496 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chl1 |
cell adhesion molecule L1-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CHL1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:136,291,504...136,505,830
Ensembl chr 4:136,291,463...136,503,265
|
|
G |
Chodl |
chondrolectin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CHODL mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:17,654,137...17,676,450
Ensembl chr11:17,654,206...17,676,441
|
|
G |
Chrd |
chordin |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of CHRD mRNA |
CTD |
PMID:21195148 |
|
NCBI chr11:80,171,994...80,181,166
Ensembl chr11:80,171,994...80,180,673
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CHRM2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CHRM3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Chrna9 |
cholinergic receptor nicotinic alpha 9 subunit |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of CHRNA9 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr14:42,235,218...42,241,939
Ensembl chr14:42,235,226...42,242,192
|
|
G |
Chrnd |
cholinergic receptor nicotinic delta subunit |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CHRND mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:87,862,417...87,870,833
Ensembl chr 9:87,862,407...87,870,833
|
|
G |
Chst11 |
carbohydrate sulfotransferase 11 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CHST11 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:20,524,535...20,743,008
Ensembl chr 7:20,528,100...20,743,111
|
|
G |
Chst2 |
carbohydrate sulfotransferase 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CHST2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 8:95,960,067...95,966,312
Ensembl chr 8:95,959,826...95,966,955
|
|
G |
Chst8 |
carbohydrate sulfotransferase 8 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CHST8 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:87,294,144...87,435,900
Ensembl chr 1:87,294,540...87,435,900
|
|
G |
Chst9 |
carbohydrate sulfotransferase 9 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CHST9 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr18:6,576,391...6,851,078
Ensembl chr18:6,577,348...6,850,868
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CIDEA mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CIDEA mRNA |
CTD |
PMID:32522588 PMID:36189433 |
|
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Ciita |
class II, major histocompatibility complex, transactivator |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CIITA mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of CIITA mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
|
|
G |
Cimap3 |
ciliary microtubule associated protein 3 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PIFO mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PIFO mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:193,475,785...193,493,092
Ensembl chr 2:193,475,782...193,493,139
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CITED4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:134,246,936...134,247,827
Ensembl chr 5:134,246,682...134,248,135
|
|
G |
Ckm |
creatine kinase, M-type |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CKM mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CKM mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Ckmt1 |
creatine kinase, mitochondrial 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CKMT1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:108,329,859...108,335,760
Ensembl chr 3:108,330,705...108,335,758
|
|
G |
Clasp2 |
cytoplasmic linker associated protein 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CLASP2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:113,677,345...113,859,957
Ensembl chr 8:113,677,284...113,858,731
|
|
G |
Clca1 |
chloride channel accessory 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CLCA1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
|
|
G |
Cldn1 |
claudin 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CLDN1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn11 |
claudin 11 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CLDN11 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:112,207,745...112,221,050
Ensembl chr 2:112,207,745...112,221,050
|
|
G |
Cldn18 |
claudin 18 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CLDN18 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:100,246,499...100,265,797
Ensembl chr 8:100,247,633...100,273,351
|
|
G |
Cldn2 |
claudin 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CLDN2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Cldn4 |
claudin 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CLDN4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Cldn6 |
claudin 6 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CLDN6 mRNA |
CTD |
PMID:22321834 |
|
NCBI chr10:12,710,302...12,713,987
Ensembl chr10:12,709,960...12,715,973
|
|
G |
Cldn7 |
claudin 7 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CLDN7 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
|
|
G |
Clec18a |
C-type lectin domain family 18, member A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CLEC18A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:39,038,498...39,053,425
Ensembl chr19:39,038,273...39,056,017
|
|
G |
Clec4a1 |
C-type lectin domain family 4, member A1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CLEC4A1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008
|
|
G |
Clec7a |
C-type lectin domain containing 7A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CLEC7A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
|
|
G |
Clic6 |
chloride intracellular channel 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CLIC6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:31,737,813...31,780,360
Ensembl chr11:31,737,813...31,780,061
|
|
G |
Clstn3 |
calsyntenin 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CLSTN3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:157,331,494...157,364,769
Ensembl chr 4:157,331,494...157,364,769
|
|
G |
Clul1 |
clusterin like 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CLUL1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 9:113,344,501...113,370,077
Ensembl chr 9:113,344,501...113,370,077
|
|
G |
Clvs1 |
clavesin 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CLVS1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:22,408,384...22,604,281
Ensembl chr 5:22,408,384...22,604,270
|
|
G |
Cmtm2b |
CKLF-like MARVEL transmembrane domain containing 2B |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CMTM2B mRNA |
CTD |
PMID:22401849 |
|
NCBI chr19:640,838...651,872
Ensembl chr19:640,824...651,939
|
|
G |
Cnga2 |
cyclic nucleotide gated channel subunit alpha 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CNGA2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr X:149,696,999...149,715,051
Ensembl chr X:149,696,997...149,715,051
|
|
G |
Cnga4 |
cyclic nucleotide gated channel subunit alpha 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CNGA4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:159,752,357...159,756,369
Ensembl chr 1:159,752,357...159,756,375
|
|
G |
Cnksr1 |
connector enhancer of kinase suppressor of Ras 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CNKSR1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:146,447,495...146,458,332
Ensembl chr 5:146,447,497...146,458,212
|
|
G |
Cnmd |
chondromodulin |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CNMD mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of CNMD mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:55,041,548...55,066,297
Ensembl chr15:55,041,561...55,066,297
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CNP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Cnpy1 |
canopy FGF signaling regulator 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CNPY1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:7,182,311...7,191,408
Ensembl chr 4:7,136,533...7,189,761
|
|
G |
Cntn2 |
contactin 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CNTN2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:43,942,868...43,975,973
Ensembl chr13:43,947,265...43,975,887
|
|
G |
Cntn3 |
contactin 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CNTN3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:134,841,268...135,214,460
Ensembl chr 4:134,842,266...135,125,613
|
|
G |
Cntnap2 |
contactin associated protein 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CNTNAP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:74,109,455...76,366,434
Ensembl chr 4:74,109,472...76,362,027
|
|
G |
Cntnap5b |
contactin associated protein family member 5B |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CNTNAP5A mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CNTNAP5A mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr13:17,863,367...18,766,983
Ensembl chr13:18,093,420...18,761,014
|
|
G |
Cntrl |
centriolin |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CNTRL mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:18,428,147...18,500,362
Ensembl chr 3:18,428,103...18,500,380
|
|
G |
Col12a1 |
collagen type XII alpha 1 chain |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of COL12A1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:80,547,592...80,665,665
Ensembl chr 8:80,547,593...80,665,686
|
|
G |
Col13a1 |
collagen type XIII alpha 1 chain |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of COL13A1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr20:29,783,965...29,924,116
Ensembl chr20:29,783,965...29,924,032
|
|
G |
Col25a1 |
collagen type XXV alpha 1 chain |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of COL25A1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:218,755,152...219,154,348
Ensembl chr 2:218,755,691...219,153,501
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of COL2A1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of COL3A1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col4a3 |
collagen type IV alpha 3 chain |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of COL4A3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:83,875,849...84,004,955
Ensembl chr 9:83,875,561...84,001,895
|
|
G |
Col4a4 |
collagen type IV alpha 4 chain |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of COL4A4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:83,833,173...83,875,436
Ensembl chr 9:83,755,515...83,875,876
|
|
G |
Col4a6 |
collagen type IV alpha 6 chain |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of COL4A6 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of COL4A6 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr X:104,766,463...105,117,499
Ensembl chr X:104,766,957...105,117,500
|
|
G |
Col8a1 |
collagen type VIII alpha 1 chain |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of COL8A1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424
|
|
G |
Colec12 |
collectin sub-family member 12 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of COLEC12 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
|
|
G |
Comp |
cartilage oligomeric matrix protein |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of COMP mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of COMP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:19,047,206...19,055,584
Ensembl chr16:19,047,207...19,055,845
|
|
G |
Coro2a |
coronin 2A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CORO2A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:60,825,630...60,881,917
Ensembl chr 5:60,828,247...60,859,035
|
|
G |
Coro6 |
coronin 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CORO6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of COX4I1 protein |
CTD |
PMID:37692514 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of COX6A2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
|
|
G |
Cox7a1 |
cytochrome c oxidase subunit 7A1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of COX7A1 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 1:85,422,162...85,447,530
Ensembl chr 1:85,441,871...85,445,151
|
|
G |
Cp |
ceruloplasmin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpa4 |
carboxypeptidase A4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CPA4 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 4:59,188,284...59,212,255
Ensembl chr 4:59,188,284...59,212,255
|
|
G |
Cpa5 |
carboxypeptidase A5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CPA5 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:59,229,754...59,249,503
Ensembl chr 4:59,230,964...59,249,490
|
|
G |
Cplane2 |
ciliogenesis and planar polarity effector complex subunit 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RSG1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:153,515,507...153,516,455
Ensembl chr 5:153,515,376...153,522,508
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
decreases expression affects expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CPT1A mRNA mono-(2-ethylhexyl)phthalate affects the expression of CPT1A mRNA |
CTD |
PMID:22401849 PMID:32522588 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CPT2 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Crabp1 |
cellular retinoic acid binding protein 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CRABP1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CRABP2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
|
|
G |
Crb1 |
crumbs cell polarity complex component 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CRB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:50,801,484...50,989,261
Ensembl chr13:50,800,959...50,989,261
|
|
G |
Crhbp |
corticotropin releasing hormone binding protein |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CRHBP mRNA |
CTD |
PMID:22401849 PMID:36314267 |
|
NCBI chr 2:26,692,403...26,704,710
Ensembl chr 2:26,692,403...26,704,710
|
|
G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CRHR2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:84,222,897...84,265,924
Ensembl chr 4:84,224,002...84,265,904
|
|
G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CRISPLD2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr19:48,053,153...48,111,485
Ensembl chr19:48,053,287...48,110,465
|
|
G |
Crybb1 |
crystallin, beta B1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CRYBB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:44,369,734...44,383,344
Ensembl chr12:44,369,735...44,383,344
|
|
G |
Csdc2 |
cold shock domain containing C2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CSDC2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 7:113,451,998...113,466,464
Ensembl chr 7:113,451,998...113,466,463
|
|
G |
Csmd3 |
CUB and Sushi multiple domains 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CSMD3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:78,747,322...80,066,466
Ensembl chr 7:78,748,480...80,066,369
|
|
G |
Csnk1a1 |
casein kinase 1, alpha 1 |
multiple interactions |
ISO |
[IC 261 results in decreased activity of CSNK1A1 protein] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of CELSR2 protein] |
CTD |
PMID:16484285 |
|
NCBI chr18:55,017,049...55,050,184
Ensembl chr18:55,017,055...55,049,271
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CSPG4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CSRP1 mRNA |
CTD |
PMID:38113427 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Cst11 |
cystatin 11 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CST11 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:136,211,414...136,214,138
Ensembl chr 3:136,211,414...136,214,138
|
|
G |
Cth |
cystathionine gamma-lyase |
affects expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of CTH mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CTH mRNA |
CTD |
PMID:21195148 PMID:36189433 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnnb1 |
catenin beta 1 |
increases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of CTNNB1 mRNA [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein]; mono-(2-ethylhexyl)phthalate results in increased expression of and affects the localization of CTNNB1 protein |
CTD |
PMID:22321834 PMID:29940330 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctrl |
chymotrypsin-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CTRB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:33,827,279...33,829,129
Ensembl chr19:33,827,229...33,833,626
|
|
G |
Ctsl |
cathepsin L |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of CTSL mRNA |
CTD |
PMID:16809437 PMID:38113427 |
|
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Ctsw |
cathepsin W |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CTSW mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:202,772,395...202,777,021
Ensembl chr 1:202,772,572...202,775,964
|
|
G |
Cubn |
cubilin |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CUBN mRNA |
CTD |
PMID:22401849 |
|
NCBI chr17:76,385,046...76,593,133
Ensembl chr17:76,385,060...76,593,231
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CXCL1 mRNA |
CTD |
PMID:16809437 PMID:36695872 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CXCL10 mRNA [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of CXCL10 mRNA |
CTD |
PMID:16809437 PMID:30398665 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CXCL1 mRNA |
CTD |
PMID:27384973 PMID:36695872 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyb5r2 |
cytochrome b5 reductase 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CYB5R2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:161,655,862...161,664,359
Ensembl chr 1:161,655,864...161,664,097
|
|
G |
Cyc1 |
cytochrome c-1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CYC1 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 7:108,067,106...108,069,483
Ensembl chr 7:108,067,115...108,069,479
|
|
G |
Cycs |
cytochrome c, somatic |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of CYCS mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyct |
cytochrome c, testis |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CYCT mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:61,290,090...61,297,158
Ensembl chr 3:60,913,562...61,297,158
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
increases activity decreases expression multiple interactions increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased activity of CYP11A1 protein mono-(2-ethylhexyl)phthalate results in decreased expression of CYP11A1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of CYP11A1 protein [Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of CYP11A1 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP11A1 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of CYP11A1 mRNA |
CTD |
PMID:22401849 PMID:22525294 PMID:27181934 PMID:29089286 PMID:31884101 PMID:34627990 More...
|
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
increases expression affects expression decreases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CYP17A1 mRNA mono-(2-ethylhexyl)phthalate affects the expression of CYP17A1 mono-(2-ethylhexyl)phthalate results in decreased expression of CYP17A1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of CYP17A1 protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:16809437 PMID:19560483 PMID:22087261 PMID:31884101 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases activity multiple interactions decreases expression increases expression |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased activity of CYP19A1 protein mono-(2-ethylhexyl)phthalate inhibits the reaction [Colforsin results in increased expression of CYP19A1 mRNA] mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA alitretinoin promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA] mono-(2-ethylhexyl)phthalate results in increased expression of CYP19A1 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP19A1 mRNA |
CTD |
PMID:12706301 PMID:19501113 PMID:19822197 PMID:19874833 PMID:22401849 PMID:29089286 PMID:31884101 More...
|
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CYP1A1 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CYP1A1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:15521013 PMID:31884101 PMID:34954075 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression multiple interactions decreases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CYP1B1 mRNA 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CYP1B1 mRNA]; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP1B1 mRNA |
CTD |
PMID:12706301 PMID:31884101 PMID:34954075 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CYP26A1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CYP26B1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp26c1 |
cytochrome P450, family 26, subfamily C, polypeptide 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CYP26C1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:235,458,961...235,468,433
Ensembl chr 1:235,459,356...235,466,842
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
decreases activity |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased activity of CYP2C11 protein |
CTD |
PMID:27432241 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
increases metabolic processing multiple interactions |
EXP ISO |
CYP2C6 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate [CYP2C6 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate; [CYP2C6 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate; [CYP2C6 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of phthalic acid CYP2C19 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate [CYP2C19 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate; [CYP2C19 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate |
CTD |
PMID:22186153 PMID:23545481 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CYP2D22 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CYP2F2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing multiple interactions increases expression |
EXP ISO |
CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate [CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate; [CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate; [CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of phthalic acid mono-(2-ethylhexyl)phthalate results in increased expression of CYP3A4 mRNA [CYP3A4 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate; [CYP3A4 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate; [CYP3A4 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of phthalic acid; [Dexamethasone co-treated with mono-(2-ethylhexyl)phthalate] results in increased activity of CYP3A4 protein |
CTD |
PMID:18332045 PMID:22186153 PMID:23545481 PMID:27551952 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
decreases activity |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased activity of CYP3A62 protein |
CTD |
PMID:27432241 |
|
NCBI chr12:16,397,998...16,433,833
Ensembl chr12:16,397,998...16,433,833
|
|
G |
Cyp4x1 |
cytochrome P450, family 4, subfamily x, polypeptide 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CYP4X1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:128,651,681...128,683,338
Ensembl chr 5:128,651,776...128,682,779
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of CYP51 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of CYP51 mRNA |
CTD |
PMID:22087261 PMID:37364752 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CYP7B1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
|
|
G |
Cytip |
cytohesin 1 interacting protein |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of CYTIP mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CYTIP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:42,698,058...42,774,955
Ensembl chr 3:42,698,768...42,725,993
|
|
G |
Dach1 |
dachshund family transcription factor 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DACH1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:74,528,122...74,909,811
Ensembl chr15:74,529,208...74,909,922
|
|
G |
Dact2 |
dishevelled-binding antagonist of beta-catenin 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DACT2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:55,181,023...55,191,026
Ensembl chr 1:55,181,024...55,191,096
|
|
G |
Dazl |
deleted in azoospermia-like |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DAZL protein |
CTD |
PMID:37364752 |
|
NCBI chr 9:10,695,593...10,712,330
Ensembl chr 9:10,695,592...10,712,323
|
|
G |
Dbh |
dopamine beta-hydroxylase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DBH mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
|
|
G |
Dcakd |
dephospho-CoA kinase domain containing |
multiple interactions |
ISO |
[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of DCAKD mRNA |
CTD |
PMID:37160244 |
|
NCBI chr10:87,957,738...87,989,002
Ensembl chr10:87,957,740...87,980,054
|
|
G |
Dcdc2 |
doublecortin domain containing 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DCDC2A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:39,845,952...40,031,781
Ensembl chr17:39,845,952...40,030,743
|
|
G |
Dclk3 |
doublecortin-like kinase 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DCLK3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:111,401,544...111,453,999
Ensembl chr 8:111,401,358...111,453,999
|
|
G |
Dcn |
decorin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DCN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
|
|
G |
Dct |
dopachrome tautomerase |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DCT mRNA mono-(2-ethylhexyl)phthalate results in increased expression of DCT mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:95,062,006...95,100,863
Ensembl chr15:95,062,003...95,100,836
|
|
G |
Dcx |
doublecortin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DCX mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
|
|
G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DDAH1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:234,667,499...234,800,322
Ensembl chr 2:234,667,491...234,799,339
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression affects expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of DDIT3 mRNA mono-(2-ethylhexyl)phthalate affects the expression of DDIT3 protein arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of DDIT3 protein] 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of DDIT3 protein] |
CTD |
PMID:22321834 PMID:37979351 PMID:38048874 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DDIT4 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DDIT4L mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
|
|
G |
Ddx4 |
DEAD-box helicase 4 |
decreases expression increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DDX4 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of DDX4 protein |
CTD |
PMID:30476341 PMID:37364752 |
|
NCBI chr 2:44,227,946...44,282,867
Ensembl chr 2:44,227,946...44,282,723
|
|
G |
Defb44 |
defensin beta 44 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DEFB42 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:37,311,888...37,313,579
Ensembl chr15:37,312,308...37,313,370
|
|
G |
Derl3 |
derlin 3 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of DERL3 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr20:12,754,490...12,768,454
Ensembl chr20:12,763,543...12,767,027
|
|
G |
Dgkb |
diacylglycerol kinase, beta |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DGKB mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 6:54,640,948...55,397,210
Ensembl chr 6:54,641,614...55,397,043
|
|
G |
Dgki |
diacylglycerol kinase, iota |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DGKI mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 4:65,410,878...65,872,733
Ensembl chr 4:65,420,108...65,872,733
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DHCR24 mRNA |
CTD |
PMID:23360888 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
affects expression decreases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate affects the expression of DHCR7; mono-(2-ethylhexyl)phthalate affects the expression of DHCR7 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of DHCR7 mRNA |
CTD |
PMID:16809437 PMID:19560483 PMID:22401849 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DHRS3 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DHRS3 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dhrs4 |
dehydrogenase/reductase 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DHRS4 protein |
CTD |
PMID:27384973 |
|
NCBI chr15:28,966,544...28,978,135
Ensembl chr15:28,966,553...28,978,127
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
decreases expression increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DIABLO mRNA mono-(2-ethylhexyl)phthalate results in increased expression of DIABLO protein |
CTD |
PMID:18755736 PMID:24706461 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dicer1 |
dicer 1 ribonuclease III |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of DICER1 mRNA |
CTD |
PMID:35861251 |
|
NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DIO2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of and results in decreased methylation of DIO3 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
|
|
G |
Dipk2a |
divergent protein kinase domain 2A |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of DIPK2A mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 8:95,070,695...95,089,815
Ensembl chr 8:95,030,279...95,089,815
|
|
G |
Diras2 |
DIRAS family GTPase 2 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DIRAS2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DIRAS2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:12,730,040...12,761,511
Ensembl chr17:12,725,149...12,761,663
|
|
G |
Disp3 |
dispatched RND transporter family member 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DISP3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:158,672,015...158,720,806
Ensembl chr 5:158,672,015...158,720,806
|
|
G |
Dlgap2 |
DLG associated protein 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DLGAP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:74,786,771...75,496,402
Ensembl chr16:74,791,509...75,496,407
|
|
G |
Dlgap3 |
DLG associated protein 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DLGAP3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:139,491,972...139,562,625
Ensembl chr 5:139,492,947...139,562,625
|
|
G |
Dlk2 |
delta like non-canonical Notch ligand 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DLK2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:14,677,102...14,681,584
Ensembl chr 9:14,676,562...14,681,594
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
increases expression affects expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of DLL1 mRNA mono-(2-ethylhexyl)phthalate affects the expression of DLL1 protein |
CTD |
PMID:36988346 |
|
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
|
|
G |
Dll4 |
delta like canonical Notch ligand 4 |
increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DLL4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of DLL4 protein |
CTD |
PMID:36988346 PMID:38042133 |
|
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
|
|
G |
Dmd |
dystrophin |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DMD mRNA |
CTD |
PMID:22401849 |
|
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
|
|
G |
Dmp1 |
dentin matrix acidic phosphoprotein 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DMP1 mRNA |
CTD |
PMID:25777084 |
|
NCBI chr14:5,528,441...5,542,078
Ensembl chr14:5,528,431...5,539,323
|
|
G |
Dnah14 |
dynein axonemal heavy chain 14 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DNAH14 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr13:93,322,653...93,540,706
Ensembl chr13:93,322,711...93,538,646
|
|
G |
Dnah5 |
dynein, axonemal, heavy chain 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DNAH5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:78,937,788...79,255,551
Ensembl chr 2:78,937,800...79,254,890
|
|
G |
Dnah8 |
dynein, axonemal, heavy chain 8 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DNAH8 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr20:8,692,939...8,946,780
Ensembl chr20:8,692,963...8,946,772
|
|
G |
Dnah9 |
dynein, axonemal, heavy chain 9 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DNAH9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:50,496,174...50,864,909
Ensembl chr10:50,497,688...50,864,949
|
|
G |
Dnai1 |
dynein, axonemal, intermediate chain 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DNAI1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:56,730,179...56,800,926
Ensembl chr 5:56,730,179...56,800,925
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DNAJB1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajc5g |
DnaJ heat shock protein family (Hsp40) member C5 gamma |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DNAJC5G mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:25,260,087...25,264,251
Ensembl chr 6:25,260,088...25,264,152
|
|
G |
Dner |
delta/notch-like EGF repeat containing |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DNER mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DNER mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 9:85,586,985...85,902,461
Ensembl chr 9:85,586,987...85,902,637
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DNMT1 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of DNMT1 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of DNMT1 mRNA |
CTD |
PMID:22401849 PMID:35861251 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3l |
DNA methyltransferase 3 like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DNMT3L mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:10,614,933...10,629,337
Ensembl chr20:10,614,934...10,629,516
|
|
G |
Dock10 |
dedicator of cytokinesis 10 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DOCK10 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:81,843,599...82,101,540
Ensembl chr 9:81,843,604...82,101,525
|
|
G |
Dock4 |
dedicator of cytokinesis 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DOCK4 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855
|
|
G |
Dock5 |
dedicator of cytokinesis 5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DOCK5 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:41,979,728...42,158,733
Ensembl chr15:41,979,729...42,158,649
|
|
G |
Dok5 |
docking protein 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DOK5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:159,515,886...159,652,811
Ensembl chr 3:159,515,893...159,652,810
|
|
G |
Dpep1 |
dipeptidase 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DPEP1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr19:51,209,831...51,237,004
Ensembl chr19:51,219,660...51,235,257
|
|
G |
Dpep2 |
dipeptidase 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DPEP2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr19:33,883,557...33,896,487
Ensembl chr19:33,885,478...33,891,954
|
|
G |
Dpp6 |
dipeptidyl peptidase like 6 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DPP6 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:7,589,386...8,508,666
Ensembl chr 4:7,591,009...8,508,532
|
|
G |
Dppa4 |
developmental pluripotency associated 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DPPA4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:52,570,279...52,578,779
Ensembl chr11:52,570,286...52,578,797
|
|
G |
Dpt |
dermatopontin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DPT mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:77,123,224...77,151,646
Ensembl chr13:77,123,115...77,151,639
|
|
G |
Dpy19l1 |
dpy-19 like C-mannosyltransferase 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DPY19L1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:22,933,163...23,021,461
Ensembl chr 8:22,933,163...23,021,751
|
|
G |
Dpysl4 |
dihydropyrimidinase-like 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DPYSL4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:193,883,039...193,898,916
Ensembl chr 1:193,883,106...193,898,914
|
|
G |
Drc1 |
dynein regulatory complex subunit 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DRC1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:26,025,004...26,059,438
Ensembl chr 6:26,025,005...26,059,414
|
|
G |
Drosha |
drosha ribonuclease III |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of DROSHA mRNA |
CTD |
PMID:35861251 |
|
NCBI chr 2:61,864,886...61,976,688
Ensembl chr 2:61,864,970...61,976,688
|
|
G |
Dsc2 |
desmocollin 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of DSC2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
Dscaml1 |
DS cell adhesion molecule-like 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DSCAML1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:45,740,298...46,057,322
Ensembl chr 8:45,740,298...46,057,320
|
|
G |
Dst |
dystonin |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DST mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DST mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression decreases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DUSP1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of DUSP1 mRNA |
CTD |
PMID:16809437 PMID:22401849 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp26 |
dual specificity phosphatase 26 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DUSP26 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:61,041,784...61,049,319
Ensembl chr16:61,041,792...61,049,051
|
|
G |
Dusp4 |
dual specificity phosphatase 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DUSP4 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DUSP5 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DUSP5 mRNA |
CTD |
PMID:16809437 PMID:36189433 PMID:36695872 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of DUSP6 mRNA |
CTD |
PMID:16809437 PMID:36695872 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DYNC1I1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of DYNC1I1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:33,852,597...34,166,159
Ensembl chr 4:33,852,927...34,166,149
|
|
G |
Ebf1 |
EBF transcription factor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EBF1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665
|
|
G |
Ebf3 |
EBF transcription factor 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of EBF3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:191,996,726...192,114,593
Ensembl chr 1:191,996,730...192,114,359
|
|
G |
Ebp |
EBP, cholestenol delta-isomerase |
increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of EBP mRNA |
CTD |
PMID:22087261 PMID:37364752 |
|
NCBI chr X:14,299,427...14,305,826
Ensembl chr X:14,299,448...14,305,826
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ECH1 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ECI1 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ECM1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ECM1 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
|
|
G |
Edn1 |
endothelin 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of EDN1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Edn2 |
endothelin 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EDN2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:133,751,316...133,756,814
Ensembl chr 5:133,751,217...133,756,814
|
|
G |
Efcab10 |
EF-hand calcium binding domain 10 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of EFCAB10 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 6:50,004,479...50,011,398
Ensembl chr 6:50,004,479...50,011,398
|
|
G |
Efcab8 |
EF-hand calcium binding domain 8 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EFCAB8 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:142,257,195...142,323,743
Ensembl chr 3:142,257,229...142,323,743
|
|
G |
Efcc1 |
EF-hand and coiled-coil domain containing 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of EFCC1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:120,188,202...120,223,464
Ensembl chr 4:120,188,470...120,217,516
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EFEMP1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
|
|
G |
Efhd1 |
EF-hand domain family, member D1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of EFHD1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:87,938,259...87,984,917
Ensembl chr 9:87,938,284...87,984,917
|
|
G |
Efnb2 |
ephrin B2 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of EFNB2 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Egf |
epidermal growth factor |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of EGF mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of EGLN1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of EGLN1 protein |
CTD |
PMID:34863575 |
|
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of EGLN3 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of EGLN3 protein |
CTD |
PMID:34863575 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Egr1 |
early growth response 1 |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of EGR1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EGR1 mRNA |
CTD |
PMID:8764118 PMID:16809437 PMID:36189433 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Egr2 |
early growth response 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EGR2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
|
|
G |
Egr3 |
early growth response 3 |
increases expression decreases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of EGR3 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of EGR3 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EGR3 mRNA |
CTD |
PMID:16809437 PMID:36189433 |
|
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
|
|
G |
Egr4 |
early growth response 4 |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of EGR4 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EGR4 mRNA |
CTD |
PMID:16809437 PMID:36189433 |
|
NCBI chr 4:118,047,869...118,050,328
Ensembl chr 4:118,047,869...118,050,328
|
|
G |
Ehf |
ets homologous factor |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of EHF mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EHF mRNA |
CTD |
PMID:36189433 PMID:36314267 |
|
NCBI chr 3:89,639,845...89,680,061
Ensembl chr 3:89,641,833...89,679,997
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases phosphorylation multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2A protein arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2A protein] |
CTD |
PMID:37979351 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression multiple interactions increases phosphorylation |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of EIF2AK3 protein; mono-(2-ethylhexyl)phthalate results in increased expression of EIF2AK3 protein modified form 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of EIF2AK3 protein modified form]; mono-(2-ethylhexyl)phthalate inhibits the reaction [4-phenylbutyric acid results in decreased expression of EIF2AK3 protein modified form] 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2AK3 protein]; 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2AK3 protein] |
CTD |
PMID:36005737 PMID:37692514 PMID:37979351 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of EIF5B mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
|
|
G |
Elapor1 |
endosome-lysosome associated apoptosis and autophagy regulator 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ELAPOR1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:196,089,199...196,169,055
Ensembl chr 2:196,091,646...196,168,716
|
|
G |
Elavl3 |
ELAV like RNA binding protein 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ELAVL3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:20,547,108...20,583,369
Ensembl chr 8:20,550,201...20,583,641
|
|
G |
Elf1 |
E74 like ETS transcription factor 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of ELF1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr15:54,890,644...54,986,721
Ensembl chr15:54,865,616...54,986,699
|
|
G |
Elf3 |
E74 like ETS transcription factor 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ELF3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
|
|
G |
Elovl2 |
ELOVL fatty acid elongase 2 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ELOVL2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ELOVL2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:23,544,598...23,584,855
Ensembl chr17:23,544,568...23,584,848
|
|
G |
Elovl3 |
ELOVL fatty acid elongase 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ELOVL3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:244,997,287...245,001,115
Ensembl chr 1:244,997,287...245,001,115
|
|
G |
Emilin3 |
elastin microfibril interfacer 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EMILIN3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:149,558,785...149,564,785
Ensembl chr 3:149,558,970...149,564,785
|
|
G |
En1 |
engrailed homeobox 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EN1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:31,750,892...31,756,477
Ensembl chr13:31,751,545...31,755,943
|
|
G |
Enkur |
enkurin, TRPC channel interacting protein |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ENKUR mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:83,690,105...83,714,756
Ensembl chr17:83,690,797...83,714,408
|
|
G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ENOX1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:52,517,833...53,079,752
Ensembl chr15:52,515,178...53,079,749
|
|
G |
Enpep |
glutamyl aminopeptidase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ENPEP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
|
|
G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ENPP1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:20,698,746...20,763,741
Ensembl chr 1:20,698,764...20,763,715
|
|
G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ENPP3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ENTPD1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
|
|
G |
Entpd3 |
ectonucleoside triphosphate diphosphohydrolase 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ENTPD3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:120,246,412...120,277,943
Ensembl chr 8:120,247,121...120,277,943
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate promotes the reaction [PPARA protein binds to EP300 protein] |
CTD |
PMID:20123618 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epb41l1 |
erythrocyte membrane protein band 4.1-like 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of EPB41L1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 3:144,929,195...145,052,723
Ensembl chr 3:144,984,640...145,052,721
|
|
G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of EPB41L3 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 9:109,056,178...109,260,607
Ensembl chr 9:109,016,113...109,260,607
|
|
G |
Epcam |
epithelial cell adhesion molecule |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of EPCAM mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Epdr1 |
ependymin related 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of EPDR1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr17:45,333,932...45,358,597
Ensembl chr17:45,333,956...45,358,594
|
|
G |
Epha5 |
EPH receptor A5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EPHA5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:23,653,393...24,020,129
Ensembl chr14:23,653,393...24,017,317
|
|
G |
Epha6 |
Eph receptor A6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EPHA6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:39,757,501...40,708,901
Ensembl chr11:39,757,181...40,698,311
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of EPHX1 mRNA |
CTD |
PMID:12706301 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of EPHX2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Epo |
erythropoietin |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of EPO mRNA |
CTD |
PMID:36314267 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Eppin |
epididymal peptidase inhibitor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EPPIN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:153,312,396...153,319,310
Ensembl chr 3:153,312,396...153,319,310
|
|
G |
Eppk1 |
epiplakin 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of EPPK1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 7:107,816,919...107,842,946
Ensembl chr 7:107,817,693...107,831,159
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ERBB3 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ERBB3 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ERBB4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Erich5 |
glutamate-rich 5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ERICH5 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 7:65,655,829...65,682,221
Ensembl chr 7:65,657,204...65,680,207
|
|
G |
Erich6b |
glutamate-rich 6B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ERICH6B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:50,979,066...51,014,394
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
increases expression multiple interactions increases phosphorylation |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ERN1 protein; mono-(2-ethylhexyl)phthalate results in increased expression of ERN1 protein modified form 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of ERN1 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of ERN1 protein] |
CTD |
PMID:36005737 PMID:37692514 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Ern2 |
endoplasmic reticulum to nucleus signaling 2 |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate promotes the reaction [INS protein results in increased phosphorylation of ERN2 protein] |
CTD |
PMID:31009676 |
|
NCBI chr 1:176,726,454...176,743,289
Ensembl chr 1:176,726,454...176,743,289
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
multiple interactions increases expression |
ISO |
7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ERO1A protein] |
CTD |
PMID:37979351 |
|
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
|
|
G |
Ervfrd-1 |
endogenous retrovirus group FRD member 1, envelope |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SYNA mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:22,151,211...22,158,264
Ensembl chr12:22,151,211...22,158,264
|
|
G |
Esm1 |
endothelial cell-specific molecule 1 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ESM1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ESM1 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
|
|
G |
Espn |
espin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ESPN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:162,626,560...162,660,439
Ensembl chr 5:162,626,560...162,660,256
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions increases expression affects expression |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of ESR1 mRNA; mono-(2-ethylhexyl)phthalate binds to and results in increased activity of ESR1 protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of ESR1 mRNA; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of ESR1 mRNA]; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of MMP2 mRNA]; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of MMP9 mRNA]; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of TIMP2 mRNA]; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA]; mono-(2-ethylhexyl)phthalate binds to and results in increased activity of ESR1 protein mono-(2-ethylhexyl)phthalate results in increased expression of ESR1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of ESR1 protein |
CTD |
PMID:20209442 PMID:31884101 PMID:33049310 PMID:33631300 PMID:35861251 PMID:38042133 More...
|
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of ESR2 mRNA mono-(2-ethylhexyl)phthalate binds to and results in increased activity of ESR2 protein |
CTD |
PMID:31884101 PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Esx1 |
ESX homeobox 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ESX1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:100,449,298...100,454,452
|
|
G |
Esyt3 |
extended synaptotagmin 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ESYT3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:99,870,418...99,917,298
Ensembl chr 8:99,871,149...99,917,232
|
|
G |
Etv4 |
ETS variant transcription factor 4 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ETV4 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ETV4 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr10:86,706,749...86,721,974
Ensembl chr10:86,706,749...86,721,974
|
|
G |
Etv5 |
ETS variant transcription factor 5 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ETV5 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr11:78,608,618...78,666,221
Ensembl chr11:78,608,710...78,666,215
|
|
G |
F10 |
coagulation factor X |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of F10 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
|
|
G |
F2rl1 |
F2R like trypsin receptor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of F2RL1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
|
|
G |
F3 |
coagulation factor III, tissue factor |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of F3 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of FABP3 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of FABP3 protein |
CTD |
PMID:12706301 PMID:15647598 |
|
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate analog results in increased expression of FABP4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of FABP4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of FABP4 protein T 0070907 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FABP4 mRNA] |
CTD |
PMID:25543134 PMID:25777084 PMID:27384973 PMID:35421560 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fads6 |
fatty acid desaturase 6 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FADS6 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:100,522,981...100,538,181
Ensembl chr10:100,522,981...100,538,181
|
|
G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FAIM2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
|
|
G |
Fam107a |
family with sequence similarity 107, member A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FAM107A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:16,608,362...16,630,398
Ensembl chr15:16,607,205...16,630,396
|
|
G |
Fam180a |
family with sequence similarity 180, member A |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of FAM180A [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FAM180A mRNA |
CTD |
PMID:36189433 PMID:36314267 |
|
NCBI chr 4:63,992,867...64,008,047
Ensembl chr 4:63,992,867...64,008,047
|
|
G |
Fam181b |
family with sequence similarity 181, member B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FAM181B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:147,166,428...147,167,925
Ensembl chr 1:147,124,740...147,168,298 Ensembl chr 1:147,124,740...147,168,298
|
|
G |
Fam43b |
family with sequence similarity 43, member B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FAM43B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:150,610,656...150,613,054
Ensembl chr 5:150,611,609...150,612,601
|
|
G |
Fam78a |
family with sequence similarity 78, member A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FAM78A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:15,355,958...15,376,330
Ensembl chr 3:15,355,955...15,373,812
|
|
G |
Fam81a |
family with sequence similarity 81, member A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FAM81A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:70,762,852...70,821,898
Ensembl chr 8:70,763,614...70,821,875
|
|
G |
Fam81b |
family with sequence similarity 81, member B |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FAM81B mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FAM81B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:5,750,678...5,870,580
Ensembl chr 2:5,771,240...5,879,440
|
|
G |
Fap |
fibroblast activation protein, alpha |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FAP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:47,138,823...47,207,671
Ensembl chr 3:47,138,813...47,225,545
|
|
G |
Far1 |
fatty acyl CoA reductase 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FAR1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:167,644,622...167,705,868
Ensembl chr 1:167,644,677...167,705,730
|
|
G |
Faslg |
Fas ligand |
affects response to substance multiple interactions |
ISO |
FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate [FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate] which affects the expression of CFLAR protein |
CTD |
PMID:20100735 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fasn |
fatty acid synthase |
increases expression decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of FASN mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of FASN mRNA [Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of FASN mRNA mono-(2-ethylhexyl)phthalate results in increased expression of FASN protein |
CTD |
PMID:23118965 PMID:25543134 PMID:27181934 PMID:27384973 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
decreases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of FAT1 mRNA |
CTD |
PMID:22087261 |
|
NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
|
|
G |
Fbln2 |
fibulin 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FBLN2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:123,704,289...123,763,857
Ensembl chr 4:123,704,373...123,763,948
|
|
G |
Fbxl22 |
F-box and leucine-rich repeat protein 22 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FBXL22 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:67,069,998...67,076,685
Ensembl chr 8:67,069,998...67,076,685
|
|
G |
Fbxo15 |
F-box protein 15 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FBXO15 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
|
|
G |
Fbxo32 |
F-box protein 32 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FBXO32 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Fbxo41 |
F-box protein 41 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FBXO41 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:118,007,517...118,039,547
Ensembl chr 4:118,010,978...118,039,406
|
|
G |
Fcgbp |
Fc gamma binding protein |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of FCGBP mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:83,374,979...83,413,082
Ensembl chr 1:83,372,127...83,413,083
|
|
G |
Fdps |
farnesyl diphosphate synthase |
decreases expression |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of FDPS mRNA |
CTD |
PMID:22087261 PMID:22401849 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fdx1 |
ferredoxin 1 |
decreases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of FDX1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FDX1 mRNA |
CTD |
PMID:22087261 PMID:22401849 PMID:36189433 |
|
NCBI chr 8:52,268,536...52,287,344
Ensembl chr 8:52,268,536...52,287,414
|
|
G |
Fdxr |
ferredoxin reductase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FDXR mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
|
|
G |
Fendrr |
FOXF1 adjacent non-coding developmental regulatory RNA |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FENDRR mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:49,127,225...49,152,780
Ensembl chr19:49,121,214...49,153,240
|
|
G |
Fer1l4 |
fer-1-like family member 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FER1L4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:144,536,099...144,571,634
Ensembl chr 3:144,536,099...144,571,634
|
|
G |
Fer1l5 |
fer-1-like family member 5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FER1L5 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:38,605,835...38,661,869
Ensembl chr 9:38,607,843...38,660,425
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FGF1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgf12 |
fibroblast growth factor 12 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FGF12 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:71,997,151...72,564,757
Ensembl chr11:71,997,099...72,562,607
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FGF18 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
increases expression multiple interactions increases secretion |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of FGF21 mRNA alpha-cyano-4-hydroxycinnamate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FGF21 mRNA]; PPARA gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FGF21 mRNA]; PPARA inhibits the reaction [PPARA gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FGF21 mRNA]] mono-(2-ethylhexyl)phthalate results in increased secretion of FGF21 protein |
CTD |
PMID:20123618 PMID:31009676 PMID:32522588 PMID:37692514 |
|
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fgf8 |
fibroblast growth factor 8 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FGF8 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FGF8 mRNA |
CTD |
PMID:31711903 PMID:36189433 |
|
NCBI chr 1:244,584,477...244,590,578
Ensembl chr 1:244,584,652...244,590,359
|
|
G |
Fgf9 |
fibroblast growth factor 9 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FGF9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of FGFR3 mRNA |
CTD |
PMID:31009676 |
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of FGFR4 mRNA |
CTD |
PMID:31009676 |
|
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fhod3 |
formin homology 2 domain containing 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FHOD3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:15,993,079...16,425,796
Ensembl chr18:15,993,324...16,425,796
|
|
G |
Fibin |
fin bud initiation factor homolog |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of FIBIN mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FIBIN mRNA |
CTD |
PMID:16809437 PMID:36189433 |
|
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
|
|
G |
Figla |
folliculogenesis specific bHLH transcription factor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FIGLA mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:118,432,517...118,436,846
Ensembl chr 4:118,432,765...118,436,690
|
|
G |
Filip1 |
filamin A interacting protein 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FILIP1 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 8:80,761,283...80,956,556
Ensembl chr 8:80,764,604...80,922,549
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FKBP1A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FKBP5 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Flg |
filaggrin |
multiple interactions |
ISO |
[FLG gene polymorphism affects the susceptibility to Diethylhexyl Phthalate] which affects the abundance of mono-(2-ethylhexyl)phthalate |
CTD |
PMID:24380925 |
|
NCBI chr 2:178,884,793...178,912,986
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of FLT1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Flt3 |
Fms related receptor tyrosine kinase 3 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FLT3 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FLT3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
|
|
G |
Flvcr2 |
FLVCR choline and putative heme transporter 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FLVCR2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:105,408,355...105,472,355
Ensembl chr 6:105,408,339...105,472,353
|
|
G |
Fmn1 |
formin 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FMN1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:100,101,103...100,485,652
Ensembl chr 3:100,134,549...100,479,220
|
|
G |
Fmnl3 |
formin-like 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FMNL3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:130,454,270...130,505,626
Ensembl chr 7:130,454,275...130,505,626
|
|
G |
Fmo2 |
flavin containing dimethylaniline monoxygenase 2 |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of FMO2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FMO2 mRNA |
CTD |
PMID:16809437 PMID:36189433 |
|
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of FMO3 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
|
|
G |
Fmr1nb |
FMR1 neighbor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FMR1NB mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:147,309,613...147,332,426
Ensembl chr X:147,309,663...147,332,418
|
|
G |
Fn1 |
fibronectin 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of FN1 mRNA |
CTD |
PMID:37364752 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fnbp1 |
formin binding protein 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FNBP1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:14,309,067...14,424,378
Ensembl chr 3:14,309,640...14,424,881
|
|
G |
Fndc1 |
fibronectin type III domain containing 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FNDC1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:47,281,839...47,364,247
Ensembl chr 1:47,281,844...47,364,259
|
|
G |
Folr1 |
folate receptor alpha |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of FOLR1 mRNA |
CTD |
PMID:27167697 |
|
NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of FOS mRNA mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased expression of FOS mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased expression of FOS protein] |
CTD |
PMID:8764118 PMID:16809437 PMID:22564763 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FOSB mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Foxa1 |
forkhead box A1 |
affects expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of FOXA1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FOXA1 mRNA |
CTD |
PMID:21195148 PMID:36189433 |
|
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Foxd3 |
forkhead box D3 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FOXD3 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of FOXD3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:114,335,084...114,337,450
Ensembl chr 5:114,335,408...114,336,817
|
|
G |
Foxd4 |
forkhead box D4 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of FOXD4 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 1:222,557,494...222,559,189
Ensembl chr 1:222,557,360...222,559,159
|
|
G |
Foxf1 |
forkhead box F1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FOXF1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:49,153,949...49,157,741
Ensembl chr19:49,153,699...49,157,738
|
|
G |
Foxh1 |
forkhead box H1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FOXH1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:108,387,969...108,391,566
Ensembl chr 7:108,387,969...108,390,049
|
|
G |
Foxj1 |
forkhead box J1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of FOXJ1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr10:101,566,299...101,570,370
Ensembl chr10:101,566,304...101,570,237
|
|
G |
Foxl2 |
forkhead box L2 |
multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [Tretinoin results in increased expression of FOXL2 mRNA] [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FOXL2 mRNA; mono-(2-ethylhexyl)phthalate promotes the reaction [Tretinoin results in increased expression of FOXL2 protein] |
CTD |
PMID:30476341 PMID:36189433 |
|
NCBI chr 8:99,512,971...99,514,500
Ensembl chr 8:99,513,303...99,514,427
|
|
G |
Foxo1 |
forkhead box O1 |
decreases phosphorylation decreases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of FOXO1 protein mono-(2-ethylhexyl)phthalate results in decreased expression of FOXO1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of FOXO1 mRNA Genistein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of FOXO1 mRNA] |
CTD |
PMID:31228551 PMID:34942354 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Foxo6 |
forkhead box O6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FOXO6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:133,856,087...133,876,387
Ensembl chr 5:133,856,072...133,876,573
|
|
G |
Foxr1 |
forkhead box R1 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FOXR1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FOXR1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:44,760,587...44,768,696
Ensembl chr 8:44,760,948...44,768,880
|
|
G |
Foxs1 |
forkhead box S1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FOXS1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:141,397,012...141,398,296
Ensembl chr 3:141,397,016...141,398,281
|
|
G |
Frem2 |
FRAS1 related extracellular matrix 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FREM2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:137,602,784...137,740,785
Ensembl chr 2:137,602,784...137,740,785
|
|
G |
Frem3 |
FRAS1 related extracellular matrix 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FREM3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:27,308,469...27,366,771
Ensembl chr19:27,308,469...27,366,771
|
|
G |
Frmd3 |
FERM domain containing 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of FRMD3 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 5:87,764,755...88,031,091
Ensembl chr 5:87,764,604...88,031,091
|
|
G |
Frmd5 |
FERM domain containing 5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FRMD5 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:108,492,099...108,763,715
Ensembl chr 3:108,474,562...108,763,498
|
|
G |
Frmpd4 |
FERM and PDZ domain containing 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FRMPD4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:25,853,849...26,814,642
Ensembl chr X:25,853,934...26,814,637
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions increases expression decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [FSHB protein results in increased abundance of Estradiol] mono-(2-ethylhexyl)phthalate results in increased expression of FSHB protein mono-(2-ethylhexyl)phthalate results in decreased expression of FSHB mRNA |
CTD |
PMID:19501113 PMID:22401849 PMID:34954075 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fshr |
follicle stimulating hormone receptor |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FSHR mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of FSHR mRNA |
CTD |
PMID:22401849 PMID:31884101 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
Fstl3 |
follistatin like 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FSTL3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:9,923,574...9,929,223
Ensembl chr 7:9,923,576...9,939,639
|
|
G |
Fth1 |
ferritin heavy chain 1 |
multiple interactions increases expression |
ISO |
ferrostatin-1 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FTH1 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FTH1 protein] mono-(2-ethylhexyl)phthalate results in increased expression of FTH1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of FTH1 protein |
CTD |
PMID:34863575 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fthl17a |
ferritin, heavy polypeptide-like 17, member A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FTHL17 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:49,595,422...49,596,399
Ensembl chr X:49,595,718...49,596,266
|
|
G |
Ftmt |
ferritin mitochondrial |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FTMT mRNA |
CTD |
PMID:38113427 |
|
NCBI chr18:45,758,874...45,760,123
Ensembl chr18:45,758,874...45,760,123
|
|
G |
Fto |
FTO, alpha-ketoglutarate dependent dioxygenase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FTO mRNA |
CTD |
PMID:36174712 |
|
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
|
|
G |
Fut9 |
fucosyltransferase 9 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FUT9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:39,351,815...39,565,256
Ensembl chr 5:39,351,819...39,565,130
|
|
G |
Fzd7 |
frizzled class receptor 7 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FZD7 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of G6PC1 protein |
CTD |
PMID:31228551 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gab1 |
GRB2-associated binding protein 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GAB1 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr19:27,131,262...27,239,236
Ensembl chr19:27,131,262...27,239,236
|
|
G |
Gabbr2 |
gamma-aminobutyric acid type B receptor subunit 2 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of GABBR2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GABBR2 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
|
|
G |
Gabrb2 |
gamma-aminobutyric acid type A receptor subunit beta 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GABRB2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:26,936,592...27,156,141
Ensembl chr10:26,936,551...27,151,251
|
|
G |
Gabrg3 |
gamma-aminobutyric acid type A receptor subunit gamma 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GABRG3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:107,627,450...108,247,483
Ensembl chr 1:107,627,390...108,246,763
|
|
G |
Gabrq |
gamma-aminobutyric acid type A receptor subunit theta |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GABRQ mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:150,696,161...150,712,948
Ensembl chr X:150,696,427...150,709,919
|
|
G |
Gal |
galanin and GMAP prepropeptide |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GAL mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GALNT13 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:38,903,695...39,560,683
Ensembl chr 3:38,974,490...39,558,803
|
|
G |
Galnt14 |
polypeptide N-acetylgalactosaminyltransferase 14 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GALNT14 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:21,756,039...21,977,533
Ensembl chr 6:21,755,195...21,972,192
|
|
G |
Galnt7 |
polypeptide N-acetylgalactosaminyltransferase 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GALNT7 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr16:32,578,643...32,703,189
Ensembl chr16:32,578,690...32,702,690
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GAMT mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of GAPDH protein |
CTD |
PMID:25543134 PMID:27384973 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Garin5a |
golgi associated RAB2 interactor 5A |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of FAM71E1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 1:94,988,959...94,995,971
Ensembl chr 1:94,988,613...94,993,539
|
|
G |
Gask1a |
golgi associated kinase 1A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FAM198A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:121,610,779...121,643,742
Ensembl chr 8:121,610,787...121,642,942
|
|
G |
Gask1b |
golgi associated kinase 1B |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GASK1B mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477
|
|
G |
Gata6 |
GATA binding protein 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GATA6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
|
|
G |
Gbp2 |
guanylate binding protein 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GBP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
|
|
G |
Gbx1 |
gastrulation brain homeobox 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GBX1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:10,645,957...10,672,486
Ensembl chr 4:10,645,957...10,672,486
|
|
G |
Gcgr |
glucagon receptor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GCGR mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:105,808,474...105,816,641
Ensembl chr10:105,808,473...105,816,640
|
|
G |
Gck |
glucokinase |
decreases expression affects expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GCK protein mono-(2-ethylhexyl)phthalate affects the expression of GCK protein |
CTD |
PMID:31228551 PMID:38048874 |
|
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of GCLC mRNA |
CTD |
PMID:34863575 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of GCLM mRNA |
CTD |
PMID:34863575 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of GDF15 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased expression of FOS mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased expression of FOS protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased phosphorylation of MAPK1 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:22564763 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gdpd4 |
glycerophosphodiester phosphodiesterase domain containing 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of GDPD4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:152,233,516...152,342,329
Ensembl chr 1:152,233,499...152,342,158
|
|
G |
Gfra2 |
GDNF family receptor alpha 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GFRA2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:45,941,841...46,033,715
Ensembl chr15:45,941,828...46,033,714
|
|
G |
Gfra4 |
GDNF family receptor alpha 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GFRA4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:118,254,937...118,262,252
Ensembl chr 3:118,255,402...118,258,329
|
|
G |
Gga2 |
golgi associated, gamma adaptin ear containing, ARF binding protein 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of GGA2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:176,552,046...176,585,332
Ensembl chr 1:176,552,046...176,585,361
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GGH mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
decreases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of GJA1 mRNA [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GJA1 protein] |
CTD |
PMID:22321834 PMID:29940330 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gja4 |
gap junction protein, alpha 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GJA4 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GJB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gjb3 |
gap junction protein, beta 3 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GJB3 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of GJB3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:139,649,227...139,654,970
Ensembl chr 5:139,649,195...139,654,980
|
|
G |
Gjb4 |
gap junction protein, beta 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GJB4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:139,675,776...139,679,551
Ensembl chr 5:139,675,780...139,679,667
|
|
G |
Gldn |
gliomedin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GLDN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:54,679,015...54,723,198
Ensembl chr 8:54,679,119...54,723,196
|
|
G |
Gli3 |
GLI family zinc finger 3 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of GLI3 mRNA |
CTD |
PMID:26710974 |
|
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
|
|
G |
Glipr2 |
GLI pathogenesis-related 2 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of GLIPR2 mRNA |
CTD |
PMID:38113427 |
|
NCBI chr 5:58,170,417...58,202,258
Ensembl chr 5:58,170,425...58,202,272
|
|
G |
Glrx2 |
glutaredoxin 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of GLRX2 mRNA |
CTD |
PMID:23360888 |
|
NCBI chr13:55,481,875...55,504,737
Ensembl chr13:55,482,694...55,492,831
|
|
G |
Glt1d1 |
glycosyltransferase 1 domain containing 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GLT1D1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:28,975,984...29,049,707
Ensembl chr12:28,975,988...29,049,695
|
|
G |
Glyatl3 |
glycine-N-acyltransferase-like 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GLYATL3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:19,977,493...19,995,723
Ensembl chr 9:19,977,302...19,995,650
|
|
G |
Gm2a |
ganglioside GM2 activator |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GM2A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:39,219,221...39,231,756
Ensembl chr10:39,219,243...39,231,757
|
|
G |
Gnas |
GNAS complex locus |
multiple interactions |
EXP |
[PTGS2 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of GNAS protein |
CTD |
PMID:36889213 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gnb3 |
G protein subunit beta 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GNB3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:157,639,468...157,645,171
Ensembl chr 4:157,639,469...157,645,173
|
|
G |
Gng4 |
G protein subunit gamma 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GNG4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:86,448,708...86,497,560
Ensembl chr17:86,449,022...86,495,254
|
|
G |
Gng7 |
G protein subunit gamma 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GNG7 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 7:8,697,458...8,761,239
Ensembl chr 7:8,697,521...8,761,240
|
|
G |
Gnmt |
glycine N-methyltransferase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GNMT mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gnrhr |
gonadotropin releasing hormone receptor |
increases expression decreases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of GNRHR mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of GNRHR mRNA |
CTD |
PMID:16809437 PMID:34954075 |
|
NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of GOT1 protein |
CTD |
PMID:35143864 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
decreases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of GOT2 mRNA |
CTD |
PMID:22087261 |
|
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Gpat2 |
glycerol-3-phosphate acyltransferase 2, mitochondrial |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GPAT2 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 3:114,646,446...114,657,051
Ensembl chr 3:114,648,498...114,657,051
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of GPD1 protein |
CTD |
PMID:27384973 |
|
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
|
|
G |
Gper1 |
G protein-coupled estrogen receptor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GPER1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
|
|
G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GPLD1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr17:40,084,427...40,132,035
Ensembl chr17:40,084,617...40,126,939
|
|
G |
Gpr141 |
G protein-coupled receptor 141 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GPR141 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr17:45,117,818...45,180,053
Ensembl chr17:45,117,812...45,180,027
|
|
G |
Gpr157 |
G protein-coupled receptor 157 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GPR157 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:160,550,703...160,566,432
Ensembl chr 5:160,550,713...160,566,432
|
|
G |
Gpr20 |
G protein-coupled receptor 20 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GPR20 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:105,601,761...105,611,959
Ensembl chr 7:105,602,368...105,603,430
|
|
G |
Gpr55 |
G protein-coupled receptor 55 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GPR55 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:86,584,906...86,640,601
Ensembl chr 9:86,590,885...86,640,613
|
|
G |
Gpr88 |
G-protein coupled receptor 88 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GPR88 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:204,191,443...204,199,576
Ensembl chr 2:204,191,427...204,199,733
|
|
G |
Gprc5a |
G protein-coupled receptor, class C, group 5, member A |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GPRC5A mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GPRC5A mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of GPT protein |
CTD |
PMID:35143864 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GPT2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases activity multiple interactions decreases expression |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased activity of GPX1 protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of GPX1 mRNA; Selenomethionine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased activity of GPX1 protein]; Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased activity of GPX1 protein] mono-(2-ethylhexyl)phthalate results in decreased expression of GPX1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of GPX1 protein zinc protoporphyrin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GPX1 protein] |
CTD |
PMID:20659492 PMID:22087261 PMID:31884101 PMID:35143864 PMID:36696656 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GPX3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions decreases expression |
ISO |
ferrostatin-1 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 protein] mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 protein RSL3 compound promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 protein]; zinc protoporphyrin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 protein] |
CTD |
PMID:34863575 PMID:36438553 PMID:36696656 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Grem1 |
gremlin 1, DAN family BMP antagonist |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GREM1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of GREM1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:100,512,313...100,524,082
|
|
G |
Grem2 |
gremlin 2, DAN family BMP antagonist |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GREM2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:86,778,543...86,871,509
Ensembl chr13:86,778,500...86,871,615
|
|
G |
Gria3 |
glutamate ionotropic receptor AMPA type subunit 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GRIA3 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
|
|
G |
Grid2 |
glutamate ionotropic receptor delta type subunit 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GRID2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:92,415,019...93,892,472
Ensembl chr 4:92,415,230...93,889,355
|
|
G |
Grik3 |
glutamate ionotropic receptor kainate type subunit 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GRIK3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:137,767,865...137,989,617
Ensembl chr 5:137,767,865...137,984,307
|
|
G |
Grik4 |
glutamate ionotropic receptor kainate type subunit 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GRIK4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:42,903,043...43,331,990
Ensembl chr 8:42,905,056...43,193,751
|
|
G |
Grin2c |
glutamate ionotropic receptor NMDA type subunit 2C |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GRIN2C mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of GRIN2C mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
|
|
G |
Grin3b |
glutamate ionotropic receptor NMDA type subunit 3B |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GRIN3B mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:9,730,861...9,737,183
Ensembl chr 7:9,730,862...9,737,183
|
|
G |
Grm7 |
glutamate metabotropic receptor 7 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GRM7 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GRM7 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:143,730,862...144,613,230
Ensembl chr 4:143,731,259...144,612,344
|
|
G |
Gsdme |
gasdermin E |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GSDME mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions decreases phosphorylation |
EXP ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of GSK3B protein] [mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of GSK3B protein; RBP4 protein promotes the reaction [[mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of GSK3B protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of GSK3B protein] |
CTD |
PMID:28526321 PMID:31228551 PMID:37364752 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of GSR mRNA |
CTD |
PMID:31884101 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
decreases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of GSTA4 mRNA |
CTD |
PMID:22087261 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of GSTM1 protein |
CTD |
PMID:27384973 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of GSTM2 mRNA |
CTD |
PMID:38113427 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gtf2a1l |
general transcription factor 2A subunit 1 like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GTF2A1L mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:5,752,814...5,834,797
Ensembl chr 6:5,752,823...5,836,472
|
|
G |
Gulp1 |
GULP PTB domain containing engulfment adaptor 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of GULP1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
|
|
G |
Gys1 |
glycogen synthase 1 |
increases phosphorylation |
ISO |
mono-(2-ethylhexyl)phthalate results in increased phosphorylation of GYS1 protein |
CTD |
PMID:31228551 |
|
NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292
|
|
G |
Gzma |
granzyme A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of GZMA mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation |
ISO |
mono-(2-ethylhexyl)phthalate results in increased phosphorylation of H2AX protein |
CTD |
PMID:36174712 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hace1 |
HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HACE1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr20:49,035,312...49,151,103
Ensembl chr20:49,035,648...49,151,103
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HADHA mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hal |
histidine ammonia lyase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HAL mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HAO2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
|
|
G |
Hap1 |
huntingtin-associated protein 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HAP1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:85,277,890...85,286,126
Ensembl chr10:85,277,890...85,286,126
|
|
G |
Has2 |
hyaluronan synthase 2 |
affects expression decreases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate affects the expression of HAS2 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of HAS2 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of HAS2 protein PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of HAS2 mRNA] [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HAS2 mRNA |
CTD |
PMID:21195148 PMID:36189433 PMID:36889213 |
|
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
|
|
G |
Hccs |
holocytochrome c synthase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HCCS mRNA |
CTD |
PMID:22401849 |
|
NCBI chr X:24,932,943...24,942,376
Ensembl chr X:24,933,002...24,942,366
|
|
G |
Hcrtr1 |
hypocretin receptor 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HCRTR1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:142,477,214...142,486,674
Ensembl chr 5:142,477,214...142,486,674
|
|
G |
Hdac6 |
histone deacetylase 6 |
multiple interactions |
ISO |
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of HDAC6 protein; [mono-(2-ethylhexyl)phthalate co-treated with bisphenol A] inhibits the reaction [HDAC6 protein affects the phosphorylation of MAPK1 protein]; [mono-(2-ethylhexyl)phthalate co-treated with bisphenol A] inhibits the reaction [HDAC6 protein affects the phosphorylation of MAPK3 protein]; HDAC6 protein affects the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of PTEN protein]; HDAC6 protein affects the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of MYC protein]; HDAC6 protein affects the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of AKT1 protein]; tubastatin A inhibits the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of HDAC6 protein] |
CTD |
PMID:34910997 |
|
NCBI chr X:14,550,645...14,572,445
Ensembl chr X:14,551,044...14,572,441
|
|
G |
Hdac9 |
histone deacetylase 9 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HDAC9 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 6:50,762,074...51,624,311
Ensembl chr 6:50,763,590...51,625,333
|
|
G |
Hecw1 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HECW1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:50,671,239...51,084,536
Ensembl chr17:50,670,954...51,080,720
|
|
G |
Hecw2 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HECW2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:55,359,462...55,753,106
Ensembl chr 9:55,365,203...55,580,327
|
|
G |
Hepacam |
hepatic and glial cell adhesion molecule |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HEPACAM mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HEPACAM mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:37,087,864...37,106,759
Ensembl chr 8:37,087,857...37,105,920
|
|
G |
Hephl1 |
hephaestin-like 1 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HEPHL1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HEPHL1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:11,896,768...11,965,282
Ensembl chr 8:11,898,532...11,965,267
|
|
G |
Hes5 |
hes family bHLH transcription factor 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HES5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:165,522,138...165,523,684
Ensembl chr 5:165,522,234...165,523,001
|
|
G |
Hgfac |
HGF activator |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HGFAC mRNA |
CTD |
PMID:36695872 |
|
NCBI chr14:75,707,588...75,714,182
Ensembl chr14:75,707,591...75,714,278
|
|
G |
Hhatl |
hedgehog acyltransferase-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HHATL mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:121,447,001...121,454,070
Ensembl chr 8:121,447,002...121,454,001
|
|
G |
Hhip |
Hedgehog-interacting protein |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HHIP mRNA |
CTD |
PMID:36695872 |
|
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
|
|
G |
Hhipl2 |
HHIP like 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HHIPL2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr13:95,054,685...95,074,609
Ensembl chr13:95,054,694...95,074,608
|
|
G |
Hic1 |
HIC ZBTB transcriptional repressor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HIC1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:60,014,520...60,019,475
Ensembl chr10:60,011,528...60,019,475
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression decreases response to substance multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HIF1A mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of HIF1A protein HIF1A gene mutant form results in decreased susceptibility to mono-(2-ethylhexyl)phthalate HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ACSL4 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FTH1 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [HIF1A protein binds to HMOX1 promoter]; mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased stability of and affects the localization of HIF1A protein |
CTD |
PMID:34627990 PMID:34863575 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hivep1 |
HIVEP zinc finger 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HIVEP1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:22,585,016...22,714,517
Ensembl chr17:22,585,016...22,711,956
|
|
G |
Hkdc1 |
hexokinase domain containing 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HKDC1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:30,335,322...30,373,792
Ensembl chr20:30,335,628...30,373,867
|
|
G |
Hmbox1 |
homeobox containing 1 |
multiple interactions |
ISO |
METTL3 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased methylation of HMBOX1 protein]; mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased methylation of HMBOX1 protein |
CTD |
PMID:36174712 |
|
NCBI chr15:39,067,805...39,200,633
Ensembl chr15:39,067,804...39,200,323
|
|
G |
Hmcn1 |
hemicentin 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HMCN1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr13:62,615,461...63,084,524
Ensembl chr13:62,615,461...63,084,524
|
|
G |
Hmcn2 |
hemicentin 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HMCN2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:14,588,353...14,738,320
Ensembl chr 3:14,588,662...14,738,025
|
|
G |
Hmga2 |
high mobility group AT-hook 2 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HMGA2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HMGA2 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HMGCR mRNA [Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of HMGCR mRNA |
CTD |
PMID:23118965 PMID:27181934 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
decreases expression increases expression |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of HMGCS1 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of HMGCS1 mRNA |
CTD |
PMID:22087261 PMID:22401849 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HMGCS2 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of HMGCS2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 protein Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 protein]; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 protein]; ferrostatin-1 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [HIF1A protein binds to HMOX1 promoter] zinc protoporphyrin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 protein] |
CTD |
PMID:34863575 PMID:36696656 PMID:37286014 PMID:37692514 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Homer3 |
homer scaffold protein 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HOMER3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr16:19,132,177...19,142,739
Ensembl chr16:19,132,162...19,142,680
|
|
G |
Hormad1 |
HORMA domain containing 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HORMAD1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:183,115,815...183,152,383
Ensembl chr 2:183,116,716...183,152,383
|
|
G |
Hotairm1 |
Hoxa transcript antisense RNA, myeloid-specific 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOTAIRM1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:81,258,793...81,262,291
|
|
G |
Hoxa1 |
homeobox A1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:81,255,814...81,258,587
Ensembl chr 4:81,255,883...81,258,504
|
|
G |
Hoxa13 |
homeo box A13 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HOXA13 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 4:81,358,956...81,361,091
Ensembl chr 4:81,358,956...81,361,091
|
|
G |
Hoxa2 |
homeobox A2 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HOXA2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA2 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 4:81,262,668...81,266,970
Ensembl chr 4:81,262,768...81,265,044
|
|
G |
Hoxa3 |
homeobox A3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:81,269,243...81,313,218
Ensembl chr 4:81,269,243...81,313,218
|
|
G |
Hoxa4 |
homeo box A4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:81,289,677...81,291,685
Ensembl chr 4:81,289,682...81,291,685
|
|
G |
Hoxa5 |
homeo box A5 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HOXA5 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA5 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 4:81,302,341...81,306,234
Ensembl chr 4:81,302,353...81,306,234
|
|
G |
Hoxa6 |
homeobox A6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:81,304,918...81,313,184
Ensembl chr 4:81,306,407...81,308,850
|
|
G |
Hoxb1 |
homeo box B1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:81,331,507...81,332,928
Ensembl chr10:81,331,507...81,332,836
|
|
G |
Hoxb3 |
homeo box B3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXB3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:81,258,739...81,314,134
Ensembl chr10:81,299,357...81,313,107
|
|
G |
Hoxb4 |
homeo box B4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXB4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:81,284,552...81,287,134
Ensembl chr10:81,284,552...81,287,128
|
|
G |
Hoxb5 |
homeo box B5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXB5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:81,269,372...81,271,580
Ensembl chr10:81,269,372...81,271,580
|
|
G |
Hoxb7 |
homeo box B7 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HOXB7 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr10:81,252,616...81,256,034
Ensembl chr10:81,252,553...81,256,034
|
|
G |
Hoxb9 |
homeo box B9 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HOXB9 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr10:81,237,312...81,240,818
Ensembl chr10:81,237,312...81,240,818
|
|
G |
Hoxc5 |
homeo box C5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HOXC5 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 7:134,150,988...134,154,410
Ensembl chr 7:134,150,988...134,154,410
|
|
G |
Hpca |
hippocalcin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HPCA mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:141,455,616...141,466,252
Ensembl chr 5:141,455,613...141,463,841
|
|
G |
Hpx |
hemopexin |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of HPX mRNA |
CTD |
PMID:38113427 |
|
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
|
|
G |
Hrct1 |
histidine rich carboxyl terminus 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HRCT1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 5:57,982,344...57,983,186
Ensembl chr 5:57,982,470...57,982,790
|
|
G |
Hrh1 |
histamine receptor H 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HRH1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:147,564,963...147,649,353
Ensembl chr 4:147,645,995...147,647,455
|
|
G |
Hrk |
harakiri, BCL2 interacting protein |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HRK mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:38,387,484...38,409,652
|
|
G |
Hs3st3a1 |
heparan sulfate-glucosamine 3-sulfotransferase 3A1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HS3ST3A1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr10:49,092,850...49,180,676
Ensembl chr10:49,094,026...49,180,676
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HSD11B1 mRNA |
CTD |
PMID:37886449 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
decreases activity affects expression decreases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased activity of HSD11B2 protein mono-(2-ethylhexyl)phthalate affects the expression of HSD11B2 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of HSD11B2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HSD11B2 mRNA |
CTD |
PMID:19786001 PMID:21195148 PMID:36189433 PMID:37886449 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HSD17B1 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of HSD17B1 mRNA |
CTD |
PMID:31884101 PMID:36189433 |
|
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HSD17B2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HSD17B3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of HSD17B4 mRNA |
CTD |
PMID:12706301 |
|
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HSDL2 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
decreases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of HSP90AA1 mRNA |
CTD |
PMID:22087261 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HSPA1B mRNA |
CTD |
PMID:24356939 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HSPA5 protein mono-(2-ethylhexyl)phthalate inhibits the reaction [4-phenylbutyric acid results in decreased expression of HSPA5 protein] mono-(2-ethylhexyl)phthalate results in increased expression of GRP78 protein 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of HSPA5 protein]; arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of GRP78 protein] |
CTD |
PMID:36005737 PMID:37979351 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Htr1b |
5-hydroxytryptamine receptor 1B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HTR1B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
|
|
G |
Htr6 |
5-hydroxytryptamine receptor 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HTR6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:151,295,269...151,312,853
Ensembl chr 5:151,296,662...151,311,912
|
|
G |
Htr7 |
5-hydroxytryptamine receptor 7 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of HTR7 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HTRA1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Hycc1 |
hyccin PI4KA lipid kinase complex subunit 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of HYCC1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:11,132,224...11,239,120
Ensembl chr 4:11,132,385...11,239,113
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ICAM1 protein |
CTD |
PMID:36113809 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ID1 mRNA |
CTD |
PMID:22321834 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of IDH1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Ier3 |
immediate early response 3 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of IER3 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifitm10 |
interferon induced transmembrane protein 10 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of IFITM10 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:197,507,501...197,524,180
Ensembl chr 1:197,507,503...197,525,151
|
|
G |
Ifng |
interferon gamma |
multiple interactions increases secretion |
ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CD163 mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CD36 mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MARCO mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; mono-(2-ethylhexyl)phthalate promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 mRNA]; mono-(2-ethylhexyl)phthalate promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] mono-(2-ethylhexyl)phthalate results in increased secretion of IFNG protein |
CTD |
PMID:29718165 PMID:37886449 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ifnl1 |
interferon, lambda 1 |
multiple interactions |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IFNL1 mRNA]; 5'-methylthioadenosine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IFNL1 mRNA]; anacardic acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IFNL1 mRNA]; GW 6471 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IFNL1 mRNA] |
CTD |
PMID:37611859 |
|
NCBI chr 1:83,798,651...83,800,297
Ensembl chr 1:83,798,703...83,800,235
|
|
G |
Ifnl3 |
interferon, lambda 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of IFNL3 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of IFNL3 protein |
CTD |
PMID:37611859 |
|
NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096
|
|
G |
Igf2bp1 |
insulin-like growth factor 2 mRNA binding protein 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of IGF2BP1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of IGFBP3 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of and results in increased methylation of IGFBP3 mRNA |
CTD |
PMID:36314267 PMID:36695872 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of IGFBP6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966
|
|
G |
Ighe |
immunoglobulin heavy constant epsilon |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of IGHE mRNA |
CTD |
PMID:36189433 |
|
|
|
G |
Iglon5 |
IgLON family member 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of IGLON5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:93,880,906...93,898,929
Ensembl chr 1:93,881,991...93,898,754
|
|
G |
Igsf10 |
immunoglobulin superfamily, member 10 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of IGSF10 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:143,575,710...143,605,044
Ensembl chr 2:143,576,070...143,604,773
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of IKBKG mRNA |
CTD |
PMID:22401849 |
|
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of IKZF1 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
|
|
G |
Il10 |
interleukin 10 |
increases expression multiple interactions decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of IL10 protein epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL10 protein] mono-(2-ethylhexyl)phthalate results in decreased expression of IL10 protein |
CTD |
PMID:37286014 PMID:37692514 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il16 |
interleukin 16 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of IL16 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il17rd |
interleukin 17 receptor D |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of IL17RD mRNA |
CTD |
PMID:22321834 |
|
NCBI chr16:2,228,438...2,295,122
Ensembl chr16:2,228,287...2,292,556
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of IL1A mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases secretion increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein]; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein] mono-(2-ethylhexyl)phthalate results in increased secretion of IL1B protein mono-(2-ethylhexyl)phthalate results in increased expression of IL1B mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein |
CTD |
PMID:29718165 PMID:31016965 PMID:37286014 PMID:37692514 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of IL1RAPL1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:51,371,969...52,876,726
Ensembl chr X:51,378,215...52,876,772
|
|
G |
Il2 |
interleukin 2 |
increases secretion |
ISO |
mono-(2-ethylhexyl)phthalate results in increased secretion of IL2 protein |
CTD |
PMID:37886449 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il22ra1 |
interleukin 22 receptor subunit alpha 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of IL22RA1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:147,961,496...147,986,296
Ensembl chr 5:147,961,349...147,986,296
|
|
G |
Il27ra |
interleukin 27 receptor subunit alpha |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of IL27RA mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of IL27RA mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938
|
|
G |
Il33 |
interleukin 33 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of IL33 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of IL33 mRNA 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL33 mRNA]]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL33 mRNA]; 5'-methylthioadenosine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL33 mRNA]; [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased secretion of IL33 protein; anacardic acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL33 mRNA]; Apigenin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL33 mRNA]; kaempferol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL33 mRNA]; mono-(2-ethylhexyl)phthalate promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL33 mRNA]; mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased secretion of IL33 protein |
CTD |
PMID:36189433 PMID:37545493 |
|
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Il34 |
interleukin 34 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of IL34 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:38,714,990...38,782,749
Ensembl chr19:38,714,991...38,764,000
|
|
G |
Il4i1 |
interleukin 4 induced 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of IL4I1 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 1:95,299,457...95,324,564
Ensembl chr 1:95,295,601...95,324,562
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of IL6 mRNA mono-(2-ethylhexyl)phthalate promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 mRNA] [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of IL6 mRNA |
CTD |
PMID:27384973 PMID:29718165 PMID:30398665 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il9r |
interleukin 9 receptor |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of IL9R mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of IL9R mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:15,431,706...15,444,144
Ensembl chr10:15,431,706...15,441,990
|
|
G |
Inha |
inhibin subunit alpha |
decreases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of INHA mRNA |
CTD |
PMID:22087261 |
|
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
|
|
G |
Inhbe |
inhibin subunit beta E |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of INHBE mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
|
|
G |
Inpp4b |
inositol polyphosphate-4-phosphatase type II B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of INPP4B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:25,920,189...26,670,085
Ensembl chr19:25,925,358...26,280,634
|
|
G |
Ins1 |
insulin 1 |
multiple interactions increases expression |
EXP ISO |
[INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of and results in decreased phosphorylation of INSR protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of IRS1 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of RAB13 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of RAB8A protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of SLC2A4 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of SRC protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of STX4 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of STXBP3 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of STXBP4 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of TBC1D4 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of SLC2A4 protein; mono-(2-ethylhexyl)phthalate affects the reaction [INS1 protein affects the expression of LNPEP protein]; mono-(2-ethylhexyl)phthalate affects the reaction [INS1 protein affects the expression of SNAP23 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased abundance of Glycogen]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased expression of ARRB2 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased expression of SLC2A4 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of GSK3B protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of IRS1 protein; Akt-I-1,2 compound inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; Cytochalasin B inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]; Wortmannin inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]] mono-(2-ethylhexyl)phthalate results in increased expression of INS1 mRNA |
CTD |
PMID:25543134 PMID:27384973 PMID:28526321 PMID:31009676 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
decreases activity multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein [mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of GSK3B protein; [mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of IRS1 protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased abundance of Glycogen]; RBP4 protein promotes the reaction [[mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of GSK3B protein]; RBP4 protein promotes the reaction [[mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of IRS1 protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased abundance of Glycogen]]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased expression of and results in increased phosphorylation of AKT1 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [INS protein results in increased phosphorylation of ERN2 protein] |
CTD |
PMID:31009676 PMID:31228551 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Insc |
INSC, spindle orientation adaptor protein |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of INSC mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:168,993,032...169,100,438
Ensembl chr 1:168,993,032...169,100,433
|
|
G |
Insl3 |
insulin-like 3 |
decreases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of INSL3 mRNA [Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of INSL3 mRNA |
CTD |
PMID:22087261 PMID:27181934 |
|
NCBI chr16:18,398,682...18,400,566
Ensembl chr16:18,384,829...18,400,560
|
|
G |
Insr |
insulin receptor |
multiple interactions |
EXP |
[INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of and results in decreased phosphorylation of INSR protein |
CTD |
PMID:28526321 |
|
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Insyn2b |
inhibitory synaptic factor family member 2B |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of INSYN2B mRNA |
CTD |
PMID:36695872 |
|
NCBI chr10:18,916,721...19,023,859
Ensembl chr10:19,003,131...19,022,139
|
|
G |
Iqch |
IQ motif containing H |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of IQCH mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:63,889,816...64,083,248
Ensembl chr 8:63,892,370...64,083,223
|
|
G |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of IQGAP2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:26,894,836...27,170,270
Ensembl chr 2:26,894,825...27,170,279
|
|
G |
Iqsec3 |
IQ motif and Sec7 domain ArfGEF 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of IQSEC3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:154,610,933...154,707,310
Ensembl chr 4:154,610,934...154,707,310
|
|
G |
Iqub |
IQ motif and ubiquitin domain containing |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of IQUB mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:52,931,768...52,993,795
Ensembl chr 4:52,931,767...52,993,834
|
|
G |
Irf1 |
interferon regulatory factor 1 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of IRF1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of IRF1 protein IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 mRNA]; IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 protein] |
CTD |
PMID:31351048 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Irs1 |
insulin receptor substrate 1 |
decreases expression multiple interactions decreases phosphorylation |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of IRS1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of IRS1 protein [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of IRS1 protein mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of IRS1 protein [mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of IRS1 protein; RBP4 protein promotes the reaction [[mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of IRS1 protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of IRS1 protein] [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of IRS1 protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein] |
CTD |
PMID:25543134 PMID:28526321 PMID:31009676 PMID:31228551 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Irs2 |
insulin receptor substrate 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of IRS2 mRNA |
CTD |
PMID:25543134 |
|
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
|
|
G |
Irs4 |
insulin receptor substrate 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of IRS4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:105,344,020...105,360,004
|
|
G |
Irx3 |
iroquois homeobox 3 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of IRX3 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr19:15,211,882...15,215,317
Ensembl chr19:15,211,878...15,215,317
|
|
G |
Irx5 |
iroquois homeobox 5 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of IRX5 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr19:14,639,052...14,643,911
Ensembl chr19:14,624,225...14,642,318
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ISG15 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Itga2 |
integrin subunit alpha 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ITGA2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
|
|
G |
Itga3 |
integrin subunit alpha 3 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ITGA3 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ITGA3 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
|
|
G |
Itga4 |
integrin subunit alpha 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ITGA4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
|
|
G |
Itga6 |
integrin subunit alpha 6 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ITGA6 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
|
|
G |
Itgb3 |
integrin subunit beta 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ITGB3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Itgb4 |
integrin subunit beta 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ITGB4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Itih1 |
inter-alpha trypsin inhibitor, heavy chain 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ITIH1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr16:6,122,246...6,136,363
Ensembl chr16:6,122,248...6,136,363
|
|
G |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ITIH3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:6,101,922...6,117,154
Ensembl chr16:6,101,930...6,116,924
|
|
G |
Itih6 |
inter-alpha-trypsin inhibitor heavy chain family member 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ITIH6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:19,753,322...19,790,381
Ensembl chr X:19,753,625...19,789,500
|
|
G |
Itpkb |
inositol-trisphosphate 3-kinase B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ITPKB mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:92,069,160...92,164,281
Ensembl chr13:92,069,216...92,162,004
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of JAG1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of JAG1 protein |
CTD |
PMID:36988346 PMID:38042133 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Jag2 |
jagged canonical Notch ligand 2 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of JAG2 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of JAG2 protein |
CTD |
PMID:36988346 |
|
NCBI chr 6:131,983,059...132,005,665
Ensembl chr 6:131,983,056...132,005,818
|
|
G |
Jak3 |
Janus kinase 3 |
multiple interactions |
ISO |
[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of JAK3 promoter; [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased expression of JAK3 mRNA |
CTD |
PMID:37093692 |
|
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
|
|
G |
Jakmip3 |
janus kinase and microtubule interacting protein 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of JAKMIP3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:193,753,134...193,881,105
Ensembl chr 1:193,811,513...193,881,104
|
|
G |
Jam2 |
junctional adhesion molecule 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of JAM2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063
|
|
G |
Jarid2 |
jumonji and AT-rich interaction domain containing 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of JARID2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr17:19,777,487...19,957,696
Ensembl chr17:19,777,266...19,955,690
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of JUN mRNA |
CTD |
PMID:8764118 PMID:9013627 PMID:16809437 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of JUNB mRNA 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of JUNB mRNA] |
CTD |
PMID:8764118 PMID:16809437 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kalrn |
kalirin, RhoGEF kinase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KALRN mRNA |
CTD |
PMID:22401849 |
|
NCBI chr11:66,198,155...66,803,166
Ensembl chr11:66,198,173...66,797,610
|
|
G |
Katnal2 |
katanin catalytic subunit A1 like 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KATNAL2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr18:70,531,759...70,607,886
Ensembl chr18:70,531,754...70,608,082
|
|
G |
Kazald1 |
Kazal-type serine peptidase inhibitor domain 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KAZALD1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:243,939,596...243,943,060
Ensembl chr 1:243,939,647...243,943,059
|
|
G |
Kcna1 |
potassium voltage-gated channel subfamily A member 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNA1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:159,464,223...159,472,905
Ensembl chr 4:159,464,188...159,472,682
|
|
G |
Kcna2 |
potassium voltage-gated channel subfamily A member 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of KCNA2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:194,704,555...194,718,387
Ensembl chr 2:194,704,639...194,718,400
|
|
G |
Kcnab3 |
potassium voltage-gated channel subfamily A regulatory beta subunit 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KCNAB3 mRNA |
CTD |
PMID:22401849 PMID:36314267 |
|
NCBI chr10:54,047,830...54,056,401
Ensembl chr10:54,047,825...54,054,174
|
|
G |
Kcnb1 |
potassium voltage-gated channel subfamily B member 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KCNB1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 3:155,820,255...155,913,383
Ensembl chr 3:155,822,963...155,916,194
|
|
G |
Kcnc2 |
potassium voltage-gated channel subfamily C member 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNC2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:47,700,035...47,883,979
Ensembl chr 7:47,700,288...47,883,968
|
|
G |
Kcnd3 |
potassium voltage-gated channel subfamily D member 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KCND3 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:192,937,950...193,155,345
Ensembl chr 2:192,937,950...193,155,345
|
|
G |
Kcne1 |
potassium voltage-gated channel subfamily E regulatory subunit 1 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KCNE1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNE1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:31,580,951...31,594,116
Ensembl chr11:31,580,742...31,593,901
|
|
G |
Kcng2 |
potassium voltage-gated channel modifier subfamily G member 2 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KCNG2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNG2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:73,742,224...73,810,420
Ensembl chr18:73,743,074...73,808,723
|
|
G |
Kcnh1 |
potassium voltage-gated channel subfamily H member 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNH1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740
|
|
G |
Kcnh5 |
potassium voltage-gated channel subfamily H member 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNH5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:93,615,174...93,908,107
Ensembl chr 6:93,624,529...93,908,107
|
|
G |
Kcnip2 |
potassium voltage-gated channel interacting protein 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNIP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:244,641,147...244,664,939
Ensembl chr 1:244,641,150...244,664,874
|
|
G |
Kcnj16 |
potassium inwardly-rectifying channel, subfamily J, member 16 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KCNJ16 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:95,990,009...96,021,356
Ensembl chr10:95,960,725...96,021,702
|
|
G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of KCNJ5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:30,724,923...30,753,083
Ensembl chr 8:30,724,925...30,753,518
|
|
G |
Kcnk6 |
potassium two pore domain channel subfamily K member 6 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of KCNK6 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 1:84,525,613...84,533,948
Ensembl chr 1:84,525,590...84,534,677
|
|
G |
Kcnmb1 |
potassium calcium-activated channel subfamily M regulatory beta subunit 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNMB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:18,557,510...18,614,824
Ensembl chr10:18,557,904...18,565,798
|
|
G |
Kcnmb4 |
potassium calcium-activated channel subfamily M regulatory beta subunit 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNMB4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:52,066,145...52,119,098
Ensembl chr 7:52,066,136...52,119,278
|
|
G |
Kcnn2 |
potassium calcium-activated channel subfamily N member 2 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNN2 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of KCNN2 mRNA |
CTD |
PMID:36189433 PMID:36314267 |
|
NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
|
|
G |
Kcns2 |
potassium voltage-gated channel, modifier subfamily S, member 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNS2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:66,022,352...66,028,422
Ensembl chr 7:66,022,352...66,028,422
|
|
G |
Kcnt1 |
potassium sodium-activated channel subfamily T member 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNT1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:8,682,964...8,736,615
Ensembl chr 3:8,682,113...8,736,667
|
|
G |
Kcnu1 |
potassium calcium-activated channel subfamily U member 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNU1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:66,141,696...66,229,493
Ensembl chr16:66,141,976...66,229,465
|
|
G |
Kdm5d |
lysine demethylase 5D |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of KDM5D mRNA |
CTD |
PMID:22401849 |
|
NCBI chr Y:527,069...624,019
Ensembl chr Y:530,401...624,018
|
|
G |
Kdm7a |
lysine demethylase 7A |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of KDM7A mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 4:67,899,407...67,974,264
Ensembl chr 4:67,904,307...67,966,998
|
|
G |
Khdc1 |
KH domain containing 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KHDC1C mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:23,812,442...23,814,932
Ensembl chr 9:23,813,746...23,814,813
|
|
G |
Khdc3 |
KH domain containing 3, subcortical maternal complex member |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KHDC3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:73,842,344...73,844,248
Ensembl chr 8:73,842,344...73,844,248
|
|
G |
Kif21b |
kinesin family member 21B |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of KIF21B mRNA |
CTD |
PMID:22401849 |
|
NCBI chr13:47,576,129...47,626,112
Ensembl chr13:47,576,160...47,626,127
|
|
G |
Kif27 |
kinesin family member 27 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of KIF27 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr17:6,299,544...6,375,106
Ensembl chr17:6,299,569...6,369,768
|
|
G |
Kif5c |
kinesin family member 5C |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of KIF5C mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:34,032,082...34,185,597
Ensembl chr 3:34,032,105...34,182,413
|
|
G |
Kif6 |
kinesin family member 6 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of KIF6 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:11,076,203...11,373,205
Ensembl chr 9:11,072,824...11,373,006
|
|
G |
Kirrel2 |
kirre like nephrin family adhesion molecule 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KIRREL2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:85,708,793...85,718,670
Ensembl chr 1:85,708,793...85,718,670
|
|
G |
Kiss1 |
KiSS-1 metastasis-suppressor |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of KISS1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612
|
|
G |
Kiss1r |
KISS1 receptor |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KISS1R mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of KIT protein |
CTD |
PMID:37364752 |
|
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Kl |
Klotho |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KL mRNA |
CTD |
PMID:22401849 |
|
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
|
|
G |
Klc3 |
kinesin light chain 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KLC3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:79,045,842...79,055,809
Ensembl chr 1:79,045,844...79,055,416
|
|
G |
Klf10 |
KLF transcription factor 10 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of KLF10 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
|
|
G |
Klf11 |
KLF transcription factor 11 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of KLF11 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 6:41,285,699...41,297,548
Ensembl chr 6:41,285,842...41,297,550
|
|
G |
Klf14 |
KLF transcription factor 14 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of KLF14 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:59,554,011...59,556,933
Ensembl chr 4:59,554,011...59,556,933
|
|
G |
Klf15 |
KLF transcription factor 15 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KLF15 mRNA |
CTD |
PMID:25543134 |
|
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
|
|
G |
Klhdc4 |
kelch domain containing 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KLHDC4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr19:49,860,975...49,894,027
Ensembl chr19:49,860,967...49,894,868
|
|
G |
Klhdc8a |
kelch domain containing 8A |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KLHDC8A mRNA |
CTD |
PMID:36314267 |
|
NCBI chr13:43,735,702...43,744,277
Ensembl chr13:43,736,192...43,744,277
|
|
G |
Klhl3 |
kelch-like family member 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KLHL3 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr17:6,523,089...6,645,971
Ensembl chr17:6,521,912...6,642,154
|
|
G |
Klk1 |
kallikrein 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KLK1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:94,642,644...94,646,760
Ensembl chr 1:94,642,687...94,646,754
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Androgens deficiency] results in increased expression of KLK3 |
CTD |
PMID:26710974 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Kmo |
kynurenine 3-monooxygenase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KMO mRNA |
CTD |
PMID:22401849 |
|
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
|
|
G |
Kndc1 |
kinase non-catalytic C-lobe domain containing 1 |
increases expression decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of KNDC1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of KNDC1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KNDC1 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 1:194,689,962...194,738,353
Ensembl chr 1:194,690,135...194,738,362
|
|
G |
Kremen2 |
kringle containing transmembrane protein 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KREMEN2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:12,763,345...12,767,622
Ensembl chr10:12,763,397...12,767,854
|
|
G |
Krt1 |
keratin 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KRT1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:132,976,620...132,981,844
|
|
G |
Krt15 |
keratin 15 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of KRT15 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt17 |
keratin 17 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of KRT17 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KRT17 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,178,675...85,183,392
|
|
G |
Krt19 |
keratin 19 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of KRT19 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt34 |
keratin 34 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of KRT34 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr10:84,969,988...84,974,098
Ensembl chr10:84,970,017...84,974,040
|
|
G |
Ky |
kyphoscoliosis peptidase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KY mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:103,086,959...103,126,305
Ensembl chr 8:103,086,630...103,126,024
|
|
G |
Lama3 |
laminin subunit alpha 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LAMA3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
|
|
G |
Lama4 |
laminin subunit alpha 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LAMA4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of LAMC2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LAMC2 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
|
|
G |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LAMP5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:123,372,462...123,384,973
Ensembl chr 3:123,372,462...123,384,952
|
|
G |
Large2 |
LARGE xylosyl- and glucuronyltransferase 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of LARGE2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:78,334,627...78,347,167
Ensembl chr 3:78,336,056...78,342,184
|
|
G |
Larp6 |
La ribonucleoprotein 6, translational regulator |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LARP6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:61,183,744...61,205,548
Ensembl chr 8:61,184,116...61,205,535
|
|
G |
Lats1 |
large tumor suppressor kinase 1 |
multiple interactions |
ISO |
LATS1 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased stability of YAP1 protein] |
CTD |
PMID:31351048 |
|
NCBI chr 1:2,160,411...2,193,640
Ensembl chr 1:2,160,411...2,193,640
|
|
G |
Lbh |
LBH regulator of WNT signaling pathway |
affects expression decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of LBH mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of LBH mRNA |
CTD |
PMID:21195148 PMID:36695872 |
|
NCBI chr 6:22,569,238...22,593,056
Ensembl chr 6:22,568,834...22,593,079
|
|
G |
Lbhd2 |
LBH domain containing 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LBHD2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:130,442,388...130,447,229
Ensembl chr 6:130,442,388...130,447,229
|
|
G |
Lcp1 |
lymphocyte cytosolic protein 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of LCP1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions increases secretion |
ISO |
L 709049 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased secretion of LDHA protein] |
CTD |
PMID:33159713 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LDLRAD4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:61,519,253...61,848,403
Ensembl chr18:61,521,428...61,843,238
|
|
G |
Lefty1 |
left right determination factor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LEFTY1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:92,649,226...92,659,722
Ensembl chr13:92,656,323...92,659,720
|
|
G |
Lep |
leptin |
decreases secretion |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased secretion of LEP protein |
CTD |
PMID:29223775 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lepr |
leptin receptor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LEPR mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LFNG mRNA |
CTD |
PMID:22321834 |
|
NCBI chr12:14,030,551...14,038,996
Ensembl chr12:14,018,333...14,039,008
|
|
G |
Lgals7 |
galectin 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LGALS7 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:84,148,612...84,152,016
Ensembl chr 1:84,150,252...84,152,015
|
|
G |
Lgi1 |
leucine-rich, glioma inactivated 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of LGI1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:236,043,269...236,084,617
Ensembl chr 1:236,042,954...236,084,616
|
|
G |
Lgmn |
legumain |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LGMN mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 6:121,544,048...121,582,495
Ensembl chr 6:121,544,053...121,582,480
|
|
G |
Lgr4 |
leucine-rich repeat-containing G protein-coupled receptor 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LGR4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:96,447,385...96,550,006
Ensembl chr 3:96,447,858...96,548,899
|
|
G |
Lgr5 |
leucine rich repeat containing G protein coupled receptor 5 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of LGR5 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions decreases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [LHB protein results in increased secretion of Testosterone] mono-(2-ethylhexyl)phthalate inhibits the reaction [LHB protein results in increased expression of STAR protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [LHB protein results in increased secretion of Progesterone] mono-(2-ethylhexyl)phthalate results in decreased expression of LHB mRNA |
CTD |
PMID:19440488 PMID:34627990 PMID:34954075 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LHCGR mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of LHCGR mRNA |
CTD |
PMID:22401849 PMID:31884101 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Lhpp |
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
affects expression decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of LHPP mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of LHPP mRNA |
CTD |
PMID:21195148 PMID:36314267 |
|
NCBI chr 1:187,403,390...187,494,577
Ensembl chr 1:187,403,433...187,494,578
|
|
G |
Lhx1 |
LIM homeobox 1 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LHX1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LHX1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:69,396,829...69,403,617
Ensembl chr10:69,396,829...69,403,617
|
|
G |
Lhx2 |
LIM homeobox 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LHX2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:22,113,619...22,143,909
Ensembl chr 3:22,126,007...22,143,908
|
|
G |
Lima1 |
LIM domain and actin binding 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of LIMA1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473
|
|
G |
Lims2 |
LIM zinc finger domain containing 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LIMS2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:23,553,937...23,592,137
Ensembl chr18:23,553,937...23,592,137
|
|
G |
Lin7a |
lin-7 homolog A, crumbs cell polarity complex component |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LIN7A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
|
|
G |
Lin7b |
lin-7 homolog B, crumbs cell polarity complex component |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LIN7B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:95,846,888...95,849,628
Ensembl chr 1:95,846,243...95,849,977
|
|
G |
Lipa |
lipase A, lysosomal acid type |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of LIP1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:232,024,356...232,057,633
|
|
G |
Lipe |
lipase E, hormone sensitive type |
increases expression multiple interactions increases phosphorylation |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of LIPE mRNA [Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of LIPE mRNA; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of LIPE protein] |
CTD |
PMID:25543134 PMID:27181934 PMID:30648648 |
|
NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310
|
|
G |
Lipg |
lipase G, endothelial type |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LIPG mRNA |
CTD |
PMID:22401849 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
G |
Liph |
lipase H |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LIPH mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:79,032,229...79,081,625
Ensembl chr11:79,033,312...79,081,625
|
|
G |
Llgl2 |
LLGL scribble cell polarity complex component 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of LLGL2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:101,050,978...101,086,527
Ensembl chr10:101,051,408...101,086,525
|
|
G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LMCD1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
|
|
G |
Lmx1b |
LIM homeobox transcription factor 1 beta |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LMX1B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:16,862,195...16,940,899
Ensembl chr 3:16,862,195...16,940,899
|
|
G |
Lnpep |
leucyl and cystinyl aminopeptidase |
multiple interactions |
EXP |
mono-(2-ethylhexyl)phthalate affects the reaction [INS1 protein affects the expression of LNPEP protein] |
CTD |
PMID:28526321 |
|
NCBI chr 1:58,258,642...58,355,532
Ensembl chr 1:58,258,642...58,354,544
|
|
G |
LOC120103107 |
PRAME family member 12-like |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ZFP27 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:156,009,794...156,012,390
Ensembl chr 5:156,009,836...156,012,357
|
|
G |
Loxl2 |
lysyl oxidase-like 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LOXL2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:44,683,449...44,773,067
Ensembl chr15:44,683,880...44,773,067
|
|
G |
Lpar3 |
lysophosphatidic acid receptor 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LPAR3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:235,125,234...235,193,916
Ensembl chr 2:235,149,065...235,193,357
|
|
G |
Lpcat2 |
lysophosphatidylcholine acyltransferase 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LPCAT2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:14,088,389...14,152,742
Ensembl chr19:14,089,686...14,152,829
|
|
G |
Lpcat3 |
lysophosphatidylcholine acyltransferase 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LPCAT3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:157,468,397...157,509,889
Ensembl chr 4:157,468,290...157,509,880
|
|
G |
Lrat |
lecithin retinol acyltransferase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LRAT mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
|
|
G |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of LRIG1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 4:127,130,899...127,230,956
Ensembl chr 4:127,130,898...127,231,513
|
|
G |
Lrrc18 |
leucine rich repeat containing 18 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRC18 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:8,253,524...8,277,141
Ensembl chr16:8,254,352...8,277,437
|
|
G |
Lrrc32 |
leucine rich repeat containing 32 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LRRC32 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:152,785,709...152,802,997
Ensembl chr 1:152,786,511...152,798,373
|
|
G |
Lrrc36 |
leucine rich repeat containing 36 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRC36 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of LRRC36 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:33,292,074...33,342,426
Ensembl chr19:33,292,074...33,360,141
|
|
G |
Lrrc3b |
leucine rich repeat containing 3B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRC3B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:9,973,580...10,050,891
Ensembl chr15:9,969,983...10,051,066
|
|
G |
Lrrc4 |
leucine rich repeat containing 4 |
affects expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of LRRC4 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRC4 mRNA |
CTD |
PMID:21195148 PMID:36189433 |
|
NCBI chr 4:57,433,518...57,437,114
Ensembl chr 4:57,433,428...57,437,911
|
|
G |
Lrrc4b |
leucine rich repeat containing 4B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRC4B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:94,922,034...94,956,309
Ensembl chr 1:94,935,603...94,956,263
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of LRRC56 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 1:196,299,843...196,315,170
Ensembl chr 1:196,299,846...196,315,172
|
|
G |
Lrrc66 |
leucine rich repeat containing 66 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LRRC66 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr14:34,578,934...34,604,977
Ensembl chr14:34,581,240...34,604,541
|
|
G |
Lrrc75b |
leucine rich repeat containing 75B |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LRRC75B mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRC75B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:13,100,302...13,106,503
Ensembl chr20:13,100,302...13,106,503
|
|
G |
Lrrfip1 |
LRR binding FLII interacting protein 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LRRFIP1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:91,592,032...91,720,250
Ensembl chr 9:91,643,197...91,720,250
|
|
G |
Lrrn1 |
leucine rich repeat neuronal 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRN1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:140,476,752...140,520,210
Ensembl chr 4:140,476,324...140,518,620
|
|
G |
Lrrn3 |
leucine rich repeat neuronal 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRN3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:58,489,060...58,520,322
Ensembl chr 6:58,489,010...58,520,330
|
|
G |
Lrrtm3 |
leucine rich repeat transmembrane neuronal 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRTM3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:24,515,627...24,689,669
Ensembl chr20:24,515,627...24,689,669
|
|
G |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LTBP1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
|
|
G |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LTBP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
|
|
G |
Lurap1l |
leucine rich adaptor protein 1-like |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of LURAP1L mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 5:95,362,005...95,409,439
Ensembl chr 5:95,362,005...95,409,438
|
|
G |
Luzp4 |
leucine zipper protein 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of OTT mRNA |
CTD |
PMID:22401849 |
|
NCBI chr X:111,280,490...111,321,363
Ensembl chr X:111,280,549...111,321,359
|
|
G |
Ly6a |
lymphocyte antigen 6 family member A |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of LY6A mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LY6A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981
|
|
G |
Ly6g6e |
lymphocyte antigen 6 family member G6E |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LY6G6E mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:3,744,999...3,749,867
Ensembl chr20:3,744,999...3,750,849
|
|
G |
Ly6h |
lymphocyte antigen 6 family member H |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of LY6H mRNA |
CTD |
PMID:38113427 |
|
NCBI chr 7:107,258,779...107,261,270
Ensembl chr 7:107,258,779...107,261,454
|
|
G |
Ly75 |
lymphocyte antigen 75 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LY75 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:44,764,702...44,852,219
Ensembl chr 3:44,765,122...44,852,374
|
|
G |
Lypd9 |
LY6/PLAUR domain containing 9 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of LYPD9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:42,626,499...42,637,182
Ensembl chr10:42,628,272...42,636,402
|
|
G |
M1ap |
meiosis 1 associated protein |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of M1AP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:115,445,910...115,536,745
Ensembl chr 4:115,455,397...115,536,487
|
|
G |
Mab21l3 |
mab-21 like 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MAB21L3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:189,248,895...189,271,652
Ensembl chr 2:189,248,895...189,271,652
|
|
G |
Mafa |
MAF bZIP transcription factor A |
affects expression decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of MAFA protein mono-(2-ethylhexyl)phthalate results in decreased expression of MAFA mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MAFA mRNA |
CTD |
PMID:36189433 PMID:38048874 |
|
NCBI chr 7:107,432,292...107,435,084
Ensembl chr 7:107,433,605...107,434,690
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MAFF mRNA |
CTD |
PMID:16809437 PMID:36695872 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafk |
MAF bZIP transcription factor K |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of MAFK mRNA |
CTD |
PMID:16809437 |
|
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
|
|
G |
Mag |
myelin-associated glycoprotein |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MAG mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656
|
|
G |
Magea10 |
MAGE family member A10 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MAGEA10 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:150,212,708...150,217,954
Ensembl chr X:150,213,245...150,214,213
|
|
G |
Magea14 |
MAGE family member A14 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MAGEA14 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:131,542,773...131,546,613
Ensembl chr X:131,542,773...131,593,006
|
|
G |
Magea9 |
MAGE family member A9 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MAGEA9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:142,619,282...142,624,654
Ensembl chr X:142,619,395...142,624,653
|
|
G |
Mageb18 |
MAGE family member B18 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MAGEB18 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr X:56,885,991...56,888,245
Ensembl chr X:56,885,991...56,888,245
|
|
G |
Majin |
membrane anchored junction protein |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MAJIN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:203,487,777...203,524,098
Ensembl chr 1:203,488,069...203,524,092
|
|
G |
Mak |
male germ cell-associated kinase |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of MAK mRNA |
CTD |
PMID:21195148 |
|
NCBI chr17:23,683,753...23,731,125
Ensembl chr17:23,693,878...23,730,001
|
|
G |
Mamstr |
MEF2 activating motif and SAP domain containing transcriptional regulator |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MAMSTR mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:96,109,715...96,116,295
Ensembl chr 1:96,110,343...96,115,744
|
|
G |
Maob |
monoamine oxidase B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MAOB mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Map1b |
microtubule-associated protein 1B |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of MAP1B mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased localization of MAP1LC3B protein |
CTD |
PMID:37692514 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Map2 |
microtubule-associated protein 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MAP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
decreases phosphorylation multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of MAP2K1 protein Zinc inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of MAP2K1 protein] |
CTD |
PMID:35841924 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
decreases phosphorylation multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of MAP2K2 protein Zinc inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of MAP2K2 protein] |
CTD |
PMID:35841924 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MAP2K6 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
|
|
G |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MAP3K13 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:79,094,087...79,235,181
Ensembl chr11:79,097,247...79,235,181
|
|
G |
Map7d3 |
MAP7 domain containing 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MAP7D3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:134,619,227...134,647,525
Ensembl chr X:134,619,227...134,685,841
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation affects phosphorylation decreases phosphorylation |
ISO EXP |
mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased phosphorylation of MAPK1 protein] mono-(2-ethylhexyl)phthalate results in increased phosphorylation of MAPK1 protein mono-(2-ethylhexyl)phthalate affects the phosphorylation of MAPK1 protein [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of MAPK1 protein; [mono-(2-ethylhexyl)phthalate co-treated with bisphenol A] inhibits the reaction [HDAC6 protein affects the phosphorylation of MAPK1 protein]; Zinc inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:22564763 PMID:28390675 PMID:30810372 PMID:34910997 PMID:35841924 PMID:37941498 More...
|
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk11 |
mitogen-activated protein kinase 11 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MAPK11 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:120,218,471...120,225,488
Ensembl chr 7:120,218,478...120,225,395
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation affects phosphorylation decreases phosphorylation |
ISO EXP |
mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased phosphorylation of MAPK3 protein] mono-(2-ethylhexyl)phthalate results in increased phosphorylation of MAPK3 protein mono-(2-ethylhexyl)phthalate affects the phosphorylation of MAPK3 protein [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of MAPK3 protein; [mono-(2-ethylhexyl)phthalate co-treated with bisphenol A] inhibits the reaction [HDAC6 protein affects the phosphorylation of MAPK3 protein]; Zinc inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:22564763 PMID:28390675 PMID:30810372 PMID:34910997 PMID:35841924 PMID:37941498 More...
|
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk4 |
mitogen-activated protein kinase 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MAPK4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:67,512,805...67,661,271
Ensembl chr18:67,512,807...67,661,842
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
affects phosphorylation |
ISO |
mono-(2-ethylhexyl)phthalate affects the phosphorylation of MAPK8 protein |
CTD |
PMID:30810372 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapkapk3 |
MAPK activated protein kinase 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MAPKAPK3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:107,929,754...107,963,638
Ensembl chr 8:107,929,762...107,963,568
|
|
G |
Mapt |
microtubule-associated protein tau |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MAPT mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Marco |
macrophage receptor with collagenous structure |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MARCO mRNA] |
CTD |
PMID:29718165 |
|
NCBI chr13:31,616,278...31,648,521
Ensembl chr13:31,616,278...31,648,521
|
|
G |
Mars1 |
methionyl-tRNA synthetase 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MARS1 mRNA |
CTD |
PMID:22321834 |
|
NCBI chr 7:63,121,142...63,138,550
Ensembl chr 7:63,121,142...63,138,495
|
|
G |
Marveld2 |
MARVEL domain containing 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MARVELD2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:31,742,652...31,764,150
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Masp1 |
MBL associated serine protease 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MASP1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:77,334,794...77,405,271
Ensembl chr11:77,334,859...77,402,974
|
|
G |
Matn2 |
matrilin 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MATN2 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 7:65,494,996...65,644,613
Ensembl chr 7:65,494,834...65,645,113
|
|
G |
Matn4 |
matrilin 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MATN4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:153,120,605...153,135,628
Ensembl chr 3:153,120,632...153,135,865
|
|
G |
Mb |
myoglobin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MB mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
|
|
G |
Mbd3l2 |
methyl-CpG binding domain protein 3-like 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MBD3L2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:15,607,477...15,614,046
Ensembl chr 8:15,611,214...15,612,563
|
|
G |
Mbp |
myelin basic protein |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MBP mRNA |
CTD |
PMID:22401849 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mcam |
melanoma cell adhesion molecule |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of MCAM mRNA |
CTD |
PMID:34942354 |
|
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
|
|
G |
Mcf2 |
MCF.2 cell line derived transforming sequence |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MCF2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:138,414,077...138,514,828
Ensembl chr X:138,409,256...138,514,446
|
|
G |
Mdga1 |
MAM domain containing glycosylphosphatidylinositol anchor 1 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MDGA1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MDGA1 mRNA |
CTD |
PMID:22401849 PMID:36189433 PMID:36695872 |
|
NCBI chr20:7,900,327...7,964,309
Ensembl chr20:7,904,358...7,963,471
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MDM2 protein |
CTD |
PMID:24706461 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Me3 |
malic enzyme 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ME3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:143,534,024...143,735,551
Ensembl chr 1:143,534,139...143,733,132
|
|
G |
Med1 |
mediator complex subunit 1 |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate promotes the reaction [PPARA protein binds to MED1 protein] |
CTD |
PMID:20123618 |
|
NCBI chr10:83,145,538...83,189,260
Ensembl chr10:83,145,568...83,189,299
|
|
G |
Megf11 |
multiple EGF-like-domains 11 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MEGF11 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:64,892,312...65,218,984
Ensembl chr 8:64,892,387...65,216,061
|
|
G |
Mei1 |
meiotic double-stranded break formation protein 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MEI1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:113,590,142...113,643,513
Ensembl chr 7:113,590,142...113,643,511
|
|
G |
Mei4 |
meiotic double-stranded break formation protein 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MEI4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:82,765,661...82,939,649
Ensembl chr 8:82,765,661...82,939,649
|
|
G |
Meioc |
meiosis specific with coiled-coil domain |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MEIOC mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:87,628,807...87,646,485
Ensembl chr10:87,628,875...87,646,752
|
|
G |
Meox1 |
mesenchyme homeobox 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MEOX1 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
|
|
G |
Mep1b |
meprin A subunit beta |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MEP1B mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MEP1B mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr18:12,366,126...12,392,840
Ensembl chr18:12,365,289...12,392,840
|
|
G |
Mesp2 |
mesoderm posterior bHLH transcription factor 2 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MESP2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MESP2 mRNA |
CTD |
PMID:31711903 PMID:36189433 |
|
NCBI chr 1:133,756,601...133,759,207
Ensembl chr 1:133,756,601...133,759,198
|
|
G |
Mest |
mesoderm specific transcript |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MEST mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MEST mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 4:59,354,445...59,364,919
Ensembl chr 4:59,354,447...59,366,145
|
|
G |
Mettl14 |
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit |
decreases expression multiple interactions increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of METTL14 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of METTL14 protein METTL14 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of SCARB1 mRNA]; mono-(2-ethylhexyl)phthalate affects the reaction [METTL14 protein affects the expression of SCARB1 mRNA] mono-(2-ethylhexyl)phthalate results in increased expression of METTL14 mRNA |
CTD |
PMID:31875672 PMID:36174712 |
|
NCBI chr 2:211,530,598...211,546,845
Ensembl chr 2:211,530,602...211,546,821
|
|
G |
Mettl16 |
methyltransferase 16, RNA N6-adenosine |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of METTL16 mRNA |
CTD |
PMID:36174712 |
|
NCBI chr10:59,640,915...59,697,291
Ensembl chr10:59,640,972...59,687,061
|
|
G |
Mettl24 |
methyltransferase like 24 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of METTL24 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:44,142,126...44,264,651
Ensembl chr20:44,142,396...44,261,310
|
|
G |
Mettl3 |
methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit |
decreases expression multiple interactions increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of METTL3 mRNA METTL3 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased methylation of HMBOX1 protein] mono-(2-ethylhexyl)phthalate results in increased expression of METTL3 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of METTL3 protein |
CTD |
PMID:31875672 PMID:36174712 |
|
NCBI chr15:25,002,505...25,014,097
Ensembl chr15:25,003,172...25,014,041
|
|
G |
Mettl4 |
methyltransferase 4, N6-adenosine |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of METTL4 mRNA |
CTD |
PMID:36174712 |
|
NCBI chr 9:111,440,976...111,523,871
Ensembl chr 9:111,441,027...111,464,749
|
|
G |
Mff |
mitochondrial fission factor |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MFF mRNA |
CTD |
PMID:37692514 |
|
NCBI chr 9:84,007,798...84,036,039
Ensembl chr 9:84,007,798...84,036,039
|
|
G |
Mfn2 |
mitofusin 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MFN2 mRNA |
CTD |
PMID:37692514 |
|
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mfsd13a |
major facilitator superfamily domain containing 13A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MFSD13A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:245,216,610...245,236,314
Ensembl chr 1:245,217,067...245,236,767
|
|
G |
Mgarp |
mitochondria-localized glutamic acid-rich protein |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MGARP mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:135,431,283...135,439,425
Ensembl chr 2:135,431,283...135,439,612
|
|
G |
Mgat4c |
MGAT4 family, member C |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MGAT4C mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:36,709,564...37,485,810
Ensembl chr 7:37,260,321...37,474,571
|
|
G |
Mgll |
monoglyceride lipase |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MGLL mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MGLL mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
decreases expression increases expression |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of MGST2 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of MGST2 mRNA |
CTD |
PMID:22401849 PMID:38113427 |
|
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
|
|
G |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MICAL2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:166,345,853...166,530,575
Ensembl chr 1:166,345,859...166,471,719 Ensembl chr 1:166,345,859...166,471,719
|
|
G |
Mid1 |
midline 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MID1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr X:24,116,674...24,491,205
Ensembl chr X:24,120,293...24,248,353
|
|
G |
Mif |
macrophage migration inhibitory factor |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MIF protein |
CTD |
PMID:27384973 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Minar1 |
membrane integral NOTCH2 associated receptor 1 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MINAR1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MINAR1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:90,137,374...90,169,152
Ensembl chr 8:90,137,374...90,169,137
|
|
G |
Miox |
myo-inositol oxygenase |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MIOX mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MIOX mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:120,405,031...120,407,529
Ensembl chr 7:120,405,031...120,407,537
|
|
G |
Mir101a |
microRNA 101a |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MIR101A mRNA |
CTD |
PMID:31875672 |
|
NCBI chr 5:115,966,332...115,966,406
Ensembl chr 5:115,966,328...115,966,410
|
|
G |
Mir106b |
microRNA 106b |
multiple interactions |
ISO |
[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which affects the expression of MIR106B |
CTD |
PMID:30481674 |
|
NCBI chr12:17,043,344...17,043,425
Ensembl chr12:17,043,344...17,043,425
|
|
G |
Mir141 |
microRNA 141 |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of MIR141 mRNA |
CTD |
PMID:35861251 |
|
NCBI chr 4:157,523,239...157,523,332
Ensembl chr 4:157,523,239...157,523,332
|
|
G |
Mir15b |
microRNA 15b |
multiple interactions |
ISO |
[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which affects the expression of MIR15B |
CTD |
PMID:30481674 |
|
NCBI chr 2:153,245,200...153,245,297
Ensembl chr 2:153,245,200...153,245,297
|
|
G |
Mir184 |
microRNA 184 |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MIR184 mRNA |
CTD |
PMID:35861251 |
|
NCBI chr 8:90,343,134...90,343,210
Ensembl chr 8:90,343,134...90,343,210
|
|
G |
Mir202 |
microRNA 202 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MIR202 mRNA |
CTD |
PMID:31875672 |
|
NCBI chr 1:194,754,730...194,754,801
Ensembl chr 1:194,754,730...194,754,801
|
|
G |
Mir208b |
microRNA 208b |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MIR208B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:28,451,638...28,451,749
Ensembl chr15:28,451,638...28,451,749
|
|
G |
Mir27b |
microRNA 27b |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MIR27B mRNA MIR27B mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA]; MIR27B mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA protein]; MYC protein affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MIR27B mRNA] |
CTD |
PMID:30858031 |
|
NCBI chr17:1,813,427...1,813,523
Ensembl chr17:1,813,426...1,813,529
|
|
G |
Mir295-1 |
microRNA 295-1 |
multiple interactions decreases expression |
ISO |
MIR372 mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA]; MIR372 mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA protein] mono-(2-ethylhexyl)phthalate results in decreased expression of MIR372 mRNA |
CTD |
PMID:30858031 |
|
NCBI chr 1:65,962,566...65,962,646
Ensembl chr 1:65,962,566...65,962,646
|
|
G |
Mir532 |
microRNA 532 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MIR532 mRNA |
CTD |
PMID:31875672 |
|
NCBI chr X:15,247,315...15,247,393
Ensembl chr X:15,247,315...15,247,393
|
|
G |
Mir542 |
microRNA 542 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MIR542 mRNA |
CTD |
PMID:31875672 |
|
NCBI chr X:132,802,623...132,802,701
Ensembl chr X:132,802,623...132,802,701
|
|
G |
Mir877 |
microRNA 877 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MIR877 mRNA |
CTD |
PMID:31875672 |
|
NCBI chr20:2,811,476...2,811,560
Ensembl chr20:2,811,476...2,811,560
|
|
G |
Misp3 |
MISP family member 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MISP3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:24,139,998...24,142,006
Ensembl chr19:24,140,033...24,142,631
|
|
G |
Mixl1 |
Mix paired-like homeobox 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MIXL1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr13:92,422,031...92,426,065
Ensembl chr13:92,422,031...92,426,065
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions increases expression |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of MKI67 protein |
CTD |
PMID:31884101 PMID:35861251 PMID:36314267 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mlana |
melan-A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MLANA mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:227,469,537...227,483,343
Ensembl chr 1:227,469,537...227,483,343
|
|
G |
Mlycd |
malonyl-CoA decarboxylase |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MLYCD mRNA |
CTD |
PMID:32522588 |
|
NCBI chr19:47,447,931...47,463,794
Ensembl chr19:47,447,970...47,463,793
|
|
G |
Mmel1 |
membrane metallo-endopeptidase-like 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MMEL1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:165,431,278...165,461,716
Ensembl chr 5:165,431,343...165,461,716
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MMP1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp15 |
matrix metallopeptidase 15 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MMP15 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:9,663,449...9,684,943
Ensembl chr19:9,663,449...9,684,943
|
|
G |
Mmp19 |
matrix metallopeptidase 19 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MMP19 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:1,221,229...1,229,555
Ensembl chr 7:1,221,343...1,229,555
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases expression increases activity increases secretion multiple interactions affects expression |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of MMP2 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of MMP2 protein mono-(2-ethylhexyl)phthalate results in increased activity of MMP2 protein mono-(2-ethylhexyl)phthalate results in increased secretion of MMP2 protein 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP2 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP2 protein]; [SB 3CT compound results in decreased activity of MMP2 protein] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased secretion of MMP2 protein]; [SB 3CT compound results in decreased activity of MMP2 protein] which results in decreased susceptibility to mono-(2-ethylhexyl)phthalate; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of MMP2 mRNA]; Fulvestrant inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP2 mRNA]; SB 3CT compound inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of MMP2 protein] STAT5A protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP2 protein] |
CTD |
PMID:22321834 PMID:28390675 PMID:33631300 PMID:35143864 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp23 |
matrix metallopeptidase 23 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MMP23B mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 5:166,239,643...166,242,734
Ensembl chr 5:166,239,644...166,242,433
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression increases expression affects expression |
ISO EXP |
2-chloro-5-nitrobenzanilide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 protein]; [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased secretion of MMP9 protein; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of MMP9 mRNA]; Fulvestrant inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 mRNA]; mifobate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein]; PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein] mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 protein mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA] STAT5A protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 protein] |
CTD |
PMID:28390675 PMID:28416457 PMID:29718165 PMID:30398665 PMID:33631300 PMID:35143864 More...
|
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mobp |
myelin-associated oligodendrocyte basic protein |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MOBP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:119,869,504...119,899,605
Ensembl chr 8:119,869,626...119,899,563
|
|
G |
Mov10l1 |
Mov10 like RNA helicase 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MOV10L1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:120,070,171...120,135,406
Ensembl chr 7:120,070,135...120,134,765
|
|
G |
Moxd1 |
monooxygenase, DBH-like 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MOXD1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:21,075,124...21,165,348
Ensembl chr 1:21,075,122...21,161,779
|
|
G |
Mpo |
myeloperoxidase |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MPO mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mpzl2 |
myelin protein zero-like 2 |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MPZL2 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of MPZL2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:45,348,285...45,359,298
Ensembl chr 8:45,348,285...45,359,298
|
|
G |
Mrap2 |
melanocortin 2 receptor accessory protein 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MRAP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:88,088,293...88,144,636
Ensembl chr 8:88,088,272...88,143,886
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
multiple interactions |
ISO |
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in decreased expression of MRC1 mRNA |
CTD |
PMID:30398665 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G |
Mroh2b |
maestro heat-like repeat family member 2B |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MROH2B mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:54,003,870...54,063,992
Ensembl chr 2:54,003,862...54,063,984
|
|
G |
Mroh5 |
maestro heat-like repeat family member 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MROH5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:105,662,737...105,737,820
Ensembl chr 7:105,662,744...105,730,060
|
|
G |
Ms4a4a |
membrane spanning 4-domains A4A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MS4A4A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:208,060,507...208,085,121
Ensembl chr 1:208,046,971...208,085,119
|
|
G |
Msc |
musculin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MSC mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:4,547,335...4,553,206
Ensembl chr 5:4,547,405...4,553,203
|
|
G |
Mt-nd1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ND1 mRNA |
CTD |
PMID:20438828 |
|
NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
|
|
G |
Mt1 |
metallothionein 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of MT1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of MT2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mt3 |
metallothionein 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MT3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Mtmr7 |
myotubularin related protein 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MTMR7 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr16:51,641,267...51,732,212
Ensembl chr16:51,641,190...51,732,182
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
increases phosphorylation multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased phosphorylation of MTOR protein epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of MTOR protein] |
CTD |
PMID:37286014 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mtus1 |
microtubule associated scaffold protein 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of MTUS1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr16:51,202,497...51,347,794
Ensembl chr16:51,253,562...51,347,793
|
|
G |
Muc1 |
mucin 1, cell surface associated |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MUC1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Muc13 |
mucin 13, cell surface associated |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MUC13 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:66,957,208...66,980,264
Ensembl chr11:66,960,595...66,984,727
|
|
G |
Muc4 |
mucin 4, cell surface associated |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MUC4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:68,008,245...68,053,242
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MUC5B mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
|
|
G |
Mug2 |
murinoglobulin 2 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MUG2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MUG2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:155,164,061...155,236,894
Ensembl chr 4:155,164,011...155,236,475
|
|
G |
Mup4 |
major urinary protein 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MUP4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:74,961,143...74,964,686
Ensembl chr 5:74,842,319...75,061,474
|
|
G |
Mvd |
mevalonate diphosphate decarboxylase |
decreases expression multiple interactions increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MVD mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MVD mRNA mono-(2-ethylhexyl)phthalate results in increased expression of MVD mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr19:50,496,366...50,506,429
Ensembl chr19:50,496,367...50,507,971
|
|
G |
Mybpc2 |
myosin binding protein C2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MYBPC2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:94,994,121...95,017,584
Ensembl chr 1:94,994,104...95,017,584
|
|
G |
Mybphl |
myosin binding protein H-like |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MYBPHL mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MYBPHL mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:196,005,297...196,018,826
Ensembl chr 2:196,005,325...196,018,824
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
affects localization increases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate affects the localization of MYC protein mono-(2-ethylhexyl)phthalate results in increased expression of MYC mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of MYC protein [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of MYC protein; HDAC6 protein affects the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of MYC protein]; MYC protein affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MIR27B mRNA]; tubastatin A inhibits the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of MYC protein] |
CTD |
PMID:21832167 PMID:22321834 PMID:30858031 PMID:34910997 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Mycbpap |
Mycbp associated protein |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MYCBPAP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:79,450,319...79,470,977
Ensembl chr10:79,450,324...79,470,828
|
|
G |
Mycn |
MYCN proto-oncogene, bHLH transcription factor |
decreases expression increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MYCN mRNA mono-(2-ethylhexyl)phthalate results in increased expression of MYCN mRNA |
CTD |
PMID:16809437 PMID:36314267 |
|
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
|
|
G |
Myh1 |
myosin heavy chain 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MYH1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:51,885,913...51,909,699
Ensembl chr10:51,885,913...51,946,295
|
|
G |
Myh8 |
myosin heavy chain 8 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MYH8 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MYH8 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr10:51,963,510...51,993,103
Ensembl chr10:51,963,510...51,993,232
|
|
G |
Mylk |
myosin light chain kinase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MYLK mRNA |
CTD |
PMID:38113427 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
Mylk2 |
myosin light chain kinase 2 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MYLK2 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of MYLK2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:141,376,450...141,388,357
Ensembl chr 3:141,376,691...141,387,728
|
|
G |
Mylk3 |
myosin light chain kinase 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MYLK3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:21,685,085...21,743,587
Ensembl chr19:21,691,929...21,742,954
|
|
G |
Myo15a |
myosin XVA |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MYO15A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:45,277,619...45,335,953
Ensembl chr10:45,278,737...45,335,340
|
|
G |
Myo6 |
myosin VI |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MYO6 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 8:81,087,157...81,242,022
Ensembl chr 8:81,087,139...81,239,292
|
|
G |
Myo7a |
myosin VIIA |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of MYO7A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:152,342,611...152,414,171
Ensembl chr 1:152,344,448...152,414,157
|
|
G |
Myo7b |
myosin VIIb |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MYO7B mRNA mono-(2-ethylhexyl)phthalate results in increased expression of MYO7B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:23,588,307...23,669,841
Ensembl chr18:23,588,307...23,669,809
|
|
G |
Myof |
myoferlin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MYOF mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:235,673,666...235,822,413
Ensembl chr 1:235,673,666...235,822,334
|
|
G |
Myom3 |
myomesin 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MYOM3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:147,992,737...148,043,282
Ensembl chr 5:147,992,737...148,043,274
|
|
G |
Myoz2 |
myozenin 2 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of MYOZ2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MYOZ2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:211,141,463...211,168,187
Ensembl chr 2:211,141,463...211,168,221
|
|
G |
Myrip |
myosin VIIA and Rab interacting protein |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MYRIP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:120,017,749...120,184,821
Ensembl chr 8:120,017,524...120,183,833
|
|
G |
Naa11 |
N(alpha)-acetyltransferase 11, NatA catalytic subunit |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NAA11 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:12,183,651...12,193,687
Ensembl chr14:12,183,651...12,193,686
|
|
G |
Naaa |
N-acylethanolamine acid amidase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NAAA mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:15,777,306...15,796,411
Ensembl chr14:15,777,306...15,796,410
|
|
G |
Nags |
N-acetylglutamate synthase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NAGS mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:87,098,330...87,102,465
Ensembl chr10:87,098,330...87,102,465
|
|
G |
Nalcn |
sodium leak channel, non-selective |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NALCN mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:100,398,583...100,741,243
Ensembl chr15:100,398,615...100,741,001
|
|
G |
Nalf1 |
NALCN channel auxiliary factor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FAM155A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:79,713,577...80,236,295
Ensembl chr16:79,713,724...80,235,120
|
|
G |
Nanog |
Nanog homeobox |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NANOG protein |
CTD |
PMID:37364752 |
|
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
|
|
G |
Nanos2 |
nanos C2HC-type zinc finger 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NANOS2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:78,635,668...78,637,128
Ensembl chr 1:78,635,668...78,637,128
|
|
G |
Nanos3 |
nanos C2HC-type zinc finger 3 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NANOS3 protein [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NANOS3 mRNA |
CTD |
PMID:36189433 PMID:37364752 |
|
NCBI chr19:23,978,465...23,988,933
Ensembl chr19:23,985,504...23,988,932
|
|
G |
Nbeal2 |
neurobeachin-like 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NBEAL2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:110,603,220...110,633,612
Ensembl chr 8:110,599,389...110,633,707
|
|
G |
Ncan |
neurocan |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NCAN mRNA |
CTD |
PMID:22401849 |
|
NCBI chr16:19,301,969...19,328,436
Ensembl chr16:19,301,969...19,328,436
|
|
G |
Ncbp2as2 |
NCBP2 antisense 2 (head to head) |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of NCBP2AS2 mRNA |
CTD |
PMID:29385630 |
|
NCBI chr11:68,829,950...68,830,715
Ensembl chr11:68,829,983...68,830,708
|
|
G |
Ncoa1 |
nuclear receptor coactivator 1 |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate promotes the reaction [NCOA1 protein binds to and results in increased activity of NR1H2 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [NCOA1 protein binds to and results in increased activity of NR1H3 protein] |
CTD |
PMID:27551952 |
|
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
|
|
G |
Ncoa3 |
nuclear receptor coactivator 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NCOA3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:154,738,566...154,821,395
Ensembl chr 3:154,738,581...154,818,594
|
|
G |
Ncoa4 |
nuclear receptor coactivator 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NCOA4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,366,542...7,409,641 Ensembl chr16:7,366,542...7,409,641
|
|
G |
Ncoa7 |
nuclear receptor coactivator 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NCOA7 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:26,856,228...27,016,950
Ensembl chr 1:26,856,530...27,015,871
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [PPARA protein binds to NCOR1 protein] |
CTD |
PMID:20123618 |
|
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
|
|
G |
Ndnf |
neuron-derived neurotrophic factor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NDNF mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:94,944,392...94,981,871
Ensembl chr 4:94,944,360...94,981,873
|
|
G |
Ndp |
norrin cystine knot growth factor NDP |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NDP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:5,796,487...5,820,934
Ensembl chr X:5,796,487...5,820,934
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of NDRG1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Ndufa3 |
NADH:ubiquinone oxidoreductase subunit A3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NDUFA3 mRNA |
CTD |
PMID:27167697 |
|
NCBI chr 1:65,597,567...65,600,197
Ensembl chr 1:65,597,578...65,600,235
|
|
G |
Ndufa6 |
NADH:ubiquinone oxidoreductase subunit A6 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NDUFA6 mRNA |
CTD |
PMID:27167697 |
|
NCBI chr 7:113,866,382...113,870,239
Ensembl chr 7:113,866,382...113,870,239
|
|
G |
Ndufa7 |
NADH:ubiquinone oxidoreductase subunit A7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NDUFA7 mRNA |
CTD |
PMID:27167697 |
|
NCBI chr 7:14,609,283...14,622,064
Ensembl chr 7:14,609,146...14,631,976
|
|
G |
Ndufaf6 |
NADH:ubiquinone oxidoreductase complex assembly factor 6 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NDUFAF6 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 5:24,147,712...24,171,981
Ensembl chr 5:24,147,735...24,171,951
|
|
G |
Ndufb11b |
NADH:ubiquinone oxidoreductase subunit B11B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NDUFB11B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:113,505,048...113,506,359
Ensembl chr 7:113,505,053...113,506,360
|
|
G |
Ndufs5 |
NADH:ubiquinone oxidoreductase subunit S5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NDUFS5 mRNA |
CTD |
PMID:27167697 |
|
NCBI chr 5:135,974,029...135,979,705
Ensembl chr 5:135,974,034...135,979,603 Ensembl chr14:135,974,034...135,979,603 Ensembl chr 2:135,974,034...135,979,603
|
|
G |
Neb |
nebulin |
affects expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of NEB mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NEB mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 3:36,613,677...36,811,618
Ensembl chr 3:36,613,716...36,811,574
|
|
G |
Nectin4 |
nectin cell adhesion molecule 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NECTIN4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:83,802,589...83,821,711
Ensembl chr13:83,803,184...83,821,709
|
|
G |
Nek1 |
NIMA-related kinase 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NEK1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr16:28,998,229...29,125,426
Ensembl chr16:28,998,231...29,117,723
|
|
G |
Neu3 |
neuraminidase 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NEU3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:154,137,732...154,148,879
Ensembl chr 1:154,050,855...154,148,813
|
|
G |
Neurl3 |
neuralized E3 ubiquitin protein ligase 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NEURL3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:38,494,486...38,503,352
Ensembl chr 9:38,494,489...38,502,649
|
|
G |
Neurog2 |
neurogenin 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NEUROG2 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 2:216,092,709...216,095,276
Ensembl chr 2:216,093,363...216,094,154
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression multiple interactions decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NFE2L2 protein Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NFE2L2 protein]; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NFE2L2 protein] mono-(2-ethylhexyl)phthalate results in decreased expression of NFE2L2 protein RSL3 compound promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of NFE2L2 protein] |
CTD |
PMID:36438553 PMID:37286014 PMID:37692514 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions increases expression |
ISO |
AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NFKB1 mRNA] |
CTD |
PMID:18755736 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkb2 |
nuclear factor kappa B subunit 2 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of NFKB2 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of NFKBIA mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbiz |
NFKB inhibitor zeta |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of NFKBIZ mRNA |
CTD |
PMID:16809437 |
|
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
|
|
G |
Ngf |
nerve growth factor |
increases response to substance multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased susceptibility to NGF protein [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NGF mRNA |
CTD |
PMID:21145954 PMID:36189433 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nkain2 |
sodium/potassium transporting ATPase interacting 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NKAIN2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:24,668,627...25,877,051
Ensembl chr 1:24,669,462...25,877,064
|
|
G |
Nkx2-4 |
NK2 homeobox 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NKX2-4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:134,514,368...134,517,243
Ensembl chr 3:134,515,039...134,516,505
|
|
G |
Nlgn3 |
neuroligin 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NLGN3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:66,427,926...66,457,378
Ensembl chr X:66,429,458...66,451,876
|
|
G |
Nlrp12 |
NLR family, pyrin domain containing 12 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NLRP12 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:65,932,610...65,969,873
Ensembl chr 1:65,932,595...65,960,934
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein]; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein]; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein] |
CTD |
PMID:31016965 PMID:33159713 PMID:37286014 PMID:37692514 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nlrp6 |
NLR family, pyrin domain containing 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NLRP6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:196,004,854...196,011,615
Ensembl chr 1:196,004,953...196,011,113
|
|
G |
Nme5 |
NME/NM23 family member 5 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of NME5 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr18:26,163,558...26,180,742
Ensembl chr18:26,163,555...26,180,794
|
|
G |
Nme8 |
NME/NM23 family member 8 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NME8 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:45,237,022...45,304,948
Ensembl chr17:45,238,120...45,304,948
|
|
G |
Noc4l |
nucleolar complex associated 4 homolog |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NOC4L mRNA |
CTD |
PMID:22401849 |
|
NCBI chr12:46,016,077...46,020,615
Ensembl chr12:46,016,069...46,020,614
|
|
G |
Nodal |
nodal growth differentiation factor |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NODAL mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:29,368,436...29,376,837
Ensembl chr20:29,368,436...29,376,837
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NOS1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] |
CTD |
PMID:29718165 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH1 protein N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH1 protein] [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased expression of NOTCH1 protein |
CTD |
PMID:36988346 PMID:38042133 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Notch2 |
notch receptor 2 |
increases expression multiple interactions |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH2 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH2 protein N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH2 protein] |
CTD |
PMID:36988346 |
|
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
|
|
G |
Notch3 |
notch receptor 3 |
increases expression affects expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH3 mRNA mono-(2-ethylhexyl)phthalate affects the expression of NOTCH3 protein |
CTD |
PMID:36988346 |
|
NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
|
|
G |
Notch4 |
notch receptor 4 |
increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH4 protein |
CTD |
PMID:36988346 PMID:38042133 |
|
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,160,445...4,184,465
|
|
G |
Npas2 |
neuronal PAS domain protein 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NPAS2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
|
|
G |
Npbwr1 |
neuropeptides B and W receptor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NPBWR1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:13,495,319...13,498,761
Ensembl chr 5:13,495,426...13,496,415
|
|
G |
Npc1l1 |
NPC1 like intracellular cholesterol transporter 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NPC1L1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
|
|
G |
Nphp4 |
nephrocystin 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NPHP4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:162,986,157...163,073,708
Ensembl chr 5:162,988,370...163,073,706
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NPHS1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:85,720,812...85,749,079
Ensembl chr 1:85,720,812...85,749,078
|
|
G |
Nppb |
natriuretic peptide B |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NPPB mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Npy2r |
neuropeptide Y receptor Y2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NPY2R mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:167,901,999...167,912,165
Ensembl chr 2:167,903,879...167,905,024
|
|
G |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
decreases expression increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NR0B1 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of NR0B1 mRNA mono-(2-ethylhexyl)phthalate promotes the reaction [Tretinoin results in increased expression of NR0B1 mRNA] [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NR0B1 mRNA |
CTD |
PMID:16809437 PMID:30476341 PMID:36189433 |
|
NCBI chr X:50,756,886...50,761,014
Ensembl chr X:50,756,886...50,761,011
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate promotes the reaction [NCOA1 protein binds to and results in increased activity of NR1H2 protein] |
CTD |
PMID:27551952 |
|
NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NR1H3 mRNA mono-(2-ethylhexyl)phthalate promotes the reaction [NCOA1 protein binds to and results in increased activity of NR1H3 protein] |
CTD |
PMID:23118965 PMID:27551952 |
|
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NR1H4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases activity |
ISO |
mono-(2-ethylhexyl)phthalate binds to and results in increased activity of NR1I2 protein mono-(2-ethylhexyl)phthalate results in increased activity of NR1I2 protein |
CTD |
PMID:16054614 PMID:27551952 PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions increases activity |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of NR1I3 mRNA; mono-(2-ethylhexyl)phthalate binds to and results in increased activity of NR1I3 protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [Androstane-3,17-diol binds to and results in decreased activity of NR1I3 protein] mono-(2-ethylhexyl)phthalate results in increased activity of NR1I3 protein alternative form |
CTD |
PMID:18832183 PMID:27551952 PMID:31884101 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr2f2 |
nuclear receptor subfamily 2, group F, member 2 |
multiple interactions decreases expression |
ISO |
[Genistein co-treated with mono-(2-ethylhexyl)phthalate] affects the expression of NR2F2 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of NR2F2 mRNA |
CTD |
PMID:27181934 |
|
NCBI chr 1:124,008,282...124,022,521
Ensembl chr 1:124,009,181...124,022,031
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
increases expression decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NR4A1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of NR4A1 mRNA |
CTD |
PMID:19822197 PMID:22401849 PMID:23118965 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NR4A2 mRNA |
CTD |
PMID:19822197 |
|
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NR4A3 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NR4A3 mRNA |
CTD |
PMID:19822197 PMID:36189433 |
|
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
|
|
G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
multiple interactions |
ISO |
[Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of NR5A1 mRNA |
CTD |
PMID:27181934 |
|
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328
|
|
G |
Nrap |
nebulin-related anchoring protein |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NRAP mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NRAP mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 1:255,350,113...255,427,704
Ensembl chr 1:255,350,113...255,427,693
|
|
G |
Nrcam |
neuronal cell adhesion molecule |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NRCAM mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
|
|
G |
Nrep |
neuronal regeneration related protein |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of NREP mRNA |
CTD |
PMID:21195148 |
|
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of NRF1 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
G |
Nrg1 |
neuregulin 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NRG1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Nrn1 |
neuritin 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NRN1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr17:28,129,969...28,138,898
Ensembl chr17:28,129,977...28,138,896
|
|
G |
Nrp2 |
neuropilin 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NRP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:64,122,815...64,238,007
Ensembl chr 9:64,123,132...64,237,958
|
|
G |
Nrsn2 |
neurensin 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NRSN2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:140,838,813...140,847,291
Ensembl chr 3:140,838,814...140,847,297
|
|
G |
Nrxn3 |
neurexin 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NRXN3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:107,641,760...109,272,849
Ensembl chr 6:107,641,780...109,272,044
|
|
G |
Nsdhl |
NAD(P) dependent steroid dehydrogenase-like |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NSDHL mRNA |
CTD |
PMID:37364752 |
|
NCBI chr X:150,775,034...150,807,161
Ensembl chr X:150,775,080...150,807,142
|
|
G |
Nsun7 |
NOP2/Sun RNA methyltransferase family member 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NSUN7 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr14:41,878,562...41,935,238
Ensembl chr14:41,879,293...41,934,949
|
|
G |
Ntm |
neurotrimin |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NTM mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 8:27,376,582...28,366,604
Ensembl chr 8:27,377,773...28,366,595
|
|
G |
Ntmt1 |
N-terminal Xaa-Pro-Lys N-methyltransferase 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NTMT1 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 3:14,093,374...14,110,565
Ensembl chr 3:14,093,977...14,110,663
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NTRK2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Nts |
neurotensin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NTS mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
|
|
G |
Ntsr1 |
neurotensin receptor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NTSR1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:167,606,215...167,656,371
Ensembl chr 3:167,606,215...167,656,377
|
|
G |
Nup210l |
nucleoporin 210-like |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of NUP210L mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:175,545,999...175,665,332
Ensembl chr 2:175,547,988...175,665,332
|
|
G |
Nup62cl |
nucleoporin 62 C-terminal like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NUP62CL mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:103,668,458...103,724,957
Ensembl chr X:103,668,455...103,724,081
|
|
G |
Nutm1 |
NUT midline carcinoma, family member 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NUTM1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:99,053,510...99,064,311
Ensembl chr 3:99,053,510...99,064,311
|
|
G |
Nxf2 |
nuclear RNA export factor 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of NXF7 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr X:98,135,953...98,157,117
Ensembl chr X:98,135,950...98,157,089
|
|
G |
Nxph4 |
neurexophilin 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of NXPH4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:63,367,758...63,376,579
Ensembl chr 7:63,367,761...63,376,579
|
|
G |
Oat |
ornithine aminotransferase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of OAT mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
|
|
G |
Oaz3 |
ornithine decarboxylase antizyme 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of OAZ3 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:182,073,212...182,076,147
Ensembl chr 2:182,073,215...182,082,399
|
|
G |
Ocln |
occludin |
decreases expression affects localization multiple interactions |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of OCLN protein mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein]; mono-(2-ethylhexyl)phthalate results in decreased expression of and results in decreased localization of OCLN protein |
CTD |
PMID:18214902 PMID:29940330 PMID:37941498 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Odad4 |
outer dynein arm docking complex subunit 4 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of ODAD4 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr10:85,480,089...85,508,603
Ensembl chr10:85,480,094...85,508,603
|
|
G |
Ogn |
osteoglycin |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of OGN mRNA |
CTD |
PMID:36314267 |
|
NCBI chr17:15,032,069...15,052,626
Ensembl chr17:15,032,069...15,052,739
|
|
G |
Oip5-as1 |
OIP5 antisense RNA 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of OIP5-AS1 mRNA |
CTD |
PMID:29385630 |
|
NCBI chr 3:106,578,309...106,591,845
|
|
G |
Oit3 |
oncoprotein induced transcript 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of OIT3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:27,390,113...27,410,692
Ensembl chr20:27,390,113...27,410,692
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of OLR1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
|
|
G |
Opcml |
opioid binding protein/cell adhesion molecule-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OPCML mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:26,788,988...27,304,551
Ensembl chr 8:26,192,841...27,300,620
|
|
G |
Oprd1 |
opioid receptor, delta 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of OPRD1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:144,306,188...144,340,960
Ensembl chr 5:144,306,188...144,340,960
|
|
G |
Oprl1 |
opioid related nociceptin receptor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OPRL1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920
|
|
G |
Optc |
opticin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OPTC mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:45,353,954...45,368,254
Ensembl chr13:45,355,148...45,365,237
|
|
G |
Or5m9 |
olfactory receptor family 5 subfamily M member 9 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of OR5M9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:71,072,647...71,073,579
Ensembl chr 3:71,072,647...71,073,579
|
|
G |
Oscar |
osteoclast associated Ig-like receptor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of OSCAR mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:65,607,214...65,615,395
Ensembl chr 1:65,607,410...65,613,758
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of OSGIN1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
|
|
G |
Osr1 |
odd-skipped related transcription factor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OSR1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:32,369,561...32,380,822
Ensembl chr 6:32,373,816...32,380,817
|
|
G |
Otoa |
otoancorin |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of OTOA mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:175,642,978...175,710,528
Ensembl chr 1:175,642,975...175,710,435
|
|
G |
Otog |
otogelin |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of OTOG mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:96,746,336...96,815,416
Ensembl chr 1:96,746,336...96,815,415
|
|
G |
Otud6a |
OTU deubiquitinase 6A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of OTUD6A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:65,514,113...65,516,287
Ensembl chr X:65,514,191...65,515,063
|
|
G |
Otx2 |
orthodenticle homeobox 2 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OTX2 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of OTX2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:21,942,233...21,953,034
Ensembl chr15:21,943,191...21,953,416
|
|
G |
Oxct1 |
3-oxoacid CoA transferase 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of OXCT1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 2:53,236,370...53,384,715
Ensembl chr 2:53,236,368...53,384,714
|
|
G |
Oxnad1 |
oxidoreductase NAD-binding domain containing 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of OXNAD1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:7,293,470...7,322,540
Ensembl chr16:7,293,470...7,322,540
|
|
G |
Oxtr |
oxytocin receptor |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of OXTR mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:145,598,549...145,614,674
Ensembl chr 4:145,599,561...145,614,674
|
|
G |
P2ry14 |
purinergic receptor P2Y14 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of P2RY14 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:143,372,697...143,413,213
Ensembl chr 2:143,372,697...143,413,141
|
|
G |
Pacs1 |
phosphofurin acidic cluster sorting protein 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PACS1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:202,437,503...202,569,473
Ensembl chr 1:202,437,505...202,569,473
|
|
G |
Padi2 |
peptidyl arginine deiminase 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PADI2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 5:153,209,053...153,251,632
Ensembl chr 5:153,209,053...153,251,632
|
|
G |
Padi6 |
peptidyl arginine deiminase 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PADI6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:153,021,855...153,037,443
Ensembl chr 5:153,021,965...153,037,414
|
|
G |
Pah |
phenylalanine hydroxylase |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PAH mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
|
|
G |
Pak5 |
p21 (RAC1) activated kinase 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PAK7 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:123,395,678...123,703,967
Ensembl chr 3:123,396,497...123,703,930
|
|
G |
Pak6 |
p21 (RAC1) activated kinase 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PAK6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:105,638,248...105,674,399
Ensembl chr 3:105,638,653...105,672,975
|
|
G |
Pals2 |
protein associated with LIN7 2, MAGUK p55 family member |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MPP6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:79,173,488...79,257,542
Ensembl chr 4:79,124,806...79,254,140
|
|
G |
Pam |
peptidylglycine alpha-amidating monooxygenase |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of PAM mRNA |
CTD |
PMID:38113427 |
|
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
|
|
G |
Pappa2 |
pappalysin 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PAPPA2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:70,873,918...71,147,874
Ensembl chr13:70,876,794...71,147,779
|
|
G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PAPSS2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
|
|
G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PARP14 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
|
|
G |
Parvb |
parvin, beta |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PARVB mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:115,360,254...115,445,767
Ensembl chr 7:115,360,261...115,445,766
|
|
G |
Patl2 |
PAT1 homolog 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PATL2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:109,072,958...109,087,425
Ensembl chr 3:109,075,290...109,083,253
|
|
G |
Pax2 |
paired box 2 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PAX2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PAX2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:243,616,509...243,697,454
Ensembl chr 1:243,616,606...243,695,321
|
|
G |
Pax3 |
paired box 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PAX3 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 9:79,567,455...79,664,042
Ensembl chr 9:79,568,634...79,664,042
|
|
G |
Pax6 |
paired box 6 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PAX6 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PAX6 mRNA |
CTD |
PMID:31711903 PMID:36189433 |
|
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
|
|
G |
Pax8 |
paired box 8 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PAX8 protein |
CTD |
PMID:36005737 |
|
NCBI chr 3:7,185,721...7,242,363
Ensembl chr 3:7,185,723...7,242,363
|
|
G |
Pbx3 |
PBX homeobox 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PBX3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:17,488,691...17,682,412
Ensembl chr 3:17,488,693...17,682,791
|
|
G |
Pcdh10 |
protocadherin 10 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PCDH10 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:128,617,212...128,683,354
Ensembl chr 2:128,617,174...128,677,190
|
|
G |
Pcdh15 |
protocadherin related 15 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PCDH15 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:13,997,094...15,496,446
Ensembl chr20:13,963,565...15,494,719
|
|
G |
Pcdh7 |
protocadherin 7 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PCDH7 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr14:52,471,801...52,901,696
Ensembl chr14:52,475,610...52,902,051 Ensembl chr14:52,475,610...52,902,051
|
|
G |
Pcdh8 |
protocadherin 8 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PCDH8 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of PCDH8 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:55,198,470...55,203,039
Ensembl chr15:55,198,459...55,205,872
|
|
G |
Pced1b |
PC-esterase domain containing 1B |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PCED1B mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 7:128,394,388...128,528,231
Ensembl chr 7:128,391,319...128,528,231
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PCK1 mRNA |
CTD |
PMID:27384973 PMID:32522588 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PCK2 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PCK2 protein |
CTD |
PMID:31228551 PMID:36695872 |
|
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression multiple interactions decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PCNA protein ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA]; MIR27B mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA]; MIR27B mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA protein]; MIR372 mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA]; MIR372 mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA protein] mono-(2-ethylhexyl)phthalate results in decreased expression of PCNA protein |
CTD |
PMID:30858031 PMID:31351048 PMID:33631300 PMID:37364752 PMID:38048874 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pcnx2 |
pecanex 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PCNX2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:53,718,920...53,869,559
Ensembl chr19:53,718,655...53,871,364
|
|
G |
Pcnx3 |
pecanex 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PCNX3 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 1:202,951,322...202,974,167
Ensembl chr 1:202,951,322...202,976,561
|
|
G |
Pcolce |
procollagen C-endopeptidase enhancer |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PCOLCE mRNA |
CTD |
PMID:22401849 |
|
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
|
|
G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PCSK2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127
|
|
G |
Pcsk7 |
proprotein convertase subtilisin/kexin type 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PCSK7 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:46,202,079...46,224,699
Ensembl chr 8:46,202,131...46,224,705
|
|
G |
Pcsk9 |
proprotein convertase subtilisin/kexin type 9 |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PCSK9 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of PCSK9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:121,211,278...121,233,688
Ensembl chr 5:121,211,278...121,233,688
|
|
G |
Pcyt1a |
phosphate cytidylyltransferase 1A, choline |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PCYT1A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr11:68,313,860...68,357,828
Ensembl chr11:68,313,882...68,357,357
|
|
G |
Pde2a |
phosphodiesterase 2A |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PDE2A mRNA mono-(2-ethylhexyl)phthalate results in increased expression of PDE2A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:155,823,590...155,915,434
Ensembl chr 1:155,813,180...155,915,434
|
|
G |
Pde4d |
phosphodiesterase 4D |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PDE4D mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:40,014,933...41,529,190
Ensembl chr 2:40,019,933...41,525,884
|
|
G |
Pde6b |
phosphodiesterase 6B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PDE6B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:1,323,310...1,366,450
Ensembl chr14:1,323,310...1,366,450
|
|
G |
Pde6c |
phosphodiesterase 6C |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PDE6C mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:235,909,583...235,965,435
Ensembl chr 1:235,909,775...235,965,315
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PDGFA mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PDGFA mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
|
|
G |
Pdha2 |
pyruvate dehydrogenase E1 subunit alpha 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PDHA2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:229,872,300...229,873,848
|
|
G |
Pdilt |
protein disulfide isomerase-like, testis expressed |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PDILT mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:173,837,477...173,868,685
Ensembl chr 1:173,837,478...173,868,685
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PDK4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PDK4 protein |
CTD |
PMID:32522588 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pdlim2 |
PDZ and LIM domain 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PDLIM2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:45,235,421...45,250,187
Ensembl chr15:45,237,477...45,249,242
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PDX1 protein |
CTD |
PMID:38048874 |
|
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
|
|
G |
Pdyn |
prodynorphin |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PDYN mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PDYN mRNA |
CTD |
PMID:36189433 PMID:38113427 |
|
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
|
|
G |
Pdzk1 |
PDZ domain containing 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PDZK1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:184,376,161...184,407,514
Ensembl chr 2:184,376,161...184,407,514
|
|
G |
Pdzrn4 |
PDZ domain containing RING finger 4 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PDZRN4 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PDZRN4 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 7:123,816,961...123,965,491
Ensembl chr 7:123,816,961...123,965,491
|
|
G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
decreases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of PBP mRNA |
CTD |
PMID:22087261 |
|
NCBI chr12:39,302,864...39,307,064
Ensembl chr12:39,302,840...39,307,862
|
|
G |
Peg3 |
paternally expressed 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PEG3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:67,097,874...67,124,692
Ensembl chr 1:67,097,904...67,124,671
|
|
G |
Per2 |
period circadian regulator 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PER2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
|
|
G |
Per3 |
period circadian regulator 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PER3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
|
|
G |
Perp |
p53 apoptosis effector related to PMP22 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PERP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:13,542,067...13,554,514
Ensembl chr 1:13,542,067...13,554,511
|
|
G |
Pex1 |
peroxisomal biogenesis factor 1 |
decreases expression increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PEX1 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of PEX1 mRNA |
CTD |
PMID:22401849 PMID:32522588 |
|
NCBI chr 4:30,519,950...30,558,953
Ensembl chr 4:30,519,955...30,558,921
|
|
G |
Pex16 |
peroxisomal biogenesis factor 16 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PEX16 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 3:78,347,212...78,352,603
Ensembl chr 3:78,343,164...78,353,207
|
|
G |
Pex19 |
peroxisomal biogenesis factor 19 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PEX19 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr13:84,592,277...84,608,793
Ensembl chr13:84,592,312...84,608,608
|
|
G |
Pex5l |
peroxisomal biogenesis factor 5-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PEX5L mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:115,694,868...115,908,365
Ensembl chr 2:115,700,972...115,913,628
|
|
G |
Pf4 |
platelet factor 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PF4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
|
|
G |
Pfas |
phosphoribosylformylglycinamidine synthase |
multiple interactions |
ISO |
[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA |
CTD |
PMID:37160244 |
|
NCBI chr10:53,690,301...53,711,811
Ensembl chr10:53,691,626...53,708,420
|
|
G |
Pgbd5 |
piggyBac transposable element derived 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PGBD5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:52,336,751...52,401,906
Ensembl chr19:52,336,751...52,402,397
|
|
G |
Pgpep1l |
pyroglutamyl-peptidase I-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PGPEP1L mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:121,835,243...121,868,368
Ensembl chr 1:121,840,697...121,869,407
|
|
G |
Pgr |
progesterone receptor |
increases secretion multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased secretion of PGR protein Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased secretion of PGR protein] |
CTD |
PMID:30648648 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Phex |
phosphate regulating endopeptidase X-linked |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PHEX mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:37,607,553...37,856,183
Ensembl chr X:37,610,760...37,854,469
|
|
G |
Phf11 |
PHD finger protein 11 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PHF11D mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:33,390,290...33,414,647
Ensembl chr15:33,390,292...33,413,009
|
|
G |
Phf21b |
PHD finger protein 21B |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of PHF21B mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 7:115,913,704...115,984,215
Ensembl chr 7:115,915,412...115,984,215
|
|
G |
Phlda2 |
pleckstrin homology-like domain, family A, member 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PHLDA2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:198,696,897...198,699,292
Ensembl chr 1:198,696,897...198,697,836
|
|
G |
Phyhip |
phytanoyl-CoA 2-hydroxylase interacting protein |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PHYHIP mRNA |
CTD |
PMID:36695872 |
|
NCBI chr15:45,533,974...45,545,223
Ensembl chr15:45,533,974...45,545,221
|
|
G |
Pid1 |
phosphotyrosine interaction domain containing 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PID1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
|
|
G |
Pik3c2g |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PIK3C2G mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:172,483,752...172,851,623
Ensembl chr 4:172,484,345...172,850,544
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
decreases phosphorylation multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of PIK3R1 protein RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of PIK3R1 protein] |
CTD |
PMID:31228551 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Pink1 |
PTEN induced kinase 1 |
multiple interactions increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein] |
CTD |
PMID:37692514 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase type 1 beta |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PIP5K1B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:221,907,220...222,183,672
Ensembl chr 1:221,914,159...222,183,672
|
|
G |
Pitpnm3 |
PITPNM family member 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PITPNM3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:56,674,697...56,766,552
Ensembl chr10:56,676,261...56,766,584
|
|
G |
Pitx2 |
paired-like homeodomain 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PITX2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:217,717,738...217,737,293
Ensembl chr 2:217,717,693...217,737,293
|
|
G |
Pitx3 |
paired-like homeodomain 3 |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PITX3 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of PITX3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:245,001,106...245,013,881
Ensembl chr 1:245,001,164...245,013,892
|
|
G |
Piwil4 |
piwi-like RNA-mediated gene silencing 4 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PIWIL4 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PIWIL4 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 8:11,536,520...11,579,883
Ensembl chr 8:11,536,520...11,579,761
|
|
G |
Pkhd1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PKHD1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:22,547,396...23,037,443
Ensembl chr 9:22,549,513...23,037,381
|
|
G |
Pklr |
pyruvate kinase L/R |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PKLR mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pla1a |
phospholipase A1 member A |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of PLA1A mRNA |
CTD |
PMID:38113427 |
|
NCBI chr11:62,320,112...62,357,779
Ensembl chr11:62,320,493...62,357,779
|
|
G |
Pla2g10 |
phospholipase A2, group X |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PLA2G10 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:1,597,761...1,610,822
Ensembl chr10:1,597,761...1,609,000
|
|
G |
Pla2r1 |
phospholipase A2 receptor 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PLA2R1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 3:44,883,943...45,013,793
Ensembl chr 3:44,883,943...45,013,660
|
|
G |
Plaat1 |
phospholipase A and acyltransferase 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HRASLS mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:71,517,492...71,537,142
Ensembl chr11:71,517,493...71,527,020
|
|
G |
Plaat3 |
phospholipase A and acyltransferase 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PLAAT3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:204,782,608...204,816,397
Ensembl chr 1:204,782,729...204,817,667
|
|
G |
Plac8 |
placenta associated 8 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PLAC8 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,063,048...9,074,264
|
|
G |
Plat |
plasminogen activator, tissue type |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PLAT mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PLAUR mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Plb1 |
phospholipase B1 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PLB1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PLB1 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 6:24,087,051...24,227,167
Ensembl chr 6:24,089,214...24,210,117
|
|
G |
Plcb1 |
phospholipase C beta 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PLCB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:122,059,988...122,772,896
Ensembl chr 3:122,060,031...122,772,869
|
|
G |
Plcb2 |
phospholipase C, beta 2 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PLCB2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PLCB2 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 3:105,683,676...105,704,384
Ensembl chr 3:105,684,815...105,704,302
|
|
G |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PLCXD2 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr11:54,800,977...54,853,348
Ensembl chr11:54,789,477...54,853,344
|
|
G |
Pld1 |
phospholipase D1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of PLD1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692
|
|
G |
Plekha7 |
pleckstrin homology domain containing A7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PLEKHA7 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 1:170,364,524...170,547,843
Ensembl chr 1:170,365,135...170,547,775
|
|
G |
Plekhb1 |
pleckstrin homology domain containing B1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PLEKHB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:154,998,798...155,013,094
Ensembl chr 1:154,998,800...155,016,142
|
|
G |
Plekhg4 |
pleckstrin homology and RhoGEF domain containing G4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PLEKHG4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:33,251,788...33,266,490
Ensembl chr19:33,249,706...33,266,357
|
|
G |
Plin1 |
perilipin 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate analog results in increased expression of PLIN1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PLIN1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PLIN1 protein |
CTD |
PMID:25777084 PMID:27384973 |
|
NCBI chr 1:133,664,294...133,676,854
Ensembl chr 1:133,664,892...133,676,828
|
|
G |
Plin2 |
perilipin 2 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of PLIN2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plin4 |
perilipin 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PLIN4 protein |
CTD |
PMID:27384973 |
|
NCBI chr 9:929,168...938,062
Ensembl chr 9:929,176...938,056
|
|
G |
Plin5 |
perilipin 5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PLIN5 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:939,745...946,188
Ensembl chr 9:939,747...946,120
|
|
G |
Plk5 |
polo-like kinase 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PLK5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:9,346,777...9,367,923
Ensembl chr 7:9,346,777...9,355,196
|
|
G |
Pls1 |
plastin 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of PLS1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 8:96,316,703...96,426,592
Ensembl chr 8:96,317,849...96,385,195
|
|
G |
Plxna2 |
plexin A2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PLXNA2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr13:106,163,103...106,358,979
Ensembl chr13:106,163,103...106,358,979
|
|
G |
Plxnb3 |
plexin B3 |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PLXNB3 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of PLXNB3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:151,493,832...151,508,688
Ensembl chr X:151,494,207...151,508,674
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
increases expression decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PMAIP1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PMAIP1 protein mono-(2-ethylhexyl)phthalate results in decreased expression of PMAIP1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PMAIP1 mRNA |
CTD |
PMID:24706461 PMID:36189433 PMID:36695872 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pnliprp1 |
pancreatic lipase-related protein 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PNLIPRP1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:257,867,885...257,883,514
Ensembl chr 1:257,867,885...257,883,514
|
|
G |
Pnmt |
phenylethanolamine-N-methyltransferase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PNMT mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:83,383,019...83,386,557
Ensembl chr10:83,384,923...83,386,556
|
|
G |
Pnoc |
prepronociceptin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PNOC mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:39,624,635...39,652,463
Ensembl chr15:39,624,641...39,651,867
|
|
G |
Podn |
podocan |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PODN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:122,774,536...122,796,755
Ensembl chr 5:122,776,549...122,881,287
|
|
G |
Popdc3 |
popeye domain containing 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of POPDC3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr20:48,772,397...48,800,677
Ensembl chr20:48,772,462...48,800,593
|
|
G |
Postn |
periostin |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of POSTN mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of and results in increased methylation of POSTN mRNA |
CTD |
PMID:36314267 PMID:36695872 |
|
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Pot1 |
protection of telomeres 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of POT1A protein |
CTD |
PMID:36174712 |
|
NCBI chr 4:54,205,330...54,263,137
Ensembl chr 4:54,205,332...54,263,042
|
|
G |
Pou3f1 |
POU class 3 homeobox 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of POU3F1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:136,910,391...136,913,371
Ensembl chr 5:136,910,391...136,913,371
|
|
G |
Pou4f1 |
POU class 4 homeobox 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of POU4F1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:81,253,714...81,260,057
Ensembl chr15:81,257,781...81,259,728
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
decreases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of POU5F1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of POU5F1 protein |
CTD |
PMID:30476341 PMID:37364752 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions increases activity increases expression affects binding decreases expression |
ISO EXP |
mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARA protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [PPARA protein binds to NCOR1 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [PPARA protein binds to EP300 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [PPARA protein binds to MED1 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [PPARA protein binds to PPARGC1A protein] mono-(2-ethylhexyl)phthalate results in increased activity of PPARA protein mono-(2-ethylhexyl)phthalate results in increased expression of PPARA mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PPARA protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of PPARA mRNA; mono-(2-ethylhexyl)phthalate inhibits the reaction [PPARA protein binds to NCOR1 protein]; PPARA gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FGF21 mRNA]; PPARA inhibits the reaction [PPARA gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FGF21 mRNA]] mono-(2-ethylhexyl)phthalate binds to PPARA protein mono-(2-ethylhexyl)phthalate results in decreased expression of PPARA protein |
CTD |
PMID:10581215 PMID:15647598 PMID:16326050 PMID:20123618 PMID:27551952 PMID:28571686 PMID:31884101 PMID:35019730 PMID:38048874 More...
|
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
affects expression affects binding increases activity multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate affects the expression of PPARD mRNA; mono-(2-ethylhexyl)phthalate affects the expression of PPARD protein mono-(2-ethylhexyl)phthalate binds to PPARB protein mono-(2-ethylhexyl)phthalate results in increased activity of PPARD protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARD mRNA |
CTD |
PMID:15647598 PMID:23843199 PMID:27551952 PMID:31884101 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions increases expression decreases expression affects binding increases activity affects activity affects expression |
ISO EXP |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]; [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of PPARG promoter; mono-(2-ethylhexyl)phthalate binds to and affects the folding of and results in increased activity of PPARG protein; mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein; PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein]; PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 protein]; PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]; Rosiglitazone promotes the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]] mono-(2-ethylhexyl)phthalate results in increased expression of PPARG mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PPARG protein mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG protein mono-(2-ethylhexyl)phthalate binds to PPARG protein mono-(2-ethylhexyl)phthalate analog results in increased activity of PPARG protein; mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein mono-(2-ethylhexyl)phthalate affects the activity of PPARG protein mono-(2-ethylhexyl)phthalate affects the expression of PPARG mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA; mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein |
CTD |
PMID:10581215 PMID:12927354 PMID:15322177 PMID:15647598 PMID:16326050 PMID:21561829 PMID:23118965 PMID:23843199 PMID:25543134 PMID:25777084 PMID:26172262 PMID:27551952 PMID:28282128 PMID:28416457 PMID:28571686 PMID:30085373 PMID:30138673 PMID:30810372 PMID:31884101 PMID:33049310 PMID:35019730 PMID:37093692 PMID:38048874 More...
|
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions increases expression |
ISO |
mono-(2-ethylhexyl)phthalate promotes the reaction [PPARA protein binds to PPARGC1A protein] mono-(2-ethylhexyl)phthalate results in increased expression of PPARGC1A mRNA |
CTD |
PMID:20123618 PMID:25543134 PMID:32522588 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppargc1b |
PPARG coactivator 1 beta |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of PPARGC1B mRNA |
CTD |
PMID:32522588 |
|
NCBI chr18:54,758,891...54,861,103
Ensembl chr18:54,758,902...54,861,194
|
|
G |
Ppef2 |
protein phosphatase with EF-hand domain 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PPEF2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:15,797,414...15,831,620
Ensembl chr14:15,797,435...15,831,491
|
|
G |
Ppfia3 |
PTPRF interacting protein alpha 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PPFIA3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:95,817,110...95,845,950
Ensembl chr 1:95,817,110...95,845,798
|
|
G |
Ppfibp2 |
PPFIA binding protein 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PPFIBP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:161,504,774...161,687,339
Ensembl chr 1:161,504,890...161,655,212
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of PPP1R15A mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Ppp1r18 |
protein phosphatase 1, regulatory subunit 18 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of PPP1R18 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr20:2,877,567...2,887,526
Ensembl chr20:2,877,567...2,891,802
|
|
G |
Ppp1r1a |
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of PPP1R1A mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 7:134,654,578...134,662,236
Ensembl chr 7:134,654,579...134,662,230
|
|
G |
Ppp2ca |
protein phosphatase 2 catalytic subunit alpha |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of and results in increased activity of PPP2CA protein; Zinc inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of PPP2CA protein] |
CTD |
PMID:35841924 |
|
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
|
|
G |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PPP2R2B mRNA |
CTD |
PMID:36695872 |
|
NCBI chr18:34,653,716...35,080,889
Ensembl chr18:34,653,721...35,081,025
|
|
G |
Prcd |
photoreceptor disc component |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PRCD mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:101,887,192...101,907,647
|
|
G |
Prdm14 |
PR/SET domain 14 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PRDM14 protein |
CTD |
PMID:37364752 |
|
NCBI chr 5:6,082,163...6,092,712
Ensembl chr 5:6,082,442...6,092,712
|
|
G |
Prdm16 |
PR/SET domain 16 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PRDM16 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 5:164,879,864...165,203,986
Ensembl chr 5:164,880,587...165,203,601
|
|
G |
Prdx2 |
peroxiredoxin 2 |
decreases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of PRDX2 mRNA |
CTD |
PMID:22087261 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prkab2 |
protein kinase AMP-activated non-catalytic subunit beta 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PRKAB2 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 2:185,257,218...185,272,846
Ensembl chr 2:185,257,213...185,269,872
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
increases expression decreases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of PRKACA mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of PRKACA mRNA PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of PRKACA mRNA] |
CTD |
PMID:25543134 PMID:36889213 |
|
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Prkag2 |
protein kinase AMP-activated non-catalytic subunit gamma 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PRKAG2 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 4:10,010,890...10,252,155
Ensembl chr 4:10,010,890...10,252,142
|
|
G |
Prkag3 |
protein kinase AMP-activated non-catalytic subunit gamma 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PRKAG3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:76,295,715...76,304,959
Ensembl chr 9:76,295,715...76,304,959
|
|
G |
Prkca |
protein kinase C, alpha |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PRKCA mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PRKG1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Prlr |
prolactin receptor |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PRLR mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
|
|
G |
Prnp |
prion protein |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PRNP mRNA |
CTD |
PMID:23360888 |
|
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
|
|
G |
Prph |
peripherin |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PRPH mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PRPH mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 7:130,218,149...130,222,136
Ensembl chr 7:130,218,357...130,222,136
|
|
G |
Prr15l |
proline rich 15-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PRR15L mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:81,916,491...81,922,454
Ensembl chr10:81,906,471...81,923,283
|
|
G |
Prr23a3 |
proline rich 23A, member 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PRR23A3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:99,446,461...99,447,356
Ensembl chr 8:99,446,461...99,447,249
|
|
G |
Prrt3 |
proline-rich transmembrane protein 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PRRT3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:146,641,173...146,650,487
Ensembl chr 4:146,641,173...146,650,317
|
|
G |
Prss12 |
serine protease 12 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PRSS12 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:211,624,134...211,684,126
Ensembl chr 2:211,624,134...211,684,126
|
|
G |
Prtg |
protogenin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PRTG mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:73,548,440...73,657,945
Ensembl chr 8:73,548,466...73,653,259
|
|
G |
Psat1 |
phosphoserine aminotransferase 1 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PSAT1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PSAT1 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
|
|
G |
Ptafr |
platelet-activating factor receptor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PTAFR mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
|
|
G |
Ptch1 |
patched 1 |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Androgens deficiency] results in increased expression of PTCH1 mRNA; mono-(2-ethylhexyl)phthalate inhibits the reaction [cyclopamine results in decreased expression of PTCH1 mRNA] mono-(2-ethylhexyl)phthalate results in increased expression of PTCH1 mRNA |
CTD |
PMID:26710974 |
|
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
|
|
G |
Ptchd3 |
patched domain containing 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PTCHD3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:107,097,551...107,108,575
Ensembl chr10:107,097,483...107,108,496
|
|
G |
Ptchd4 |
patched domain containing 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PTCHD4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:18,462,934...18,666,272
Ensembl chr 9:18,463,737...18,665,705
|
|
G |
Pten |
phosphatase and tensin homolog |
multiple interactions |
ISO |
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of PTEN mRNA; [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of PTEN protein; [mono-(2-ethylhexyl)phthalate co-treated with bisphenol A co-treated with tubastatin A] results in increased expression of PTEN mRNA; [mono-(2-ethylhexyl)phthalate co-treated with tubastatin A] results in increased expression of PTEN mRNA; HDAC6 protein affects the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of PTEN protein] |
CTD |
PMID:34910997 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgds |
prostaglandin D2 synthase |
multiple interactions decreases expression |
ISO |
[Genistein co-treated with mono-(2-ethylhexyl)phthalate] affects the expression of PTGDS mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of PTGDS mRNA |
CTD |
PMID:34942354 |
|
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
decreases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PTGER2 mRNA PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of PTGER2 mRNA]; PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of PTGER2 protein] [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PTGER2 mRNA |
CTD |
PMID:36189433 PMID:36889213 |
|
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
decreases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PTGER4 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of PTGER4 protein PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of PTGER4 mRNA]; PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of PTGER4 protein] [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PTGER4 mRNA |
CTD |
PMID:36189433 PMID:36889213 |
|
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
|
|
G |
Ptges |
prostaglandin E synthase |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Genistein] affects the expression of PTGES mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of PTGES mRNA |
CTD |
PMID:34942354 PMID:36695872 |
|
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in decreased expression of PTGS1 mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in decreased expression of PTGS1 protein mono-(2-ethylhexyl)phthalate results in decreased expression of PTGS1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of PTGS1 protein |
CTD |
PMID:34942354 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression decreases expression |
ISO EXP |
[mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of PTGS2 protein; Dexamethasone inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PTGS2 mRNA] mono-(2-ethylhexyl)phthalate results in increased expression of PTGS2 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PTGS2 protein mono-(2-ethylhexyl)phthalate results in decreased expression of PTGS2 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of PTGS2 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of PTGS2 protein [PTGS2 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of GNAS protein; PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of HAS2 mRNA]; PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of PRKACA mRNA]; PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of PTGER2 mRNA]; PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of PTGER2 protein]; PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of PTGER4 mRNA]; PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of PTGER4 protein]; PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BAX mRNA]; PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP3 protein]; PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP7 protein] |
CTD |
PMID:9013627 PMID:23360888 PMID:29089286 PMID:34942354 PMID:36889213 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pth2r |
parathyroid hormone 2 receptor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PTH2R mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:66,706,050...66,810,601
Ensembl chr 9:66,706,050...66,810,036
|
|
G |
Ptk2b |
protein tyrosine kinase 2 beta |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PTK2B mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
|
|
G |
Ptp4a3 |
protein tyrosine phosphatase 4A3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PTP4A3 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 7:105,650,640...105,660,921
Ensembl chr 7:105,628,029...105,660,919
|
|
G |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PTPN13 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
|
|
G |
Ptpn18 |
protein tyrosine phosphatase, non-receptor type 18 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PTPN18 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:36,672,325...36,689,963
Ensembl chr 9:36,672,362...36,690,995
|
|
G |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PTPRD mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:90,046,993...90,698,977 NCBI chr 5:91,122,354...91,641,754
Ensembl chr 5:90,048,966...92,369,396
|
|
G |
Ptprh |
protein tyrosine phosphatase, receptor type, H |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PTPRH mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:69,243,704...69,276,294
Ensembl chr 1:69,242,321...69,285,077
|
|
G |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PTPRO mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:170,164,071...170,374,790
Ensembl chr 4:170,164,431...170,374,771
|
|
G |
Ptprq |
protein tyrosine phosphatase, receptor type, Q |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of PTPRQ mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 7:42,834,455...43,016,807
Ensembl chr 7:42,837,109...43,016,917
|
|
G |
Ptx3 |
pentraxin 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PTX3 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
|
|
G |
Pycard |
PYD and CARD domain containing |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of PYCARD protein |
CTD |
PMID:31016965 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Qrich2 |
glutamine rich 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of QRICH2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:101,669,240...101,697,643
Ensembl chr10:101,669,224...101,697,656
|
|
G |
Rab13 |
RAB13, member RAS oncogene family |
multiple interactions |
EXP |
[INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of RAB13 protein |
CTD |
PMID:28526321 |
|
NCBI chr 2:175,674,894...175,680,043
Ensembl chr 2:175,675,005...175,680,036
|
|
G |
Rab20 |
RAB20, member RAS oncogene family |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of RAB20 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr16:78,019,337...78,043,529
Ensembl chr16:78,019,337...78,043,529
|
|
G |
Rab27a |
RAB27A, member RAS oncogene family |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RAB27A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:73,782,730...73,836,630
Ensembl chr 8:73,782,694...73,847,829
|
|
G |
Rab8a |
RAB8A, member RAS oncogene family |
multiple interactions |
EXP |
[INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of RAB8A protein |
CTD |
PMID:28526321 |
|
NCBI chr16:17,654,027...17,675,385
Ensembl chr16:17,654,034...17,675,678
|
|
G |
Rabggta |
Rab geranylgeranyltransferase subunit alpha |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RABGGTA mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:29,206,328...29,213,398
Ensembl chr15:29,206,157...29,213,348
|
|
G |
Ranbp17 |
RAN binding protein 17 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of RANBP17 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:17,800,406...18,102,947
Ensembl chr10:17,800,999...18,102,831
|
|
G |
Rarb |
retinoic acid receptor, beta |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RARB mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rasal1 |
RAS protein activator like 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RASAL1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr12:35,881,269...35,913,727
Ensembl chr12:35,881,270...35,913,727
|
|
G |
Rasd1 |
ras related dexamethasone induced 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RASD1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
|
|
G |
Rasd2 |
RASD family, member 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RASD2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:13,594,291...13,605,016
Ensembl chr19:13,594,291...13,605,016
|
|
G |
Rasgef1c |
RasGEF domain family, member 1C |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of RASGEF1C mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RASGEF1C mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr10:34,227,483...34,293,676
Ensembl chr10:34,227,483...34,293,675
|
|
G |
Rasgrf2 |
RAS protein-specific guanine nucleotide-releasing factor 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of RASGRF2 mRNA |
CTD |
PMID:22401849 PMID:36695872 |
|
NCBI chr 2:23,113,613...23,361,537
Ensembl chr 2:23,117,004...23,361,240
|
|
G |
Rassf10 |
Ras association domain family member 10 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RASSF10 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:167,058,277...167,063,591
Ensembl chr 1:167,058,099...167,063,572
|
|
G |
Rassf4 |
Ras association domain family member 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RASSF4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:149,897,525...149,932,658
Ensembl chr 4:149,897,543...149,932,411
|
|
G |
Rbbp7 |
RB binding protein 7, chromatin remodeling factor |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of RBBP7 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr X:31,913,080...31,931,245
Ensembl chr X:31,913,081...31,931,226
|
|
G |
Rbks |
ribokinase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RBKS mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:24,747,651...24,824,290
Ensembl chr 6:24,747,293...24,824,290
|
|
G |
Rbm24 |
RNA binding motif protein 24 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RBM24 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:18,275,681...18,288,231
Ensembl chr17:18,275,688...18,288,102
|
|
G |
Rbm3 |
RNA binding motif protein 3 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of RBM3 mRNA |
CTD |
PMID:38113427 |
|
NCBI chr X:14,348,909...14,352,387
Ensembl chr X:14,348,910...14,353,580
|
|
G |
Rbm44 |
RNA binding motif protein 44 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of RBM44 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RBM44 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 9:91,731,153...91,756,783
Ensembl chr 9:91,731,115...91,756,772
|
|
G |
Rbmx |
RNA binding motif protein, X-linked |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of RBMX mRNA |
CTD |
PMID:21195148 |
|
NCBI chr X:135,305,237...135,314,806
Ensembl chr X:135,305,325...135,314,743
|
|
G |
Rbp1 |
retinol binding protein 1 |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of RBP1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RBP1 mRNA |
CTD |
PMID:30476341 PMID:36189433 |
|
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
|
|
G |
Rbp4 |
retinol binding protein 4 |
multiple interactions increases expression |
ISO |
RBP4 protein promotes the reaction [[mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of GSK3B protein]; RBP4 protein promotes the reaction [[mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of IRS1 protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased abundance of Glycogen]]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of GSK3B protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of IRS1 protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of PIK3R1 protein] mono-(2-ethylhexyl)phthalate results in increased expression of RBP4 protein |
CTD |
PMID:31228551 |
|
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
|
|
G |
Rbpjl |
recombination signal binding protein for immunoglobulin kappa J region-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RBPJL mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:153,134,044...153,147,421
Ensembl chr 3:153,134,140...153,146,513
|
|
G |
Rec8 |
REC8 meiotic recombination protein |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of REC8 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:29,109,862...29,117,327
Ensembl chr15:29,109,863...29,117,326
|
|
G |
Recql |
RecQ like helicase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RECQL mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases expression multiple interactions affects expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of RELA mRNA fulvestrant inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of RELA protein]; mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased activity of RELA protein; mono-(2-ethylhexyl)phthalate results in increased phosphorylation of and affects the localization of RELA protein mono-(2-ethylhexyl)phthalate results in increased expression of RELA protein modified form mono-(2-ethylhexyl)phthalate affects the expression of RELA protein |
CTD |
PMID:28390675 PMID:31016965 PMID:38048874 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rem2 |
RRAD and GEM like GTPase 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of REM2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:27,933,950...27,938,429
Ensembl chr15:27,933,950...27,938,429
|
|
G |
Rgcc |
regulator of cell cycle |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RGCC mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
|
|
G |
Rgs16 |
regulator of G-protein signaling 16 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RGS16 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
|
|
G |
Rgs4 |
regulator of G-protein signaling 4 |
increases expression decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of RGS4 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of RGS4 mRNA |
CTD |
PMID:36314267 PMID:36695872 |
|
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
|
|
G |
Rgs6 |
regulator of G-protein signaling 6 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RGS6 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 6:102,264,451...102,796,311
Ensembl chr 6:102,264,447...102,824,753
|
|
G |
Rgs7 |
regulator of G-protein signaling 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RGS7 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr13:86,979,269...87,408,834
Ensembl chr13:86,979,279...87,408,888
|
|
G |
Rhod |
ras homolog family member D |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RHOD mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:201,708,699...201,724,405
Ensembl chr 1:201,708,699...201,722,632
|
|
G |
Rhox13 |
Rhox homeobox family member 13 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RHOX13 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:116,911,226...116,917,758
Ensembl chr X:116,911,329...116,917,644
|
|
G |
Rhox8 |
reproductive homeobox 8 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RHOX8 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of RHOX8 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:116,584,742...116,588,365
Ensembl chr X:116,584,582...116,588,365
|
|
G |
Rhox9 |
reproductive homeobox 9 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RHOX9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:116,641,863...116,644,714
Ensembl chr X:116,641,863...116,644,714
|
|
G |
Rimbp2 |
RIMS binding protein 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of RIMBP2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr12:27,747,615...27,946,256
Ensembl chr12:27,747,980...27,956,763
|
|
G |
Rims1 |
regulating synaptic membrane exocytosis 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of RIMS1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:24,696,959...25,196,404
Ensembl chr 9:24,698,854...25,196,631
|
|
G |
Rims4 |
regulating synaptic membrane exocytosis 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RIMS4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:152,520,982...152,585,070
Ensembl chr 3:152,524,095...152,584,780
|
|
G |
Rin3 |
Ras and Rab interactor 3 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of RIN3 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 6:121,431,776...121,540,956
Ensembl chr 6:121,431,339...121,540,957
|
|
G |
Ripor3 |
RIPOR family member 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RIPOR3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:156,687,253...156,760,524
Ensembl chr 3:156,687,517...156,715,061
|
|
G |
Rnd1 |
Rho family GTPase 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of RND1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
|
|
G |
Rnd3 |
Rho family GTPase 3 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of RND3 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
|
|
G |
Rnf112 |
ring finger protein 112 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RNF112 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:46,121,146...46,126,691
Ensembl chr10:46,121,148...46,126,699
|
|
G |
Rnf123 |
ring finger protein 123 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RNF123 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:108,740,176...108,768,177
Ensembl chr 8:108,739,620...108,767,675
|
|
G |
Rnf152 |
ring finger protein 152 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RNF152 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:21,324,039...21,403,405
Ensembl chr13:21,323,824...21,403,113
|
|
G |
Rnf180 |
ring finger protein 180 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RNF180 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:36,330,285...36,511,168
Ensembl chr 2:36,330,292...36,512,614
|
|
G |
Rnf207 |
ring finger protein 207 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RNF207 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:162,815,351...162,828,325
Ensembl chr 5:162,815,357...162,828,375
|
|
G |
Rnf222 |
ring finger protein 222 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of RNF222 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RNF222 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:53,596,751...53,603,305
Ensembl chr10:53,596,751...53,603,300
|
|
G |
Robo2 |
roundabout guidance receptor 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ROBO2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536
|
|
G |
Rora |
RAR-related orphan receptor A |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RORA mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
|
|
G |
Rorb |
RAR-related orphan receptor B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RORB mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:216,363,629...216,544,390
Ensembl chr 1:216,363,629...216,544,390
|
|
G |
Rph3a |
rabphilin 3A |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of RPH3A mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RPH3A mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr12:35,542,389...35,618,901
Ensembl chr12:35,542,728...35,617,592
|
|
G |
Rpl23 |
ribosomal protein L23 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of RPL23 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr10:82,771,878...82,775,840
Ensembl chr10:82,771,538...82,775,870
|
|
G |
Rpl3l |
ribosomal protein L3-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RPL3L mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:13,753,914...13,764,458
Ensembl chr10:13,753,886...13,764,457
|
|
G |
Rpp25 |
ribonuclease P and MRP subunit p25 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RPP25 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:57,907,352...57,908,732
Ensembl chr 8:57,907,352...57,908,732
|
|
G |
Rprml |
reprimo-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RPRML mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:88,560,248...88,561,252
Ensembl chr10:88,560,248...88,561,252
|
|
G |
Rps6 |
ribosomal protein S6 |
increases phosphorylation multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased phosphorylation of RPS6 protein epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of RPS6 protein] |
CTD |
PMID:37286014 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Rrad |
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RRAD mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RRAD mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
|
|
G |
Rragd |
Ras-related GTP binding D |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RRAGD mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:47,373,902...47,409,369
Ensembl chr 5:47,373,463...47,409,356
|
|
G |
Rsph1 |
radial spoke head component 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RSPH1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:9,341,910...9,360,640
Ensembl chr20:9,341,913...9,360,640
|
|
G |
Rsph4a |
radial spoke head component 4A |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of RSPH4A mRNA |
CTD |
PMID:21195148 |
|
NCBI chr20:30,764,409...30,780,574
Ensembl chr20:30,764,409...30,780,574
|
|
G |
Rsph9 |
radial spoke head component 9 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of RSPH9 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 9:14,840,115...14,852,950
Ensembl chr 9:14,840,115...14,860,062
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of H2-AB1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of H2-AB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
|
|
G |
RT1-CE2 |
RT1 class I, locus CE2 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of RT1-CE2 mRNA |
CTD |
PMID:38113427 |
|
NCBI chr20:3,538,452...3,541,841
Ensembl chr20:3,537,809...3,541,790
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of H2-EB1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of H2-EB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
Rtl3 |
retrotransposon Gag like 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RTL3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:71,947,343...71,951,008
Ensembl chr X:71,948,253...71,950,121
|
|
G |
Rtn4r |
reticulon 4 receptor |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RTN4R mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of RTN4R mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:82,844,309...82,869,251
Ensembl chr11:82,844,309...82,869,466
|
|
G |
Rufy4 |
RUN and FYVE domain containing 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RUFY4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:75,702,937...75,727,719
Ensembl chr 9:75,703,750...75,723,525
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RUNX1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RUNX2 mRNA |
CTD |
PMID:22401849 PMID:25777084 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Rxra |
retinoid X receptor alpha |
affects binding |
ISO |
mono-(2-ethylhexyl)phthalate binds to RXRA protein |
CTD |
PMID:23843199 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Rxrb |
retinoid X receptor beta |
affects binding |
ISO |
mono-(2-ethylhexyl)phthalate binds to RXRB protein |
CTD |
PMID:23843199 |
|
NCBI chr20:4,816,813...4,823,267
Ensembl chr20:4,816,815...4,828,773
|
|
G |
Rxrg |
retinoid X receptor gamma |
affects binding |
ISO |
mono-(2-ethylhexyl)phthalate binds to RXRG protein |
CTD |
PMID:23843199 |
|
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
|
|
G |
Ryr1 |
ryanodine receptor 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of RYR1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
|
|
G |
Samd5 |
sterile alpha motif domain containing 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SAMD5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:4,041,547...4,090,909
Ensembl chr 1:3,677,784...4,091,120
|
|
G |
Satb2 |
SATB homeobox 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SATB2 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 9:58,348,027...58,534,256
Ensembl chr 9:58,350,246...58,530,707
|
|
G |
Sbk3 |
SH3 domain binding kinase family, member 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SBK3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:68,867,847...68,873,249
Ensembl chr 1:68,868,238...68,871,392
|
|
G |
Scara3 |
scavenger receptor class A, member 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SCARA3 mRNA |
CTD |
PMID:23360888 |
|
NCBI chr15:40,139,873...40,172,866
Ensembl chr15:40,140,161...40,172,894
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
decreases expression increases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of SCARB1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SCARB1 protein mono-(2-ethylhexyl)phthalate results in increased expression of SCARB1 mRNA [Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of SCARB1 mRNA; METTL14 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of SCARB1 mRNA]; mono-(2-ethylhexyl)phthalate affects the reaction [METTL14 protein affects the expression of SCARB1 mRNA]; mono-(2-ethylhexyl)phthalate results in decreased expression of and results in decreased methylation of SCARB1 mRNA |
CTD |
PMID:22087261 PMID:22401849 PMID:27181934 PMID:31875672 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Scd |
stearoyl-CoA desaturase |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SCD mRNA |
CTD |
PMID:23118965 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scg3 |
secretogranin III |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SCG3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 8:76,399,777...76,442,015
Ensembl chr 8:76,399,777...76,442,015
|
|
G |
Scin |
scinderin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SCIN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:57,109,500...57,188,123
Ensembl chr 6:57,109,403...57,188,242
|
|
G |
Scn10a |
sodium voltage-gated channel alpha subunit 10 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SCN10A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
|
|
G |
Scn1a |
sodium voltage-gated channel alpha subunit 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SCN1A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:50,952,790...51,071,804
Ensembl chr 3:50,952,791...51,071,699
|
|
G |
Scn3b |
sodium voltage-gated channel beta subunit 3 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SCN3B mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SCN3B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:40,630,372...40,652,869
Ensembl chr 8:40,630,455...40,652,868
|
|
G |
Scn9a |
sodium voltage-gated channel alpha subunit 9 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SCN9A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:51,145,148...51,293,342
Ensembl chr 3:51,145,146...51,293,516
|
|
G |
Sct |
secretin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SCT mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:196,382,856...196,383,658
|
|
G |
Scube2 |
signal peptide, CUB domain and EGF like domain containing 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SCUBE2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:163,831,876...163,899,925
Ensembl chr 1:163,832,015...163,899,393
|
|
G |
Sec14l4 |
SEC14-like lipid binding 4 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of SEC14L4 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr14:78,912,750...78,928,799
Ensembl chr14:78,912,750...78,956,099
|
|
G |
Sec62 |
SEC62 homolog, preprotein translocation factor |
decreases methylation |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased methylation of SEC62 mRNA |
CTD |
PMID:31875672 |
|
NCBI chr 2:112,570,810...112,598,198
Ensembl chr 2:112,570,819...112,601,814
|
|
G |
Sel1l3 |
SEL1L family member 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SEL1L3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:57,775,515...57,882,076
Ensembl chr14:57,775,501...57,882,644
|
|
G |
Sema3d |
semaphorin 3D |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SEMA3D mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:22,316,769...22,505,930
Ensembl chr 4:22,316,779...22,505,930
|
|
G |
Sema3g |
semaphorin 3G |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SEMA3G mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:6,413,589...6,425,221
Ensembl chr16:6,413,589...6,425,221
|
|
G |
Sema4g |
semaphorin 4G |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SEMA4G mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:243,849,979...243,865,343
Ensembl chr 1:243,853,854...243,865,341
|
|
G |
Septin12 |
septin 12 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SEPT12 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:10,580,900...10,590,582
Ensembl chr10:10,581,008...10,590,581
|
|
G |
Serpina12 |
serpin family A member 12 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SERPINA12 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:122,952,552...122,967,271
Ensembl chr 6:122,952,552...122,967,271
|
|
G |
Serpina16 |
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 16 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SERPINA16 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SERPINA16 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:122,800,869...122,808,247
Ensembl chr 6:122,800,873...122,808,247
|
|
G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SERPINA3N mRNA |
CTD |
PMID:38113427 |
|
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
|
|
G |
Serpina5 |
serpin family A member 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SERPINA5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:123,023,306...123,028,407
|
|
G |
Serpinb1a |
serpin family B member 1A |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SERPINB1A mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SERPINB1A mRNA |
CTD |
PMID:36189433 PMID:38113427 |
|
NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102
|
|
G |
Serpine1 |
serpin family E member 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SERPINE1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sertm1 |
serine-rich and transmembrane domain containing 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SERTM1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:139,086,905...139,106,528
Ensembl chr 2:139,086,908...139,106,459
|
|
G |
Sertm2 |
serine rich and transmembrane domain containing 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SERTM2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:107,727,772...107,739,795
Ensembl chr X:107,727,813...107,740,264
|
|
G |
Sesn2 |
sestrin 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SESN2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Sez6 |
seizure related 6 homolog |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SEZ6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:62,818,931...62,868,686
Ensembl chr10:62,819,069...62,868,671
|
|
G |
Sfn |
stratifin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SFN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sfrp4 |
secreted frizzled-related protein 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SFRP4 mRNA |
CTD |
PMID:37364752 |
|
NCBI chr17:45,278,867...45,330,806
Ensembl chr17:45,234,097...45,330,736
|
|
G |
Sftpc |
surfactant protein C |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SFTPC mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
|
|
G |
Sgcd |
sarcoglycan, delta |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SGCD mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:31,346,480...32,328,364
Ensembl chr10:31,280,511...31,724,840
|
|
G |
Sgcg |
sarcoglycan, gamma |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SGCG mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:35,388,836...35,435,072
Ensembl chr15:35,386,534...35,435,148
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SGK1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Sgpp2 |
sphingosine-1-phosphate phosphatase 2 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SGPP2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SGPP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:79,762,658...79,884,665
Ensembl chr 9:79,763,284...79,880,457
|
|
G |
Sgtb |
small glutamine rich tetratricopeptide repeat co-chaperone beta |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SGTB mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:35,233,045...35,269,527
Ensembl chr 2:35,233,042...35,269,518
|
|
G |
Sh2d2a |
SH2 domain containing 2A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SH2D2A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:173,312,253...173,318,810
Ensembl chr 2:173,312,253...173,318,810
|
|
G |
Sh3bgr |
SH3 domain binding glutamate-rich protein |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SH3BGR mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SH3BGR mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr11:35,503,663...35,527,853
Ensembl chr11:35,503,725...35,527,853
|
|
G |
Sh3bp5 |
SH3-domain binding protein 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SH3BP5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:6,583,462...6,678,344
Ensembl chr16:6,583,465...6,698,975
|
|
G |
Sh3rf1 |
SH3 domain containing ring finger 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of SH3RF1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr16:28,735,522...28,901,261
Ensembl chr16:28,735,440...28,901,644
|
|
G |
Sh3rf2 |
SH3 domain containing ring finger 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SH3RF2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:34,045,715...34,148,342
Ensembl chr18:34,046,879...34,146,856
|
|
G |
Shbg |
sex hormone binding globulin |
decreases secretion increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased secretion of SHBG protein mono-(2-ethylhexyl)phthalate results in increased expression of SHBG mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SHBG mRNA |
CTD |
PMID:24945889 PMID:36189433 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
|
|
G |
Shc3 |
SHC adaptor protein 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SHC3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:13,652,247...13,772,710
Ensembl chr17:13,651,202...13,772,710
|
|
G |
Shc4 |
SHC adaptor protein 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SHC4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:112,880,598...112,974,216
Ensembl chr 3:112,880,600...112,974,366
|
|
G |
Shh |
sonic hedgehog signaling molecule |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SHH mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
|
|
G |
Shisa3 |
shisa family member 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SHISA3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:40,563,672...40,568,244
Ensembl chr14:40,563,673...40,568,244
|
|
G |
Shisa6 |
shisa family member 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SHISA6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:50,897,740...51,192,111
Ensembl chr10:50,903,333...51,192,063
|
|
G |
Shisa9 |
shisa family member 9 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SHISA9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:3,335,616...3,629,334
Ensembl chr10:3,337,979...3,627,773
|
|
G |
Shkbp1 |
Sh3kbp1 binding protein 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SHKBP1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:82,636,797...82,650,330
Ensembl chr 1:82,636,797...82,650,375
|
|
G |
Shox1 |
SHOX homeobox 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RHOX10 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:116,688,163...116,695,111
Ensembl chr X:116,688,163...116,695,058
|
|
G |
Si |
sucrase-isomaltase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SIS mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 2:157,505,893...157,586,228
Ensembl chr 2:157,506,342...157,585,260
|
|
G |
Sidt1 |
SID1 transmembrane family, member 1 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SIDT1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SIDT1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:56,362,788...56,459,939
Ensembl chr11:56,363,512...56,459,050
|
|
G |
Sirt1 |
sirtuin 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT1 protein |
CTD |
PMID:31016965 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Sirt2 |
sirtuin 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT2 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT2 protein |
CTD |
PMID:31016965 |
|
NCBI chr 1:84,053,883...84,076,975
Ensembl chr 1:84,052,903...84,076,975
|
|
G |
Sirt3 |
sirtuin 3 |
increases expression decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SIRT3 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT3 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT3 protein |
CTD |
PMID:25543134 PMID:31016965 PMID:32522588 |
|
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
|
|
G |
Sirt4 |
sirtuin 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT4 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT4 protein |
CTD |
PMID:31016965 |
|
NCBI chr12:41,125,533...41,139,440
Ensembl chr12:41,131,262...41,139,439
|
|
G |
Sirt5 |
sirtuin 5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT5 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT5 protein |
CTD |
PMID:31016965 |
|
NCBI chr17:21,310,028...21,337,137
Ensembl chr17:21,310,028...21,337,101
|
|
G |
Sirt6 |
sirtuin 6 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT6 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT6 protein |
CTD |
PMID:31016965 |
|
NCBI chr 7:8,082,312...8,087,776
Ensembl chr 7:8,082,364...8,098,914
|
|
G |
Sirt7 |
sirtuin 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT7 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT7 protein |
CTD |
PMID:31016965 |
|
NCBI chr10:105,896,476...105,903,301
Ensembl chr10:105,896,476...105,903,172
|
|
G |
Six2 |
SIX homeobox 2 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of SIX2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 6:8,974,859...8,981,345
Ensembl chr 6:8,967,157...8,981,193
|
|
G |
Skida1 |
SKI/DACH domain containing 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SKIDA1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr17:80,798,241...80,809,062
Ensembl chr17:80,803,716...80,806,463
|
|
G |
Skor1 |
SKI family transcriptional corepressor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SKOR1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:63,599,153...63,609,727
Ensembl chr 8:63,599,165...63,607,756
|
|
G |
Skp2 |
S-phase kinase associated protein 2 |
multiple interactions |
ISO |
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of SKP2 mRNA |
CTD |
PMID:31884101 |
|
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
|
|
G |
Slc10a7 |
solute carrier family 10, member 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC10A7 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr19:29,183,143...29,407,470
Ensembl chr19:29,183,155...29,407,464
|
|
G |
Slc12a1 |
solute carrier family 12 member 1 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC12A1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC12A1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:112,406,140...112,482,913
Ensembl chr 3:112,406,140...112,482,899
|
|
G |
Slc12a8 |
solute carrier family 12, member 8 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC12A8 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr11:67,116,876...67,266,548
Ensembl chr11:67,116,877...67,266,834
|
|
G |
Slc13a1 |
solute carrier family 13 member 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SLC13A1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 4:52,569,179...52,647,126
Ensembl chr 4:52,569,375...52,647,099
|
|
G |
Slc13a2 |
solute carrier family 13 member 2 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC13A2 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of SLC13A2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:63,291,813...63,319,127
Ensembl chr10:63,291,815...63,319,127
|
|
G |
Slc16a10 |
solute carrier family 16 member 10 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC16A10 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:43,454,819...43,567,839
Ensembl chr20:43,459,709...43,567,839
|
|
G |
Slc16a5 |
solute carrier family 16 member 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC16A5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:100,707,434...100,721,338
Ensembl chr10:100,707,434...100,721,338
|
|
G |
Slc16a8 |
solute carrier family 16 member 8 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC16A8 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:110,818,274...110,822,069
Ensembl chr 7:110,818,274...110,822,069
|
|
G |
Slc17a1 |
solute carrier family 17 member 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC17A1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr17:41,219,461...41,255,199
Ensembl chr17:41,222,049...41,253,304
|
|
G |
Slc1a3 |
solute carrier family 1 member 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC1A3 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:57,755,495...57,830,605
Ensembl chr 2:57,755,497...57,830,605
|
|
G |
Slc22a4 |
solute carrier family 22 member 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC22A4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
|
|
G |
Slc25a20 |
solute carrier family 25 member 20 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SLC25A20 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
|
|
G |
Slc25a30 |
solute carrier family 25, member 30 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC25A30 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:51,076,998...51,099,613
Ensembl chr15:51,077,002...51,099,613
|
|
G |
Slc25a34 |
solute carrier family 25, member 34 |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC25A34 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of SLC25A34 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:153,932,081...153,936,854
|
|
G |
Slc25a38 |
solute carrier family 25, member 38 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of SLC25A38 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 8:119,835,546...119,848,334
Ensembl chr 8:119,835,634...119,848,332
|
|
G |
Slc25a41 |
solute carrier family 25, member 41 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC25A41 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 9:1,873,692...1,881,405
Ensembl chr 9:1,873,692...1,881,424
|
|
G |
Slc25a45 |
solute carrier family 25, member 45 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC25A45 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:203,166,362...203,174,473
Ensembl chr 1:203,166,683...203,174,473
|
|
G |
Slc25a48 |
solute carrier family 25, member 48 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SLC25A48 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC25A48 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr17:8,119,964...8,161,293
Ensembl chr17:8,121,175...8,160,748
|
|
G |
Slc26a3 |
solute carrier family 26 member 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC26A3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 6:48,023,892...48,064,829
Ensembl chr 6:48,023,892...48,064,772
|
|
G |
Slc26a5 |
solute carrier family 26 member 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC26A5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:13,210,260...13,249,289
Ensembl chr 4:13,210,260...13,249,289
|
|
G |
Slc27a1 |
solute carrier family 27 member 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of SLC27A1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of SLC27A1 protein |
CTD |
PMID:15647598 |
|
NCBI chr16:18,278,984...18,300,173
Ensembl chr16:18,278,984...18,296,063
|
|
G |
Slc27a2 |
solute carrier family 27 member 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC27A2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
increases expression decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SLC2A1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of SLC2A1 protein |
CTD |
PMID:31009676 PMID:38048874 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a12 |
solute carrier family 2 member 12 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC2A12 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC2A12 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 1:22,803,068...22,862,204
Ensembl chr 1:22,804,418...22,860,971
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
increases expression multiple interactions |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of SLC2A4 mRNA [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of SLC2A4 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of SLC2A4 protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased expression of SLC2A4 protein] |
CTD |
PMID:25543134 PMID:28526321 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc32a1 |
solute carrier family 32 member 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC32A1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:147,267,373...147,271,842
Ensembl chr 3:147,267,373...147,271,844
|
|
G |
Slc34a2 |
solute carrier family 34 member 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC34A2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436
|
|
G |
Slc35d2 |
solute carrier family 35 member D2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC35D2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr17:987,899...1,019,747
Ensembl chr17:988,157...1,019,743
|
|
G |
Slc35f1 |
solute carrier family 35, member F1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC35F1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:32,030,350...32,418,762
Ensembl chr20:32,030,368...32,418,611
|
|
G |
Slc38a11 |
solute carrier family 38, member 11 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SLC38A11 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:49,987,119...50,033,615
Ensembl chr 3:49,987,124...50,033,615
|
|
G |
Slc44a3 |
solute carrier family 44, member 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC44A3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:209,552,138...209,628,182
Ensembl chr 2:209,552,144...209,629,044
|
|
G |
Slc45a4 |
solute carrier family 45, member 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC45A4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:105,478,886...105,550,160
Ensembl chr 7:105,481,792...105,550,170
|
|
G |
Slc4a10 |
solute carrier family 4 member 10 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC4A10 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:46,665,076...46,959,088
Ensembl chr 3:46,665,265...46,957,268
|
|
G |
Slc52a3 |
solute carrier family 52 member 3 |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC52A3 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of SLC52A3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:140,498,924...140,515,845
Ensembl chr 3:140,509,473...140,514,096
|
|
G |
Slc5a10 |
solute carrier family 5 member 10 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC5A10 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr10:46,352,060...46,400,795
Ensembl chr10:46,352,061...46,399,811
|
|
G |
Slc5a11 |
solute carrier family 5 member 11 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SLC5A11 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:177,735,511...177,795,193
Ensembl chr 1:177,756,561...177,795,193
|
|
G |
Slc5a4 |
solute carrier family 5 member 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC5A4A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr20:12,475,644...12,518,738
Ensembl chr20:12,475,644...12,518,738
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC5A5 protein |
CTD |
PMID:36005737 |
|
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
|
|
G |
Slc5a6 |
solute carrier family 5 member 6 |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [4-phenylbutyric acid results in increased expression of SLC5A6 protein] |
CTD |
PMID:36005737 |
|
NCBI chr 6:25,319,187...25,331,713
Ensembl chr 6:25,320,442...25,331,712
|
|
G |
Slc5a9 |
solute carrier family 5 member 9 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SLC5A9 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:126,709,762...126,733,468
Ensembl chr 5:126,709,769...126,733,468
|
|
G |
Slc6a14 |
solute carrier family 6 member 14 |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC6A14 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of SLC6A14 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
|
|
G |
Slc6a15 |
solute carrier family 6 member 15 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC6A15 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:38,553,055...38,607,239
Ensembl chr 7:38,553,196...38,607,239
|
|
G |
Slc6a2 |
solute carrier family 6 member 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC6A2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr19:14,010,292...14,055,317
Ensembl chr19:14,010,386...14,050,357
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC6A3 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC6A4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Slc6a9 |
solute carrier family 6 member 9 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SLC6A9 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 5:131,374,562...131,408,733
Ensembl chr 5:131,374,542...131,408,728
|
|
G |
Slc7a10 |
solute carrier family 7 member 10 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC7A10 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:87,829,084...87,845,073
Ensembl chr 1:87,829,175...87,845,071
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression multiple interactions decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 protein ferrostatin-1 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 protein] RSL3 compound promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of SLC7A11 protein] |
CTD |
PMID:24356939 PMID:34863575 PMID:36438553 PMID:36695872 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc7a3 |
solute carrier family 7 member 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC7A3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:66,210,071...66,216,482
Ensembl chr X:66,210,081...66,215,708
|
|
G |
Slc7a9 |
solute carrier family 7 member 9 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC7A9 mRNA |
CTD |
PMID:27167697 |
|
NCBI chr 1:88,109,517...88,132,653
Ensembl chr 1:88,110,644...88,132,641
|
|
G |
Slc8b1 |
solute carrier family 8 member B1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC8B1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:36,029,759...36,053,087
Ensembl chr12:36,029,760...36,053,031
|
|
G |
Slc9a2 |
solute carrier family 9 member A2 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SLC9A2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC9A2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:42,932,001...43,014,447
Ensembl chr 9:42,931,346...43,014,444
|
|
G |
Slc9a3 |
solute carrier family 9 member A3 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLC9A3 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC9A3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:29,124,633...29,167,912
Ensembl chr 1:29,124,674...29,167,417
|
|
G |
Slc9a4 |
solute carrier family 9 member A4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC9A4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 9:42,825,334...42,879,729
Ensembl chr 9:42,825,064...42,879,422
|
|
G |
Slc9a9 |
solute carrier family 9 member A9 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC9A9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:95,232,889...95,797,262
Ensembl chr 8:95,232,905...95,796,318
|
|
G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLCO2B1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
|
|
G |
Slco6b1 |
solute carrier organic anion transporter family member 6B1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SLCO6B1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:97,266,655...97,347,336
Ensembl chr 9:97,271,334...97,347,336
|
|
G |
Slfn9 |
schlafen family member 9 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SLFN11 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr10:67,909,105...67,955,912
Ensembl chr10:67,909,106...67,925,383
|
|
G |
Slit1 |
slit guidance ligand 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLIT1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:240,409,559...240,558,127
Ensembl chr 1:240,409,561...240,558,127
|
|
G |
Slit3 |
slit guidance ligand 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SLIT3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:19,571,798...20,156,634
Ensembl chr10:19,571,684...20,156,634
|
|
G |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLITRK1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:85,723,252...85,727,290
Ensembl chr15:85,724,475...85,727,509
|
|
G |
Slitrk2 |
SLIT and NTRK-like family, member 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLITRK2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:145,246,448...145,259,983
Ensembl chr X:145,246,460...145,271,220
|
|
G |
Slitrk4 |
SLIT and NTRK-like family, member 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLITRK4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:142,706,495...142,718,968
Ensembl chr X:142,706,338...142,718,575
|
|
G |
Slitrk5 |
SLIT and NTRK-like family, member 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLITRK5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:88,848,123...88,858,809
Ensembl chr15:88,847,535...88,856,836
|
|
G |
Smad6 |
SMAD family member 6 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SMAD6 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 8:64,450,114...64,519,673
Ensembl chr 8:64,450,114...64,519,763
|
|
G |
Smad7 |
SMAD family member 7 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of SMAD7 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Smc1b |
structural maintenance of chromosomes 1B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SMC1B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:116,180,987...116,242,778
Ensembl chr 7:116,180,987...116,242,744
|
|
G |
Smo |
smoothened, frizzled class receptor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Androgens deficiency] results in increased expression of SMO mRNA; mono-(2-ethylhexyl)phthalate inhibits the reaction [cyclopamine results in increased expression of SMO mRNA] |
CTD |
PMID:26710974 |
|
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
|
|
G |
Snap23 |
synaptosome associated protein 23 |
multiple interactions |
EXP |
mono-(2-ethylhexyl)phthalate affects the reaction [INS1 protein affects the expression of SNAP23 protein] |
CTD |
PMID:28526321 |
|
NCBI chr 3:107,514,088...107,546,177
Ensembl chr 3:107,514,131...107,544,320
|
|
G |
Snap25 |
synaptosome associated protein 25 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SNAP25 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
|
|
G |
Snrnp35 |
small nuclear ribonucleoprotein U11/U12 subunit 35 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SNRNP35 mRNA |
CTD |
PMID:38113427 |
|
NCBI chr12:32,112,032...32,119,829
Ensembl chr12:32,110,993...32,122,660
|
|
G |
Sntb1 |
syntrophin, beta 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SNTB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:87,060,926...87,329,315
Ensembl chr 7:87,060,926...87,329,315
|
|
G |
Soat2 |
sterol O-acyltransferase 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SOAT2 mRNA |
CTD |
PMID:22401849 PMID:36695872 |
|
NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:133,281,818...133,294,915
|
|
G |
Socs2 |
suppressor of cytokine signaling 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SOCS2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SOD1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of SOD1 protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of SOD1 mRNA Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of SOD1 protein] |
CTD |
PMID:20438828 PMID:35861251 PMID:37692514 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SOD2 protein |
CTD |
PMID:34627990 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sohlh2 |
spermatogenesis and oogenesis specific basic helix-loop-helix 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SOHLH2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:139,362,246...139,384,700
Ensembl chr 2:139,362,246...139,384,699
|
|
G |
Sorbs2 |
sorbin and SH3 domain containing 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SORBS2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr16:46,435,220...46,748,743
Ensembl chr16:46,435,237...46,626,514
|
|
G |
Sostdc1 |
sclerostin domain containing 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SOSTDC1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:53,051,336...53,055,510
Ensembl chr 6:53,051,354...53,055,579
|
|
G |
Sowahb |
sosondowah ankyrin repeat domain family member B |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SOWAHB mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:15,029,203...15,033,038
Ensembl chr14:15,029,395...15,031,698
|
|
G |
Sowahd |
sosondowah ankyrin repeat domain family member D |
decreases expression increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SOWAHD mRNA mono-(2-ethylhexyl)phthalate results in increased expression of SOWAHD mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SOWAHD mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr X:116,292,030...116,293,660
Ensembl chr X:116,292,030...116,293,660
|
|
G |
Sox3 |
SRY-box transcription factor 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SOX3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:139,308,608...139,310,687
Ensembl chr X:139,309,329...139,310,678
|
|
G |
Sox6 |
SRY-box transcription factor 6 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SOX6 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 1:169,723,306...170,334,846
Ensembl chr 1:169,729,194...170,277,386
|
|
G |
Sox7 |
SRY-box transcription factor 7 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SOX7 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:38,180,503...38,187,264
Ensembl chr15:38,180,503...38,187,264
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SOX9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Sp7 |
Sp7 transcription factor |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate analog results in decreased expression of SP7 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SP7 mRNA |
CTD |
PMID:25777084 |
|
NCBI chr 7:133,484,609...133,494,788
Ensembl chr 7:133,484,609...133,494,847
|
|
G |
Spaca5 |
sperm acrosome associated 5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SPACA5 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr X:918,817...922,000
Ensembl chr X:918,817...922,049
|
|
G |
Spag1 |
sperm associated antigen 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SPAG1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:67,361,474...67,421,369
Ensembl chr 7:67,361,477...67,421,368
|
|
G |
Spam1 |
sperm adhesion molecule 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SPAM1 mRNA |
CTD |
PMID:38113427 |
|
NCBI chr 4:53,302,745...53,312,913
Ensembl chr 4:53,302,745...53,312,908
|
|
G |
Spata21 |
spermatogenesis associated 21 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPATA21 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:153,393,309...153,419,430
Ensembl chr 5:153,393,365...153,418,561
|
|
G |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of SPECC1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr10:46,638,947...46,912,989
Ensembl chr10:46,638,809...46,912,802
|
|
G |
Spef1 |
sperm flagellar 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of SPEF1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 3:118,390,659...118,396,842
Ensembl chr 3:118,390,575...118,394,531
|
|
G |
Spic |
Spi-C transcription factor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SPIC mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:23,069,815...23,077,517
Ensembl chr 7:23,069,821...23,077,548
|
|
G |
Spin4 |
spindlin family, member 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SPIN4 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr X:59,888,728...59,892,817
Ensembl chr X:59,891,581...59,892,330
|
|
G |
Spmip8 |
sperm microtubule inner protein 8 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TEPP mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:9,713,281...9,722,257
Ensembl chr19:9,712,641...9,722,257
|
|
G |
Spn |
sialophorin |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SPN mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:181,746,937...181,759,564
Ensembl chr 1:181,746,429...181,759,628
|
|
G |
Spns3 |
sphingolipid transporter 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SPNS3 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr10:57,114,247...57,169,056
Ensembl chr10:57,114,266...57,168,951
|
|
G |
Spocd1 |
SPOC domain containing 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPOCD1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:142,288,822...142,297,113
|
|
G |
Spon2 |
spondin 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SPON2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:77,505,695...77,518,001
Ensembl chr14:77,511,901...77,517,996
|
|
G |
Spry4 |
sprouty RTK signaling antagonist 4 |
increases expression multiple interactions decreases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SPRY4 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SPRY4 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of SPRY4 mRNA |
CTD |
PMID:16809437 PMID:36189433 PMID:36314267 PMID:36695872 |
|
NCBI chr18:30,436,513...30,451,426
Ensembl chr18:30,436,443...30,453,004
|
|
G |
Spsb1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPSB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:160,358,292...160,418,541
Ensembl chr 5:160,358,308...160,418,468
|
|
G |
Spta1 |
spectrin, alpha, erythrocytic 1 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SPTA1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPTA1 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr13:86,203,504...86,279,371
Ensembl chr13:86,203,504...86,279,371
|
|
G |
Sptbn2 |
spectrin, beta, non-erythrocytic 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SPTBN2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:202,002,970...202,045,343
Ensembl chr 1:202,002,970...202,044,283
|
|
G |
Sptbn4 |
spectrin, beta, non-erythrocytic 4 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SPTBN4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:82,650,750...82,738,345
Ensembl chr 1:82,650,751...82,737,228
|
|
G |
Sptbn5 |
spectrin, beta, non-erythrocytic 5 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SPTBN5 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPTBN5 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr 3:107,013,783...107,054,878
Ensembl chr 3:107,013,265...107,054,324
|
|
G |
Sqle |
squalene epoxidase |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SQLE mRNA |
CTD |
PMID:23118965 |
|
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions |
EXP |
[INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of SRC protein |
CTD |
PMID:28526321 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
increases expression multiple interactions affects expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SREBF1 mRNA [Genistein co-treated with mono-(2-ethylhexyl)phthalate] affects the expression of SREBF1 mRNA mono-(2-ethylhexyl)phthalate affects the expression of SREBF1 mRNA |
CTD |
PMID:23118965 PMID:27181934 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SREBF2 mRNA |
CTD |
PMID:23118965 |
|
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
|
|
G |
Srpk3 |
SRSF protein kinase 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SRPK3 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr X:151,510,452...151,515,208
Ensembl chr X:151,510,539...151,515,198
|
|
G |
Sspo |
SCO-spondin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SSPO mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:77,394,915...77,450,526
Ensembl chr 4:77,397,059...77,450,412
|
|
G |
Sstr1 |
somatostatin receptor 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SSTR1 mRNA |
CTD |
PMID:22401849 PMID:36695872 |
|
NCBI chr 6:75,832,292...75,836,806
Ensembl chr 6:75,832,530...75,836,802
|
|
G |
Sstr3 |
somatostatin receptor 3 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SSTR3 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SSTR3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:110,092,563...110,109,043
Ensembl chr 7:110,092,575...110,099,769
|
|
G |
St6galnac3 |
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ST6GALNAC3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:242,129,755...242,645,120
Ensembl chr 2:242,129,763...242,645,133
|
|
G |
St8sia5 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ST8SIA5 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ST8SIA5 mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr18:70,736,395...70,802,537
Ensembl chr18:70,736,602...70,797,789
|
|
G |
St8sia6 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ST8SIA6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr17:76,740,755...76,884,178
Ensembl chr17:76,745,224...76,884,299
|
|
G |
Stab2 |
stabilin 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of STAB2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:21,249,426...21,433,051
Ensembl chr 7:21,249,391...21,434,042
|
|
G |
Stac2 |
SH3 and cysteine rich domain 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STAC2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:83,032,418...83,048,260
Ensembl chr10:83,032,417...83,048,260
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression affects expression increases activity increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of STAR mRNA mono-(2-ethylhexyl)phthalate affects the expression of STAR mono-(2-ethylhexyl)phthalate results in increased activity of STAR protein mono-(2-ethylhexyl)phthalate results in increased expression of STAR mRNA mono-(2-ethylhexyl)phthalate results in increased expression of STAR mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of STAR protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of STAR mRNA; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of STAR protein]; Genistein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of STAR mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [LHB protein results in increased expression of STAR protein] mono-(2-ethylhexyl)phthalate promotes the reaction [Tretinoin results in decreased expression of STAR mRNA] |
CTD |
PMID:16809437 PMID:19560483 PMID:22087261 PMID:22401849 PMID:22525294 PMID:25677926 PMID:27181934 PMID:30476341 PMID:30648648 PMID:31884101 PMID:34627990 More...
|
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
decreases expression multiple interactions |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of STAT5A mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of and results in decreased phosphorylation of STAT5A protein; STAT5A protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CTGF protein]; STAT5A protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP2 protein]; STAT5A protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 protein]; STAT5A protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TIMP2 protein] |
CTD |
PMID:35143864 |
|
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
|
|
G |
Stc1 |
stanniocalcin 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of STC1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
|
|
G |
Stc2 |
stanniocalcin 2 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of STC2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of STC2 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
|
|
G |
Steap4 |
STEAP4 metalloreductase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of STEAP4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:26,077,182...26,099,859
Ensembl chr 4:26,054,671...26,099,859
|
|
G |
Stim1 |
stromal interaction molecule 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STIM1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:156,656,246...156,818,777
Ensembl chr 1:156,656,013...156,818,363
|
|
G |
Stk32a |
serine/threonine kinase 32A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of STK32A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:35,258,865...35,374,985
Ensembl chr18:35,259,052...35,369,451
|
|
G |
Stk32c |
serine/threonine kinase 32C |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of STK32C mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STK32C mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:193,900,718...193,981,723
Ensembl chr 1:193,900,718...193,981,723
|
|
G |
Stmn2 |
stathmin 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STMN2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:93,204,690...93,252,011
Ensembl chr 2:93,204,692...93,252,011
|
|
G |
Stmn4 |
stathmin 4 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of STMN4 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of STMN4 mRNA |
CTD |
PMID:36189433 PMID:36314267 |
|
NCBI chr15:40,541,305...40,559,253
Ensembl chr15:40,541,357...40,559,253
|
|
G |
Stra8 |
stimulated by retinoic acid 8 |
multiple interactions increases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of STRA8 mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STRA8 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of STRA8 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of STRA8 protein |
CTD |
PMID:34942354 PMID:36189433 PMID:37364752 |
|
NCBI chr 4:63,601,443...63,624,777
Ensembl chr 4:63,601,604...63,624,771
|
|
G |
Strc |
stereocilin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of STRC mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:108,335,920...108,355,114
Ensembl chr 3:108,335,747...108,354,134
|
|
G |
Strip2 |
striatin interacting protein 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of STRIP2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:58,536,034...58,578,279
Ensembl chr 4:58,536,055...58,578,291
|
|
G |
Stx4 |
syntaxin 4 |
multiple interactions |
EXP |
[INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of STX4 protein |
CTD |
PMID:28526321 |
|
NCBI chr 1:182,451,108...182,459,701
Ensembl chr 1:182,451,117...182,459,979
|
|
G |
Stxbp3 |
syntaxin binding protein 3 |
multiple interactions |
EXP |
[INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of STXBP3 protein |
CTD |
PMID:28526321 |
|
NCBI chr 2:196,442,738...196,485,733
Ensembl chr 2:196,442,634...196,485,671
|
|
G |
Stxbp4 |
syntaxin binding protein 4 |
multiple interactions |
EXP |
[INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of STXBP4 protein |
CTD |
PMID:28526321 |
|
NCBI chr10:75,301,868...75,458,741
Ensembl chr10:75,305,463...75,458,663
|
|
G |
Stxbp6 |
syntaxin binding protein 6 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of STXBP6 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 6:61,920,756...62,157,405
Ensembl chr 6:61,920,756...62,158,024
|
|
G |
Sult2b1 |
sulfotransferase family 2B member 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SULT2B1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:96,200,155...96,261,295
Ensembl chr 1:96,200,156...96,261,295
|
|
G |
Susd3 |
sushi domain containing 3 |
decreases expression increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of SUSD3 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of SUSD3 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr17:15,400,845...15,417,851
Ensembl chr17:15,400,845...15,417,044
|
|
G |
Sv2c |
synaptic vesicle glycoprotein 2c |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SV2C mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:27,232,933...27,428,479
Ensembl chr 2:27,232,933...27,428,477
|
|
G |
Syce1l |
synaptonemal complex central element protein 1-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SYCE1L mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:41,625,074...41,635,541
Ensembl chr19:41,617,180...41,635,526
|
|
G |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SYNE3 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 6:123,872,895...123,964,773
Ensembl chr 6:123,873,174...123,953,409
|
|
G |
Syngr4 |
synaptogyrin 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SYNGR4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:96,358,679...96,371,840
Ensembl chr 1:96,360,456...96,371,663
|
|
G |
Synpr |
synaptoporin |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SYNPR mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:11,573,373...11,900,255
Ensembl chr15:11,574,231...11,900,243
|
|
G |
Syt1 |
synaptotagmin 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SYT1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:43,813,204...44,358,020
Ensembl chr 7:43,815,785...44,357,803
|
|
G |
Syt12 |
synaptotagmin 12 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of SYT12 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 1:201,729,307...201,760,192
Ensembl chr 1:201,730,371...201,759,609
|
|
G |
Syt15 |
synaptotagmin 15 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SYT15 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:9,532,478...9,543,288
Ensembl chr16:9,532,478...9,543,281
|
|
G |
Syt2 |
synaptotagmin 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SYT2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:46,088,046...46,197,976
Ensembl chr13:46,185,282...46,193,859
|
|
G |
Syt4 |
synaptotagmin 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SYT4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:23,036,973...23,046,380
Ensembl chr18:23,038,378...23,046,332
|
|
G |
Syt6 |
synaptotagmin 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SYT6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:191,093,009...191,152,283
Ensembl chr 2:191,093,007...191,149,956
|
|
G |
Syt7 |
synaptotagmin 7 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of SYT7 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 1:207,031,359...207,093,787
Ensembl chr 1:207,031,592...207,089,026
|
|
G |
Sytl3 |
synaptotagmin-like 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SYTL3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:46,896,308...46,967,461
Ensembl chr 1:46,911,217...46,967,460
|
|
G |
Sytl5 |
synaptotagmin-like 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SYTL5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:12,775,529...13,030,134
Ensembl chr X:12,788,698...13,030,175
|
|
G |
Taf1 |
TATA-box binding protein associated factor 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TAF1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr X:66,640,915...66,716,543
Ensembl chr X:66,640,982...66,716,543
|
|
G |
Tafa2 |
TAFA chemokine like family member 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FAM19A2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:58,942,598...59,418,640
Ensembl chr 7:58,942,610...59,417,299
|
|
G |
Tapbp |
TAP binding protein |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TAPBP mRNA |
CTD |
PMID:38113427 |
|
NCBI chr20:4,956,937...4,966,191
Ensembl chr20:4,956,937...4,966,181
|
|
G |
Tbc1d4 |
TBC1 domain family, member 4 |
multiple interactions |
EXP |
[INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of TBC1D4 protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein] |
CTD |
PMID:28526321 |
|
NCBI chr15:78,256,030...78,434,168
Ensembl chr15:78,257,121...78,434,265
|
|
G |
Tbc1d9b |
TBC1 domain family member 9B |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TBC1D9B mRNA |
CTD |
PMID:38113427 |
|
NCBI chr10:34,459,930...34,497,146
Ensembl chr10:34,459,953...34,497,145
|
|
G |
Tbx22 |
T-box transcription factor 22 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TBX22 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:72,723,619...72,774,647
Ensembl chr X:72,723,617...72,774,647
|
|
G |
Tbx3 |
T-box transcription factor 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TBX3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
|
|
G |
Tcerg1l |
transcription elongation regulator 1-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TCERG1L mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:193,012,937...193,201,860
Ensembl chr 1:193,012,937...193,200,913
|
|
G |
Tcl1a |
Tcl1 family Akt coactivator A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TCL1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:124,125,032...124,131,025
Ensembl chr 6:124,125,032...124,131,025
|
|
G |
Tdh |
L-threonine dehydrogenase |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TDH mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:37,739,823...37,753,365
Ensembl chr15:37,739,823...37,753,365
|
|
G |
Tdrd5 |
tudor domain containing 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TDRD5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:68,394,180...68,447,745
Ensembl chr13:68,394,061...68,441,319
|
|
G |
Tdrd9 |
tudor domain containing 9 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TDRD9 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 6:131,029,644...131,145,076
Ensembl chr 6:131,029,652...131,144,651
|
|
G |
Tecrl |
trans-2,3-enoyl-CoA reductase-like |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TECRL mRNA |
CTD |
PMID:22401849 |
|
NCBI chr14:24,732,241...24,805,272
Ensembl chr14:24,732,241...24,805,272
|
|
G |
Tef |
TEF transcription factor, PAR bZIP family member |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TEF mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:113,317,191...113,341,783
Ensembl chr 7:113,317,283...113,341,783
|
|
G |
Tekt5 |
tektin 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TEKT5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:5,279,856...5,316,619
Ensembl chr10:5,279,893...5,316,619
|
|
G |
Tenm1 |
teneurin transmembrane protein 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TENM1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:121,400,466...122,289,877
Ensembl chr X:121,403,649...122,290,207
|
|
G |
Tent5c |
terminal nucleotidyltransferase 5C |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FAM46C mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:187,853,026...187,875,260
Ensembl chr 2:187,853,024...187,894,744
|
|
G |
Tent5d |
terminal nucleotidyltransferase 5D |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FAM46D mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:72,901,287...72,974,562
Ensembl chr X:72,901,241...72,970,573
|
|
G |
Terb1 |
telomere repeat binding bouquet formation protein 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TERB1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr19:473,720...528,069
Ensembl chr19:473,218...528,084
|
|
G |
Terb2 |
telomere repeat binding bouquet formation protein 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TERB2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:109,138,343...109,156,700
Ensembl chr 3:109,138,343...109,156,683
|
|
G |
Terf1 |
telomeric repeat binding factor 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TRF1 protein |
CTD |
PMID:36174712 |
|
NCBI chr 5:3,443,103...3,472,377
Ensembl chr 5:3,443,106...3,472,340
|
|
G |
Tert |
telomerase reverse transcriptase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TERT protein |
CTD |
PMID:36174712 |
|
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tesmin |
testis expressed metallothionein like protein |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TESMIN mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:200,629,688...200,648,434
Ensembl chr 1:200,630,144...200,648,433
|
|
G |
Testin |
testin gene |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of TESTIN mRNA |
CTD |
PMID:38113427 |
|
NCBI chr17:3,824,222...3,859,385
Ensembl chr17:3,846,899...3,859,385
|
|
G |
Tet3 |
tet methylcytosine dioxygenase 3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TET3 mRNA |
CTD |
PMID:36535558 |
|
NCBI chr 4:115,867,412...115,964,433
Ensembl chr 4:115,871,265...115,964,193
|
|
G |
Tex11 |
testis expressed 11 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TEX11 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:65,932,904...66,196,525
Ensembl chr X:65,932,988...66,196,187
|
|
G |
Tex13b |
testis expressed 13B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TEX13B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:104,490,937...104,511,224
Ensembl chr X:104,490,091...104,494,201
|
|
G |
Tfam |
transcription factor A, mitochondrial |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TFAM mRNA |
CTD |
PMID:32522588 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Tfap2c |
transcription factor AP-2 gamma |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TFAP2C mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:161,315,114...161,322,998
Ensembl chr 3:161,315,031...161,322,995
|
|
G |
Tfap2e |
transcription factor AP-2 epsilon |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TFAP2E mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:139,009,447...139,030,695
Ensembl chr 5:139,009,453...139,031,108
|
|
G |
Tfcp2l1 |
transcription factor CP2-like 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TFCP2L1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:29,733,813...29,793,870
Ensembl chr13:29,733,840...29,793,870
|
|
G |
Tfr2 |
transferrin receptor 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TFR2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:19,107,673...19,124,622
Ensembl chr12:19,107,673...19,124,591
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TFRC mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tg |
thyroglobulin |
multiple interactions decreases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TG protein] |
CTD |
PMID:36005737 |
|
NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
|
|
G |
Tgfa |
transforming growth factor alpha |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TGFA mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TGFB2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgm1 |
transglutaminase 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TGM1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
|
|
G |
Tgm2 |
transglutaminase 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TGM2 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
|
|
G |
Tgm5 |
transglutaminase 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TGM5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:108,008,087...108,044,013
Ensembl chr 3:108,008,143...108,043,976
|
|
G |
Th |
tyrosine hydroxylase |
decreases expression increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TH mRNA mono-(2-ethylhexyl)phthalate results in increased expression of TH mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TH mRNA |
CTD |
PMID:21145954 PMID:22401849 PMID:36189433 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thap8 |
THAP domain containing 8 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of THAP8 mRNA |
CTD |
PMID:36189433 |
|
|
|
G |
Thbs1 |
thrombospondin 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of THBS1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Thsd7b |
thrombospondin type 1 domain containing 7B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of THSD7B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:40,768,567...41,667,262
Ensembl chr13:40,768,570...41,666,501
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
decreases expression multiple interactions increases expression |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of TIMP1 mRNA 2-chloro-5-nitrobenzanilide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 protein]; mifobate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 protein]; PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 protein] mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 mRNA |
CTD |
PMID:22401849 PMID:28416457 PMID:38113427 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
decreases expression multiple interactions affects expression increases expression |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of TIMP2 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of TIMP2 protein Colforsin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TIMP2 protein]; STAT5A protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TIMP2 protein] mono-(2-ethylhexyl)phthalate affects the expression of TIMP2 mRNA; mono-(2-ethylhexyl)phthalate affects the expression of TIMP2 protein ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of TIMP2 mRNA] |
CTD |
PMID:21832167 PMID:33631300 PMID:35143864 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
decreases expression multiple interactions increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TINAGL1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TINAGL1 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of TINAGL1 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 5:142,513,710...142,523,730
Ensembl chr 5:142,513,714...142,523,720
|
|
G |
Tjp1 |
tight junction protein 1 |
decreases expression multiple interactions |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein]; mono-(2-ethylhexyl)phthalate results in decreased expression of and results in decreased localization of TJP1 protein |
CTD |
PMID:18214902 PMID:29940330 PMID:37941498 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tktl2 |
transketolase-like 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TKTL2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:23,202,460...23,209,741
Ensembl chr16:23,202,453...23,209,742
|
|
G |
Tlcd3b |
TLC domain containing 3B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FAM57B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:181,421,104...181,439,744
Ensembl chr 1:181,422,830...181,439,743
|
|
G |
Tle2 |
TLE family member 2, transcriptional corepressor |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TLE2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:8,119,049...8,135,385
Ensembl chr 7:8,119,053...8,134,306
|
|
G |
Tll1 |
tolloid-like 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TLL1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:25,509,146...25,710,330
Ensembl chr16:25,509,146...25,709,543
|
|
G |
Tll2 |
tolloid-like 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TLL2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:239,912,648...240,028,168
Ensembl chr 1:239,915,508...240,028,120
|
|
G |
Tlr2 |
toll-like receptor 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TLR2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlx1 |
T-cell leukemia, homeobox 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TLX1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 1:244,005,057...244,011,318
Ensembl chr 1:244,005,057...244,011,318
|
|
G |
Tm6sf1 |
transmembrane 6 superfamily member 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TM6SF1 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 1:135,799,844...135,828,515
Ensembl chr 1:135,786,381...135,828,443
|
|
G |
Tm7sf2 |
transmembrane 7 superfamily member 2 |
decreases expression affects expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TM7SF2 mRNA mono-(2-ethylhexyl)phthalate affects the expression of TM7SF2 mRNA |
CTD |
PMID:22401849 PMID:37364752 |
|
NCBI chr 1:203,355,930...203,360,287
Ensembl chr 1:203,355,931...203,360,270
|
|
G |
Tmed5 |
transmembrane p24 trafficking protein 5 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TMED5 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr14:1,607,895...1,619,028
Ensembl chr14:1,607,819...1,628,426
|
|
G |
Tmeff2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TMEFF2 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TMEFF2 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 9:50,445,947...50,733,473
Ensembl chr 9:50,436,079...50,733,475
|
|
G |
Tmem114 |
transmembrane protein 114 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TMEM114 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:7,168,998...7,185,251
Ensembl chr10:7,169,746...7,185,251
|
|
G |
Tmem117 |
transmembrane protein 117 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TMEM117 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:125,757,591...126,219,692
Ensembl chr 7:125,757,591...126,219,690
|
|
G |
Tmem130 |
transmembrane protein 130 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TMEM130 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr12:9,837,055...9,862,843
Ensembl chr12:9,837,055...9,862,840
|
|
G |
Tmem132c |
transmembrane protein 132C |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TMEM132C mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:29,115,213...29,437,900
Ensembl chr12:29,116,467...29,437,870
|
|
G |
Tmem145 |
transmembrane protein 145 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TMEM145 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:80,891,888...80,901,615
Ensembl chr 1:80,891,927...80,901,611
|
|
G |
Tmem150c |
transmembrane protein 150C |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TMEM150C mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:9,454,999...9,525,300
Ensembl chr14:9,508,515...9,525,298
|
|
G |
Tmem154 |
transmembrane protein 154 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TMEM154 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 2:170,015,247...170,054,903
Ensembl chr 2:170,015,184...170,052,481
|
|
G |
Tmem178b |
transmembrane protein 178B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TMEM178B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:68,659,425...69,035,690
Ensembl chr 4:68,657,343...69,035,690
|
|
G |
Tmem200a |
transmembrane protein 200A |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TMEM200A mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 1:19,323,646...19,408,324
Ensembl chr 1:19,323,829...19,406,453
|
|
G |
Tmem255a |
transmembrane protein 255A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TMEM255A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:116,970,793...117,035,008
Ensembl chr X:116,970,695...117,035,008
|
|
G |
Tmem26 |
transmembrane protein 26 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TMEM26 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:19,820,768...19,872,561
Ensembl chr20:19,822,975...19,872,023
|
|
G |
Tmem37 |
transmembrane protein 37 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of TMEM37 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr13:31,184,322...31,191,477
Ensembl chr13:31,171,355...31,191,077
|
|
G |
Tmem52 |
transmembrane protein 52 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TMEM52 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:166,048,669...166,050,423
Ensembl chr 5:166,046,565...166,050,433
|
|
G |
Tmem54 |
transmembrane protein 54 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TMEM54 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:141,449,191...141,455,683
Ensembl chr 5:141,449,191...141,455,682
|
|
G |
Tmem59l |
transmembrane protein 59-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TMEM59L mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:18,941,370...18,945,381
Ensembl chr16:18,941,567...18,945,381
|
|
G |
Tmem62 |
transmembrane protein 62 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TMEM62 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:107,921,940...107,961,830
Ensembl chr 3:107,927,307...107,961,795
|
|
G |
Tmem71 |
transmembrane protein 71 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TMEM71 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:98,276,975...98,323,161
Ensembl chr 7:98,276,975...98,315,858
|
|
G |
Tmem72 |
transmembrane protein 72 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TMEM72 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:149,946,296...149,973,550
Ensembl chr 4:149,948,257...149,973,550
|
|
G |
Tmem86a |
transmembrane protein 86A |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TMEM86A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:97,595,910...97,600,260
Ensembl chr 1:97,595,842...97,600,260
|
|
G |
Tmod1 |
tropomodulin 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TMOD1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:60,316,445...60,393,957
Ensembl chr 5:60,338,512...60,393,956
|
|
G |
Tmprss15 |
transmembrane serine protease 15 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TMPRSS15 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr11:17,677,741...17,802,255
Ensembl chr11:17,677,741...17,802,255
|
|
G |
Tmprss5 |
transmembrane serine protease 5 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TMPRSS5 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 8:49,437,321...49,461,395
Ensembl chr 8:49,441,984...49,460,071
|
|
G |
Tnf |
tumor necrosis factor |
increases secretion increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased secretion of TNF protein mono-(2-ethylhexyl)phthalate results in increased expression of TNF mRNA mono-(2-ethylhexyl)phthalate promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] |
CTD |
PMID:22143055 PMID:27384973 PMID:29718165 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
decreases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of TNFAIP6 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of TNFAIP6 protein |
CTD |
PMID:36889213 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
|
|
G |
Tnfrsf11a |
TNF receptor superfamily member 11A |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TNFRSF11A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr13:21,928,370...21,986,719
Ensembl chr13:21,928,408...21,986,695
|
|
G |
Tnfrsf12a |
TNF receptor superfamily member 12A |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TNFRSF12A mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
|
|
G |
Tnfrsf13b |
TNF receptor superfamily member 13B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TNFRSF13B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:45,801,860...45,824,932
Ensembl chr10:45,801,860...45,822,987
|
|
G |
Tnfrsf21 |
TNF receptor superfamily member 21 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TNFRSF21 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TNFRSF21 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 9:17,879,156...17,954,085
Ensembl chr 9:17,879,156...17,954,085
|
|
G |
Tnfrsf8 |
TNF receptor superfamily member 8 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TNFRSF8 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 5:157,123,183...157,168,421
Ensembl chr 5:157,123,185...157,168,421
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of and results in increased methylation of TNFSF10 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tnfsf13b |
TNF superfamily member 13b |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TNFSF13B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:79,462,406...79,492,888
Ensembl chr16:79,462,402...79,492,693
|
|
G |
Tnnc2 |
troponin C2, fast skeletal type |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TNNC2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:153,513,272...153,516,033
Ensembl chr 3:153,513,271...153,516,029
|
|
G |
Tnnt1 |
troponin T1, slow skeletal type |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TNNT1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:69,306,362...69,316,721
Ensembl chr 1:69,306,362...69,316,721
|
|
G |
Tnnt2 |
troponin T2, cardiac type |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TNNT2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
|
|
G |
Tns3 |
tensin 3 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TNS3 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr14:83,173,649...83,405,671
Ensembl chr14:83,173,649...83,405,998
|
|
G |
Tnxb |
tenascin XB |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TNXB mRNA |
CTD |
PMID:22401849 |
|
|
|
G |
Togaram2 |
TOG array regulator of axonemal microtubules 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TOGARAM2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:23,770,979...23,828,884
Ensembl chr 6:23,771,052...23,828,499
|
|
G |
Tox2 |
TOX high mobility group box family member 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TOX2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:151,853,294...151,980,086
Ensembl chr 3:151,853,294...151,980,749
|
|
G |
Tox3 |
TOX high mobility group box family member 3 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of TOX3 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr19:16,648,338...16,757,151
Ensembl chr19:16,648,342...16,757,148
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression increases activity decreases response to substance |
ISO |
Selenomethionine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TRP53 protein]; Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TRP53 protein] mono-(2-ethylhexyl)phthalate results in increased expression of TP53 protein; mono-(2-ethylhexyl)phthalate results in increased expression of TRP53 protein mono-(2-ethylhexyl)phthalate results in increased activity of TP53 protein gingerol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TP53 protein]; mono-(2-ethylhexyl)phthalate results in increased phosphorylation of and results in increased expression of TP53 protein; Selenomethionine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of TP53 protein]; Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of TP53 protein] TP53 protein results in decreased susceptibility to mono-(2-ethylhexyl)phthalate |
CTD |
PMID:20659492 PMID:21515331 PMID:24706461 PMID:28988496 PMID:36174712 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53inp2 |
tumor protein p53 inducible nuclear protein 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TRP53INP2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:143,881,427...143,890,104
Ensembl chr 3:143,882,021...143,890,097
|
|
G |
Tp63 |
tumor protein p63 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TRP63 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
|
|
G |
Tpbgl |
trophoblast glycoprotein-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TPBGL mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:153,923,722...153,926,548
Ensembl chr 1:153,925,098...153,926,252
|
|
G |
Tpm1 |
tropomyosin 1 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of TPM1 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
|
|
G |
Tpo |
thyroid peroxidase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TPO protein |
CTD |
PMID:36005737 |
|
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
|
|
G |
Tpst2 |
tyrosylprotein sulfotransferase 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TPST2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr12:44,321,875...44,363,892
Ensembl chr12:44,321,875...44,362,329
|
|
G |
Trh |
thyrotropin releasing hormone |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TRH mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:124,742,111...124,777,094
Ensembl chr 4:124,742,111...124,744,637
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TRIB3 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TRIB3 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Trim54 |
tripartite motif-containing 54 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TRIM54 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 6:25,239,340...25,258,511
Ensembl chr 6:25,239,340...25,258,511
|
|
G |
Trim6 |
tripartite motif containing 6 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of TRIM6 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 1:158,683,746...158,696,936
Ensembl chr 1:158,683,746...158,696,914
|
|
G |
Trim72 |
tripartite motif containing 72 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TRIM72 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TRIM72 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:182,613,753...182,621,613
Ensembl chr 1:182,613,712...182,621,606
|
|
G |
Trim9 |
tripartite motif-containing 9 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TRIM9 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:88,756,824...88,856,588
Ensembl chr 6:88,757,303...88,856,542
|
|
G |
Triml1 |
tripartite motif family-like 1 |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TRIML1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TRIML1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:48,994,968...49,005,343
Ensembl chr16:48,997,252...49,005,417
|
|
G |
Triml2 |
tripartite motif family-like 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TRIML2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:48,944,712...48,960,949
Ensembl chr16:48,944,838...48,955,453
|
|
G |
Trit1 |
tRNA isopentenyltransferase 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TRIT1 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 5:135,293,472...135,341,522
Ensembl chr 5:135,295,330...135,338,764
|
|
G |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TRPC4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:138,307,676...138,476,856
Ensembl chr 2:138,308,084...138,476,768
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TRPC6 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TRPM3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:219,673,200...220,557,610
Ensembl chr 1:219,672,892...220,560,717
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TRPV1 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TRPV4 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr12:41,938,533...41,977,517
Ensembl chr12:41,938,560...41,977,517
|
|
G |
Tspan15 |
tetraspanin 15 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TSPAN15 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr20:30,130,528...30,174,912
Ensembl chr20:30,130,530...30,174,930
|
|
G |
Tspan32 |
tetraspanin 32 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TSPAN32 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TSPAN32 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:198,190,128...198,204,447
Ensembl chr 1:198,190,164...198,204,445
|
|
G |
Tspan6 |
tetraspanin 6 |
affects response to substance |
ISO |
TSPAN6 gene SNP affects the susceptibility to mono-(2-ethylhexyl)phthalate |
CTD |
PMID:25622337 |
|
NCBI chr X:97,092,394...97,099,659
Ensembl chr X:97,092,388...97,099,309
|
|
G |
Tspan8 |
tetraspanin 8 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TSPAN8 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:51,444,946...51,479,360
Ensembl chr 7:51,445,074...51,479,356
|
|
G |
Tspo |
translocator protein |
multiple interactions increases expression |
ISO |
[Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of TSPO mRNA mono-(2-ethylhexyl)phthalate results in increased expression of TSPO mRNA |
CTD |
PMID:27181934 |
|
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
|
|
G |
Tspoap1 |
TSPO associated protein 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TSPOAP1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:72,554,220...72,586,402
Ensembl chr10:72,560,980...72,586,412
|
|
G |
Tssc4 |
tumor suppressing subtransferable candidate 4 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TSSC4 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:198,251,986...198,254,810
Ensembl chr 1:198,235,487...198,254,980
|
|
G |
Ttll3 |
tubulin tyrosine ligase like 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TTLL3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:146,532,958...146,558,425
Ensembl chr 4:146,533,953...146,557,889
|
|
G |
Ttn |
titin |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TTN mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 3:61,652,432...61,924,912
Ensembl chr 3:61,652,439...61,924,741
|
|
G |
Ttpa |
alpha tocopherol transfer protein |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of TTPA mRNA |
CTD |
PMID:27167697 |
|
NCBI chr 5:33,497,537...33,518,936
Ensembl chr 5:33,497,137...33,518,073
|
|
G |
Ttyh2 |
tweety family member 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TTYH2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr10:99,709,063...99,753,449
Ensembl chr10:99,709,007...99,753,444
|
|
G |
Tuba3b |
tubulin, alpha 3B |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TUBA3B mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:178,588,779...178,594,328
Ensembl chr 4:178,588,779...178,594,326
|
|
G |
Tubb6 |
tubulin, beta 6 class V |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TUBB6 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418
|
|
G |
Tug1 |
taurine up-regulated 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of TUG1 mRNA |
CTD |
PMID:29385630 |
|
NCBI chr14:78,519,894...78,526,927
Ensembl chr14:78,522,506...78,526,927
|
|
G |
Txk |
TXK tyrosine kinase |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of TXK mRNA |
CTD |
PMID:16809437 |
|
NCBI chr14:35,463,369...35,519,448
Ensembl chr14:35,463,944...35,519,448
|
|
G |
Txndc2 |
thioredoxin domain containing 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of TXNDC2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 9:105,230,575...105,235,131
Ensembl chr 9:105,230,578...105,235,126
|
|
G |
Txnip |
thioredoxin interacting protein |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of TXNIP mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of TXNRD1 mRNA |
CTD |
PMID:23360888 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Uap1l1 |
UDP-N-acetylglucosamine pyrophosphorylase 1 like 1 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of UAP1L1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 3:8,172,335...8,180,505
Ensembl chr 3:8,173,216...8,180,443
|
|
G |
Ubap1l |
ubiquitin associated protein 1-like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of UBAP1L mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:65,877,488...65,897,593
Ensembl chr 8:65,884,729...65,897,593
|
|
G |
Ubash3b |
ubiquitin associated and SH3 domain containing, B |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of UBASH3B mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 8:41,385,419...41,532,248
Ensembl chr 8:41,388,341...41,532,201
|
|
G |
Ube2u |
ubiquitin conjugating enzyme E2 U |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of UBE2U mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 5:115,118,234...115,187,296
Ensembl chr 5:115,118,495...115,186,874
|
|
G |
Ubqlnl |
ubiquilin-like |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of UBQLNL mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:158,615,177...158,617,426
Ensembl chr 1:158,615,056...158,617,512
|
|
G |
Ucp1 |
uncoupling protein 1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of UCP1 mRNA |
CTD |
PMID:32522588 |
|
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
increases glucuronidation |
ISO |
UGT1A3 protein results in increased glucuronidation of mono-(2-ethylhexyl)phthalate |
CTD |
PMID:27071666 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of mono-(2-ethylhexyl)phthalate |
CTD |
PMID:27071666 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
increases glucuronidation |
ISO |
UGT2B7 protein results in increased glucuronidation of mono-(2-ethylhexyl)phthalate |
CTD |
PMID:27071666 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Ugt8 |
UDP glycosyltransferase 8 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of UGT8A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:214,264,483...214,332,769
Ensembl chr 2:214,264,483...214,332,660
|
|
G |
Ulk1 |
unc-51 like autophagy activating kinase 1 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ULK1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
|
|
G |
Unc13d |
unc-13 homolog D |
decreases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of UNC13D mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of UNC13D mRNA |
CTD |
PMID:22401849 PMID:36189433 |
|
NCBI chr10:101,296,755...101,311,513
Ensembl chr10:101,296,776...101,311,687
|
|
G |
Upf1 |
UPF1, RNA helicase and ATPase |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of UPF1 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr16:19,076,594...19,097,365
Ensembl chr16:19,076,322...19,096,568
|
|
G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of UQCR11 mRNA |
CTD |
PMID:27167697 |
|
NCBI chr 7:9,305,042...9,309,753
Ensembl chr 7:9,305,058...9,309,750
|
|
G |
Ush1c |
USH1 protein network component harmonin |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of USH1C mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 1:96,695,303...96,743,671
Ensembl chr 1:96,695,307...96,743,671
|
|
G |
Utf1 |
undifferentiated embryonic cell transcription factor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of UTF1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:194,740,339...194,741,465
Ensembl chr 1:194,740,339...194,741,465
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of VCAM1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vcl |
vinculin |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of VCL mRNA |
CTD |
PMID:22321834 |
|
NCBI chr15:3,265,776...3,355,586
Ensembl chr15:3,265,815...3,355,606
|
|
G |
Vdr |
vitamin D receptor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of VDR mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of VEGFA mRNA |
CTD |
PMID:36314267 PMID:36695872 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vegfd |
vascular endothelial growth factor D |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of VEGFD mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
|
|
G |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of VEPH1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of VEPH1 mRNA |
CTD |
PMID:36189433 PMID:36695872 |
|
NCBI chr 2:150,291,379...150,537,491
Ensembl chr 2:150,296,573...150,537,266
|
|
G |
Vgf |
VGF nerve growth factor inducible |
increases expression |
ISO EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of VGF mRNA |
CTD |
PMID:36695872 PMID:38113427 |
|
NCBI chr12:19,637,313...19,645,123
Ensembl chr12:19,637,320...19,640,341
|
|
G |
Vim |
vimentin |
decreases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in decreased expression of VIM mRNA |
CTD |
PMID:22087261 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Vipr1 |
vasoactive intestinal peptide receptor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of VIPR1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 8:121,303,739...121,339,587
Ensembl chr 8:121,310,248...121,339,585
|
|
G |
Vldlr |
very low density lipoprotein receptor |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of VLDLR mRNA |
CTD |
PMID:24356939 PMID:36314267 |
|
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
|
|
G |
Vsig1 |
V-set and immunoglobulin domain containing 1 |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of VSIG1 mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of VSIG1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:104,607,031...104,640,128
Ensembl chr X:104,607,031...104,639,249
|
|
G |
Vstm2a |
V-set and transmembrane domain containing 2A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of VSTM2A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:90,660,012...90,897,561
Ensembl chr14:90,660,004...90,685,656
|
|
G |
Vstm2l |
V-set and transmembrane domain containing 2 like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of VSTM2L mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:146,571,099...146,600,930
Ensembl chr 3:146,571,278...146,600,325
|
|
G |
Vsx2 |
visual system homeobox 2 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of VSX2 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 6:104,214,842...104,240,264
Ensembl chr 6:104,217,230...104,240,018
|
|
G |
Vwa3a |
von Willebrand factor A domain containing 3A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of VWA3A mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:175,293,782...175,355,588
Ensembl chr 1:175,293,873...175,355,602
|
|
G |
Vwf |
von Willebrand factor |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of VWF mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
|
|
G |
Vxn |
vexin |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of VXN mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of VXN mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 5:9,659,213...9,684,684
Ensembl chr 5:9,659,213...9,684,684
|
|
G |
Wbp2 |
WW domain binding protein 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of WBP2 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr10:101,312,476...101,320,775
Ensembl chr10:101,312,446...101,320,736
|
|
G |
Wbp2nl |
WBP2 N-terminal like |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of WBP2NL mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:113,814,793...113,831,974
Ensembl chr 7:113,814,992...113,831,333
|
|
G |
Wdr17 |
WD repeat domain 17 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of WDR17 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr16:37,059,923...37,191,125
Ensembl chr16:37,059,895...37,191,122
|
|
G |
Wdr25 |
WD repeat domain 25 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of WDR25 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 6:127,807,347...127,939,795
Ensembl chr 6:127,807,421...127,938,929
|
|
G |
Wdr6 |
WD repeat domain 6 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of WDR6 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 8:109,268,079...109,274,504
Ensembl chr 8:109,268,079...109,274,499
|
|
G |
Wdr64 |
WD repeat domain 64 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of WDR64 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr13:87,624,588...87,746,749
Ensembl chr13:87,624,607...87,747,327
|
|
G |
Wfdc10a |
WAP four-disulfide core domain 10A |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of WFDC10 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:153,390,067...153,391,420
Ensembl chr 3:153,390,067...153,391,420
|
|
G |
Wfdc18 |
WAP four-disulfide core domain 18 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of WFDC18 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:68,588,818...68,590,972
Ensembl chr10:68,588,818...68,589,671
|
|
G |
Wfdc2 |
WAP four-disulfide core domain 2 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of WFDC2 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:153,286,946...153,314,832
Ensembl chr 3:153,286,131...153,292,807
|
|
G |
Wfdc8 |
WAP four-disulfide core domain 8 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of WFDC8 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:153,323,503...153,339,849
Ensembl chr 3:153,324,413...153,339,842
|
|
G |
Wif1 |
Wnt inhibitory factor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of WIF1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 7:56,548,060...56,618,364
Ensembl chr 7:56,548,053...56,618,360
|
|
G |
Wnk2 |
WNK lysine deficient protein kinase 2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of WNK2 mRNA |
CTD |
PMID:22401849 |
|
NCBI chr17:15,503,672...15,612,479
Ensembl chr17:15,504,261...15,612,479
|
|
G |
Wnt10a |
Wnt family member 10A |
affects expression decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of WNT10A mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of WNT10A protein |
CTD |
PMID:37364752 |
|
NCBI chr 9:76,349,931...76,362,400
Ensembl chr 9:76,349,931...76,362,400
|
|
G |
Wnt3 |
Wnt family member 3 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of WNT3 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:88,680,198...88,724,170
Ensembl chr10:88,680,248...88,724,099
|
|
G |
Wnt4 |
Wnt family member 4 |
increases expression multiple interactions |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of WNT4 mRNA mono-(2-ethylhexyl)phthalate promotes the reaction [Tretinoin results in increased expression of WNT4 mRNA] [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of WNT4 mRNA |
CTD |
PMID:30476341 PMID:36189433 |
|
NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
|
|
G |
Wnt8a |
Wnt family member 8A |
affects expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of WNT8A mRNA [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of WNT8A mRNA |
CTD |
PMID:21195148 PMID:36189433 |
|
NCBI chr18:26,137,690...26,143,283
Ensembl chr18:26,137,690...26,143,283
|
|
G |
Wnt9a |
Wnt family member 9A |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of WNT9A protein |
CTD |
PMID:37364752 |
|
NCBI chr10:44,094,140...44,121,134
Ensembl chr10:44,094,140...44,121,133
|
|
G |
Wtap |
WT1 associated protein |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of WTAP mRNA |
CTD |
PMID:36174712 |
|
NCBI chr 1:47,665,965...47,691,067
Ensembl chr 1:47,665,965...47,691,065
|
|
G |
Xaf1 |
XIAP associated factor 1 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of XAF1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]; mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased localization of XBP1 protein alternative form; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form] |
CTD |
PMID:37692514 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Xkrx |
XK related, X-linked |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of XKRX mRNA |
CTD |
PMID:36189433 |
|
NCBI chr X:97,341,158...97,353,175
Ensembl chr X:97,341,152...97,354,759
|
|
G |
Yap1 |
Yes1 associated transcriptional regulator |
increases expression multiple interactions |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 mRNA IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 mRNA]; IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 protein]; LATS1 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased stability of YAP1 protein]; mono-(2-ethylhexyl)phthalate results in increased expression of and results in decreased phosphorylation of and results in increased activity of and affects the localization of and results in increased stability of YAP1 protein |
CTD |
PMID:31351048 |
|
NCBI chr 8:5,095,705...5,166,808
Ensembl chr 8:5,095,722...5,167,010
|
|
G |
Ythdc1 |
YTH N6-methyladenosine RNA binding protein C1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of YTHDC1 mRNA |
CTD |
PMID:36174712 |
|
NCBI chr14:21,185,438...21,215,934
Ensembl chr14:21,185,440...21,216,028
|
|
G |
Ythdc2 |
YTH N6-methyladenosine RNA binding protein C2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of YTHDC2 mRNA |
CTD |
PMID:36174712 |
|
NCBI chr18:37,266,559...37,331,681
Ensembl chr18:37,265,836...37,331,023
|
|
G |
Ythdf1 |
YTH N6-methyladenosine RNA binding protein F1 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of YTHDF1 mRNA |
CTD |
PMID:36174712 |
|
NCBI chr 3:168,024,660...168,040,172
Ensembl chr 3:168,024,663...168,040,172
|
|
G |
Ythdf2 |
YTH N6-methyladenosine RNA binding protein F2 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of YTHDF2 mRNA |
CTD |
PMID:36174712 |
|
NCBI chr 5:144,381,426...144,407,126
Ensembl chr 5:144,381,431...144,408,144
|
|
G |
Ythdf3 |
YTH N6-methyladenosine RNA binding protein F3 |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of YTHDF3 mRNA |
CTD |
PMID:36174712 |
|
NCBI chr 2:98,350,304...98,384,608
Ensembl chr 2:98,350,588...98,384,606
|
|
G |
Zan |
zonadhesin |
increases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ZAN mRNA |
CTD |
PMID:22401849 |
|
NCBI chr12:19,215,018...19,322,789
Ensembl chr12:19,215,102...19,271,240
|
|
G |
Zar1 |
zygote arrest 1 |
multiple interactions decreases expression |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ZAR1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of ZAR1 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr14:35,193,446...35,197,382
Ensembl chr14:35,193,446...35,197,382
|
|
G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
increases expression |
EXP ISO |
mono-(2-ethylhexyl)phthalate results in increased expression of ZBTB16 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of PLZF protein |
CTD |
PMID:16809437 PMID:37364752 |
|
NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011
|
|
G |
Zbtb7b |
zinc finger and BTB domain containing 7B |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ZBTB7B mRNA |
CTD |
PMID:36314267 |
|
NCBI chr 2:174,795,831...174,811,980
Ensembl chr 2:174,797,453...174,814,236
|
|
G |
Zbtb7c |
zinc finger and BTB domain containing 7C |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ZBTB7C mRNA |
CTD |
PMID:36189433 |
|
NCBI chr18:69,441,616...69,765,744
Ensembl chr18:69,441,616...69,765,297
|
|
G |
Zc3h12a |
zinc finger CCCH type containing 12A |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of ZC3H12A mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
|
|
G |
Zfat |
zinc finger and AT hook domain containing |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ZFAT mRNA |
CTD |
PMID:22401849 |
|
NCBI chr 7:99,886,954...100,054,288
Ensembl chr 7:99,886,954...100,054,274
|
|
G |
Zfp185 |
zinc finger protein 185 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of ZFP185 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr X:150,831,869...150,877,652
Ensembl chr X:150,831,862...150,874,810
|
|
G |
Zfp36 |
zinc finger protein 36 |
increases expression |
EXP |
mono-(2-ethylhexyl)phthalate results in increased expression of ZFP36 mRNA |
CTD |
PMID:16809437 |
|
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
|
|
G |
Zfp488 |
zinc finger protein 488 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ZFP488 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr16:9,283,039...9,293,681
Ensembl chr16:9,283,043...9,293,671
|
|
G |
Zfp771 |
zinc finger protein 771 |
affects expression |
ISO |
mono-(2-ethylhexyl)phthalate affects the expression of ZFP771 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 1:181,864,035...181,875,136
Ensembl chr 1:181,864,219...181,875,141
|
|
G |
Zfp831 |
zinc finger protein 831 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ZFP831 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 3:163,393,787...163,510,654
Ensembl chr 3:163,438,006...163,509,095
|
|
G |
Zg16 |
zymogen granule protein 16 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ZG16 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr 1:181,657,722...181,660,079
Ensembl chr 1:181,657,722...181,660,079
|
|
G |
Zic5 |
Zic family member 5 |
multiple interactions |
ISO |
[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ZIC5 mRNA |
CTD |
PMID:36189433 |
|
NCBI chr15:99,558,285...99,567,023
Ensembl chr15:99,560,323...99,567,035
|
|
G |
Zmynd10 |
zinc finger, MYND-type containing 10 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ZMYND10 mRNA |
CTD |
PMID:36695872 |
|
NCBI chr 8:108,220,386...108,224,745
Ensembl chr 8:108,220,386...108,224,744
|
|
G |
Zmynd15 |
zinc finger, MYND-type containing 15 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ZMYND15 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr10:55,171,198...55,177,812
Ensembl chr10:55,171,198...55,177,812
|
|
G |
Znf81 |
zinc finger protein 81 |
decreases expression |
ISO |
mono-(2-ethylhexyl)phthalate results in decreased expression of ZNF81 mRNA |
CTD |
PMID:36314267 |
|
NCBI chr X:1,030,103...1,126,078
Ensembl chr X:1,036,153...1,126,102
|
|